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 Summary 
INTRODUCTION: There are a number of aspects of the medical course which may make 
medical students more prone to mental health problems.  There is much evidence that 
suggests that medical students have high levels of common mental health problems, but 
research results are contradictory. This may be due to methodological differences.   Tools 
validated for other populations may not be suitable for use with medical students.  There is a 
need to accurately measure depression and anxiety in medical students to provide support.  
This study aimed to investigate the suitability of the Hospital Anxiety and Depression Scale 
(HADS) for measuring anxiety and depression in a medical student population by comparing 
HADS to a structured clinical interview.    
LITERATURE REVIEW: A review was carried out to review what tools have been used for 
measuring depression and anxiety in studies with students, medical students and the general 
population.   
METHODS: Medical students from Cardiff University were recruited.  Students completed 
HADS and undertook a clinical interview using the Schedules for Clinical Assessment in 
Neuropsychiatry (SCAN).  HADS data was compared to the SCAN data.  Sensitivity, and 
specificity for HADS were calculated and optimal cut-offs ascertained. HADS and SCAN 
individual item responses were compared. 
RESULTS: 50 medical students were recruited. Three (6%) students met the ICD-10 diagnostic 
criteria for depressive disorder and four (8%) reached the threshold for generalised anxiety 
disorder (GAD) as determined by SCAN. In comparison, eight (16%) students had a HADS-D 
score of 8+ and 25 (50%) students had a HADS-A score of 8+ (indicative of caseness).  A cut-off 
of 7 for HADS-D and 13 for HADS-A was calculated as more accurate in identifying ‘caseness’ 
within this population.  
CONCLUSIONS: HADS is an appropriate tool for a medical student cohort. The cut-off for 
‘caseness’ for both subscales should be reviewed due to interpretation of some HADS items.   
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Chapter 1: Introduction  
 
1.1 Mental health of university students 
 
The mental health of university students has been prominent in both the news and academic 
literature in recent years.  Some suggest that there is a mental health crisis in UK universities 
(mentalhealth.org).  One mental health organisation reported a large increase in the number 
of first year students reporting they had a mental health problem from 3000 students in 2006 
to 15,000 in 2015/16 (Yap 2018).  The head of the university’s regulator (Nicola Dandridge) is 
quoted by the evening standard newspaper as say it is “impossible not to be concerned” at the 
scale of anxiety and depression among students (Davies writing for evening standard Wed 
31Oct 2018).   
Academic studies have also regularly reported on the mental health of students. Many suggest 
that the prevalence of mental health problems in university students is significantly higher 
than in the general population (Stallman, 2010; Ibrahim et al 2013).    The peak onset for 
mental health problems falls before the age of 25 (Macaskill, 2012).  Roughly half of all lifetime 
mental disorders in most studies start by mid‐teens and three‐fourths by mid‐20s (Kessler et 
al, 2007).  For many students this is the time they are attending university.   
Some studies suggest that mental health of students may be no worse than the general 
population of similar age.  One study looking at the global public health challenge of the 
mental health of young people reviewed a range of academic papers looking at the mental 
health in young people (Patel et al, 2007). The study concluded that “one out of every four to 
five young people in the general population will suffer from at least one mental disorder in any 
given year”. 
Studies comparing student’s mental health with age-matched peers are more scarce and less 
definitive than those comparing to general population data.  Blanco et al (2008, cited in Royal 
College of Psychiatrists, 2011 report) found no difference in overall rates of psychiatric 
disorders compared to non-students.  A study looking closely at the type and severity of 
mental health problems suggested that tertiary students in Australia had a greater prevalence 
 2 
 
of moderate, but not high distress than non-students (Cvetkovski et al, 2012) (Tertiary 
education in Australia is any education a student receives after final compulsory schooling, 
including university).  This supported a previous study in Australia which suggested that 
tertiary students were four times more likely to be classified as psychologically distressed than 
age matched peers (Leahy, et al 2010).  
In the UK similar results are seen, the 2016 HEA student academic experience survey which 
compared student’s wellbeing to data from the Office for National Statistics, found that 43% of 
young people aged 20-24 rate themselves as having very low anxiety compared to only 21% of 
students (Neves & Hillman, 2016).  In addition, a report by the Royal College of Psychiatrists 
(2003) concluded that on balance British university students report more mental health 
symptoms than age-matched controls.  
Concern over the mental health of UK students has been affected by the increase in suicides 
reported across the UK in university students.  In an 18 months period prior to September 
2018, 11 Bristol University students had taken their own life (BBC news, 2018). The BBC also 
reports that according to statistics from Universities UK, 146 students had taken their own 
lives in 2016.    This is in contrast to reports by the Office of National Statistics (ONS) that 
between 2013 and 2016 higher education students in England and Wales had a significantly 
lower suicide rate compared with the general population of similar ages.   
 
1.2 Reasons for increased rates of mental health problems 
among university students  
Attending university is considered to be synonymous with exploring new ideas, having new 
experiences, meeting new people, and trying to find oneself (Rosenberg, 2018).  Others see 
university as a place where young adults, can ‘let their hair down’ for three (or more) years, 
drink, party and generally have a good time (Hirst, 2007).  Whilst for many this may be the 
case, there are many aspects of university which may put those that attend at higher risk of 
mental health problems.  
A number of possible reasons or risk factors for why students may be more likely to experience 
mental health problems have been suggested, including moving away from home, financial 
 3 
 
difficulties, social media, academic demands and worries about future careers.  These will be 
considered in more detail below. 
Many students move away from home to attend university and as such move away from what 
is often the stability of both family life and established friendships (RCP, 2011).  Student life 
may seemingly be based around socialising, however some students may find it difficult to 
make new friends and may feel isolated and lonely (RCP, 2011).   
In addition to the isolation that can accompany moving away from home, students may for the 
first time be faced with managing the practical and financial aspects of their life. Students 
today are faced with larger amounts of debt than previous generations (Johnson & Crenna-
Jennings, 2018).  Some of these debts are in the form of student loans which can be paid off 
alongside tax, once working.  Research has shown that students feel strained financially 
managing their day to day finances (Johnson & Crenna-Jennings, 2018)  A survey carried out by 
one UK bank (HSBC) found that one fifth of students spent all of their student loan within the 
first 100 days of receiving it, with the average student spending almost three fifths of their 
loan in this time period (Johnson & Crenna-Jennings, 2018).  The relationship between finances 
and mental health problems in students are complex.  Several studies (Cooke et al 2004; Ross 
et al 2006) have suggested that there is no significant correlation between levels of debt and 
mental wellbeing. Other have suggested that students reporting financial difficulties are more 
at risk of mental health problems (Eisenberg et al 2010).  Andrews and Wilding (2004) reported 
that financial difficulties can increase British students’ levels of anxiety and depression and can 
affect academic performance.  Others have suggested that it is worrying about finances that is 
linked to mental health problems rather than the level of financial difficulty or debt (Ross et al 
2006; Jessop et al 2005).   
Financial problems or worrying about one’s finances may encourage students into finding 
employment whilst at university (RCP 2011).  Whilst this might help with financial worries the 
time this takes up along with the additional stress of working can affect the mental health of 
students (RCP, 2011).  It is estimated that approximately 40% of students are employed 
alongside their studies (Robotham & Julian, 2006).  In this study two thirds of working students 
felt that it had affected their studies (Robotham & Julian, 2006).  In addition, one study found 
that poor mental health in British students was related to working long hours alongside 
studying (Roberts et al, 1999).   
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A relatively new risk factor affecting the mental health of students is social media, internet and 
technology use. Whilst this may also affect age matched peers some have suggested that 
students are particularly vulnerable to pathological internet use (Kandell, 2009).  A number of 
reasons are suggested for this vulnerability including, ready access to the internet and the 
expectation of computer and internet use (Kandell, 2009).  Students are expected to use the 
internet as a source of information for their research, to support their university education 
(downloading course notes, webinars etc) but also as a means of communication (Loan, 2011).  
Depression and anxiety have been found to be higher in groups of people with high 
smartphone use (Demirci et al, 2015). In addition, use of multiple social media platforms is 
associated with increased symptoms of depression and anxiety, even when the effects of 
excessive time spent of social media is controlled for (Primack et al, 2017).   Excessive use of 
social media and technology has been found to impair social interactions and increase feelings 
of isolation (Rosenberg, 2018). In students who may already be suffering from poor mental 
health due to isolation and loneliness, this may exacerbate these feelings.   
The final factors which might negatively affect student mental health are the academic 
demands of university and feeling the need to achieve high grades for future career prospects 
(Johnson & Crenna-Jennings, 2018).  In one survey 71 percent of respondents reported that 
‘performing well in tests and coursework’ caused them stress, and 65 percent felt stressed 
trying to keep up with their studies (Unite Students study, reported in Johnson & Crenna-
Jennings, 2018). In a 2016 YouGov poll 71 per cent of all respondents stated that university 
work was one their main causes of stress (Aronin & Smith, 2016).  Not only might students feel 
pressure from the amount of university work required of them but first year students in 
particular may have to adapt to different ways of leaning. Students are expected to carry out 
much more self-directed learning, than students may have experienced at school and as such 
students need to learn to manage their time effectively (RCP, 2011).   
Students may worry about their job prospects following university as the graduate job market 
is highly competitive and there are not as many graduate roles as there are graduates (Johnson 
& Crenna-Jennings, 2018). Having a degree is no longer a guarantee of a job (RCP, 2011).   In 
the 2016 YouGov poll cited previously, 77% of all respondents reported that they have a fear 
of failure, one in five of these students reported that this fear is ‘very prevalent’ in their day to 
day life. In addition, the second largest concern (after university work as cited above) for 
students who completed the poll was finding a job after university (Aronin & Smith, 2016).  
There is also added pressure on students to demonstrate to employers following graduation 
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that they also have experience of extra-curricular activities such as work experience and 
voluntary work (RCP, 2011).  Students therefore feel the need to complete these activities 
alongside their studies whilst at university.   
 
1.3 Mental health of medical students 
There is considerable evidence that medical students have high levels of common mental 
health disorders (Schneider et al, 1993; Firth-Cozens, 1987; Bellini et al, 2002).  In a recent 
study of 760 UK medical students at one medical school, 18% reported having received 
treatment for a mental health disorder (Korszun et al, 2012).  In a wider UK study carried out 
by the student British Medical Journal in 2016, of the 1,122 respondents, 30% (343) said they 
had experienced or received treatment for a mental health condition (Student BMJ, 2017).  
However, the research on mental health in medical students is at times contradictory.  This is 
not only in relation to the prevalence of mental health disorders but also how this varies for 
different groups such as year of training and gender.   
When considering the research around mental ill health and year of training there are 
differences across studies.  Dyrbye suggests the mental health of students deteriorates during 
training, (Dyrbye et al, 2005).   This is also reported in a German study where they found the 
prevalence of common mental health disorders in newly enrolled medical students were 
higher than reported in the general population, but lower than in medical students already 
studying for their medical training.  In contrast, some studies have suggested that first year 
medical students have the highest level of distress over all 5 years of study (Guthrie, 1998).  A 
more recent study also supports this finding stating that the ‘first few years’ are the most 
difficult with less mental health problems seen the longer the student is in education (Knipe et 
al 2018). 
There is also disparity between studies looking at levels of distress of medical students and the 
effect of gender.  Some studies suggest female medical students are more distressed than 
their male peers (Dyrbye et al, 2006).  Others suggest levels of distress are the same for both 
male and female medical students (Moffat et al, 2004; Niemi and Vainiomaki, 2006).  The 
current study aimed to look at depression and anxiety in medical students, these specific 
disorders will now be considered in turn.  
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1.3.1 Depression  
Depression is described as a common but serious mood disorder (NIMH, 2018). In England in 
2017/2018, 4.5 million adults had a diagnosis of depression, which accounted for around 10% 
of all adults registered with a GP (NICE, 2019).  The 2014 Adult Psychiatric Morbidity Survey 
2014 in England found 3.3% of general population respondents were identified as having 
depression (McManus et al, 2016).  Depression rates tend to be higher in women than men (in 
the 2014 study above 2.9% of men were identified as having depression compared to 3.7% in 
women).  Some studies have suggested prevalence rates are between 1.5 and 2.5 times higher 
in women than men (NICE, 2019).   
There are many definitions of depression but central to most is the presence of depressed 
mood and/or the loss of pleasure (Mian et al, 2014).  Whilst many individuals may experience 
low or depressed mood, this does not in itself mean that individual has depression.  
Depression is considered a syndromal disorder, Calvo et al (2003) define a syndrome as “a 
recognizable complex of symptoms and physical findings which indicate a specific condition for 
which a direct cause is not necessarily understood”.   
There are a wide variety of symptoms related to depression and as such depression can affect 
how you think and feel and can impact on an individual ability to carry out daily activities 
(NIMH, 2018).  Not all symptoms related to depression will be present in all cases.   For a 
clinical diagnosis of depression, the Diagnostic and Statistical Manual of Mental Disorders 
(DSM-V) requires that five out of nine symptoms need to be present (APA, 2013).  The 
International Classification of Diseases (ICD-10) classification system requires that four out of 
10 symptoms are present (WHO, 1992). For both systems these symptoms must include at 
least one of the following symptoms low mood, loss of interest or loss of energy to be present.  
The symptoms required for each classification system can be seen in table 1.  Both 
classification systems require that symptoms are present for at least two weeks and symptoms 
must have been present for a significant proportion of each day (APA, 2013: WHO, 1992) . The 
more symptoms that are present the more severe the episode of depression.  Whilst 4 
symptoms are required for a clinical diagnosis of depression (according to the ICD-10 
classification), the National Institute for Health and Care Excellence (NICE) in the UK recognise 
that depressive symptoms below the threshold for depression may still be distressing and 
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disabling (NICE, 2009).  As such the NICE guidelines for management of depression also covers 
'subthreshold depressive symptoms' (NICE, 2009).   
Table 1 DSM-IV and ICD-10 diagnostic criteria for depression  
DSM-IV Diagnostic criteria Depression  ICD-10 diagnostic criteria Depression  
The individual must be experiencing 
five or more symptoms during the 
same 2-week period and at least one of 
the symptoms should be either (1) 
depressed mood or (2) loss of interest 
or pleasure 
At least one of these, most days, most of 
the time for at least 2 weeks: 
▪ persistent sadness or low mood 
▪ loss of interests or pleasure 
▪ fatigue or low energy 
1. Depressed mood most of the day, 
nearly every day. 
2. Markedly diminished interest or 
pleasure in all, or almost all, activities 
most of the day, nearly every day. 
3. Significant weight loss when not 
dieting or weight gain, or decrease or 
increase in appetite nearly every day. 
4. A slowing down of thought and a 
reduction of physical movement 
(observable by others, not merely 
subjective feelings of restlessness or 
being slowed down). 
5. Fatigue or loss of energy nearly every 
day. 
6. Feelings of worthlessness or excessive 
or inappropriate guilt nearly every day. 
7. Diminished ability to think or 
concentrate, or indecisiveness, nearly 
every day. 
8. Recurrent thoughts of death, recurrent 
suicidal ideation without a specific 
plan, or a suicide attempt or a specific 
plan for committing suicide. 
 
Associated symptoms:  
▪ disturbed sleep  
▪ poor concentration or indecisiveness 
▪ low self-confidence 
▪ poor or increased appetite 
▪ suicidal thoughts or acts 
▪ agitation or slowing of movements 
▪ guilt or self-blame  
The above 10 symptoms then define the 
degree of depression and management is 
based on the particular degree  
o not depressed (fewer than four 
symptoms)  
o mild depression (four symptoms)  
o moderate depression (five to six 
symptoms)  
o severe depression (seven or more 
symptoms, with or without psychotic 
symptoms)  
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When considering the evidence around depression in medical students, a 2016 meta-analysis 
of studies suggested a global prevalence of depression amongst medical students of 28.0% 
(Puthran et al, 2016).  Another 2016 meta-analysis of the literature suggested on average, 
27.2% of medical students experience depression or depressive symptoms (Rotenstein et al 
2016).   The review included one hundred and ninety-five studies involving a total of 129 123 
individuals in 47 countries.  Across these studies, Rotenstien et al identified prevalence rates 
from 1.4% to 73.5%. Of the seven studies based in the UK, prevalence ranged from 4.4 % 
(Newbury-Birch et al, 2001) to 48.8%.  (Honney et al, 2010).  Possible reasons for these 
differences will be explored in Section 1.5 below. 
There are a number of studies that explore depression in relation to year of study. In their 
meta-analysis Rotenstein et al (2016) included nine longitudinal studies which assessed 
depressive symptoms before and during medical school.  Analysis of this data suggested an 
increase in symptoms of 13.5% from before to during medical school. Rosal et al (1997) found 
medical students begin university with similar rates of depression as their non-medical peers.  
However, as they progress through medical school medical students’ depression scores rise to 
a greater extent than their non-medical peers (Rosal et al, 1997).  In contrast, a meta-analysis 
of studies using standardised questionnaires suggested, students in their first year of medical 
school had the highest rates of depression (at 33.5%) (Puthran et al, 2016).  The meta-analysis 
also found rates of depression gradually decreased over the course of medical school, with 
rates of 20.5% at Year 5 (Puthran et al, 2016).  This is supported by Silva et al (2017) who 
carried out a longitudinal study at a medical school in Portugal and found that medical 
students’ scores on the Beck Depression Inventory (BDI) decreased during their time at 
medical school.  Nearly 20% of students in this longitudinal study reported high BDI scores 
which were sustained over time (Silva et al, 2017).   
In terms of gender differences some have suggested that female medical students are more 
depressed than their male counterparts (Goober et al, 2009).  In contrast, in one study looking 
at medical students in one UK university, no significant gender differences were seen between 
males and females in rates of transient or persistent depression (Quince, 2012). In addition, no 
differences were found in BDI scores of males and females in the longitudinal study cited 
above (Silva et al, 2017).  In one of the 2016 meta-analyses females were more likely to be 
depressed but the results were not statistically significant (Puthran et al, 2016).   
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1.3.2 Anxiety 
There are a number of anxiety disorders including generalised anxiety disorder (GAD), panic 
disorder, post-traumatic stress disorder, obsessive–compulsive disorder, social phobia, specific 
phobias and acute stress disorder (NICE, 2011).  Generalised anxiety disorder is defined by the 
ICD-10 as “Anxiety that is generalised and persistent but not restricted to, or even strongly 
predominating in, any particular environmental circumstances (i.e. it is "free-floating")” (WHO, 
1992).  NICE state that the key feature of GAD is “worry and apprehension that is out of 
proportion to the circumstances” (NICE, 2011).  The DSM classification also defines GAD as 
“excessive and difficult to control anxiety about several different events or activities” (APA, 
1994).  The American Psychological Association (APA) defines the symptoms of anxiety rather 
than the disorder itself. It defines anxiety as “an emotion characterized by apprehension and 
somatic symptoms of tension in which an individual anticipates impending danger, 
catastrophe, or misfortune” (APA, 2018). The APA describe how the body may react to the 
anticipated threat with muscles becoming tense, faster breathing, and increased heart rate 
(APA, 2018).   
There are a number of studies looking at prevalence of anxiety both nationally and 
internationally.  In the UK prevalence of anxiety in a 2010 sample of primary care patients was 
7.2% (Martin-Merino et al, 2010).   In 2013 it was estimated there were 8.2 million cases of 
anxiety in the UK (Fineberg et al, 2013).  The studies cited above, do not distinguish between 
types of anxiety disorder, but rather report on ‘anxiety’ in general.  Generalised anxiety 
disorder (GAD) was found to be the most common mental disorder in England in 2014 (Adult 
Psychiatric Morbidity Survey, 2014).  The survey found 5.9% of respondents were identified as 
having Generalised anxiety Disorder (McManus et al, 2016). 
Both the Martin-Marino study and the Adult Psychiatric Morbidity Survey identified more 
women as having GAD than men (6.8% compared to 4.9% in the Martin Marino study and 6.8% 
to 4.9% in the Adult Psychiatric Morbidity Survey).  In relation to age, prevalence was highest 
in those aged 45-54  (McManus et al, 2016).NICE also state that studies suggest GAD is less 
common in both older age groups (Over 55 years) and younger groups (Below 35 years).   
Whilst many individuals may experience feelings or symptoms of anxiety or worry, they may 
not fall within the diagnostic criteria for GAD. Commonly people talk about feeling anxious 
about events such as change in occupation or exams.  However, for a diagnosis of GAD, specific 
symptoms need to be present for a significant amount of time.  For example a diagnosis of 
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generalised anxiety disorder, the ICD-10 classification system requires prominent tension or 
worry to have been present for at least six months with at least four other symptoms (see 
table 2) to be present, of which at least one needs to be palpitations or pounding heart, 
sweating, trembling or shaking and dry mouth (WHO, 1992).  The DSM classification system 
requires excessive anxiety and worry to be present with at least three other symptoms (see 
table 2). Symptoms must have been present for at least six months and impair daily 
functioning.    In common with the self-report scales for depression, many self-report scales for 
anxiety provide a measure of symptoms experienced by the individual but are not designed to 
provide a diagnosis of an anxiety disorder.  
Table 2 DSM-IV and ICD-10 diagnostic criteria for Anxiety  
DSM Diagnostic criteria Anxiety ICD-10 diagnostic criteria Anxiety  
A. Excessive anxiety and worry 
(apprehensive expectation), occurring on 
more days than not for at least 6 months, 
about a number of events or activities 
(such as work or school performance) 
 
 
▪ A. A period of at least six months with 
prominent tension, worry and feelings of 
apprehension, about every-day events and 
problems 
The anxiety and worry are associated with 
three (or more) of the following six 
symptoms (with at least some symptoms 
present for more days than not for the 
past 6 months). Note that only one item is 
required in children  
1. Restlessness or feeling keyed up or on 
edge 
2. Being easily fatigued 
3. Difficulty concentrating or mind going 
blank 
4. Irritability 
5. Muscle tension 
6. sleep disturbance (difficulty falling or 
staying asleep, or restless unsatisfying 
sleep) 
 
At least four symptoms out of the following 
list of items must be present, of which at 
least one from items 1 to 4 
Autonomic arousal symptoms  
1. palpitations or pounding heart, or 
accelerated heart rate 
2. sweating 
3. trembling or shaking 
4. dry mouth (not owing to medication 
or dehydration) 
Symptoms concerning chest and abdomen  
• 5. difficulty breathing 
• 6. feeling of choking 
• 7. chest pain or discomfort 
• 8. nausea or abdominal distress (e.g. 
churning in stomach) 
Symptoms concerning brain and mind  
• 9. feeling dizzy, unsteady, faint or 
light-headed 
• 10. feelings that objects are unreal 
(derealisation), or that one’s self is 
 11 
 
distant or ‘not really here’ 
(depersonalisation) 
• 11. fear of losing control, going crazy 
or passing out 
• 12. fear of dying 
General symptoms  
• 13. hot flushes or cold chills 
• 14. numbness or tingling sensations 
 Symptoms of tension  
• 15. muscle tension, or aches and pains 
• 16. restlessness and inability to relax 
• 17. feeling keyed up, or on edge, or of 
mental tension 
• 18. a sensation of a lump in the throat, 
or difficulty with swallowing 
Other non-specific symptoms  
• 19. exaggerated response to minor 
surprises or being startled 
• 20. difficulty in concentrating, or mind 
going blank, because of worrying or 
anxiety 
• 21. persistent irritability 
• 22. difficulty getting to sleep because 
of worrying 
 
The focus of the anxiety and worry is not 
confined to features of an Axis I disorder 
The disorder does not meet the criteria for 
panic disorder, phobic anxiety disorders, 
obsessive–compulsive disorder or 
hypochondriacal disorder 
 
The literature that describes anxiety in medical students has some similarities to that of the 
literature around depression but is less extensive.  Dyrbye et al, in their 2006 review, 
highlighted that “few studies examined specific anxiety disorders such as generalised anxiety 
disorder in any formal way”. There are fewer studies reviewing or carrying out meta-analyses 
of studies looking at generalised anxiety in medical students (Hope & Henderson, 2014; Dyrbye 
et al, 2006) in comparison to those looking at depression (Puthran et al, 2016; Rotenstein et al, 
2016, Hope & Henderson, 2014; Dyrbye et al, 2006).   
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The prevalence of anxiety amongst medical students is described as being higher than the 
general population (Schneider 1993; Firth Cozens 1987 Kasha 2000; Bellini 2002). In a study of 
6658 medical students in Australia the prevalence of students who reported having a diagnosis 
of anxiety (including current diagnosis and if they have ever had a diagnosis) was higher than 
for the general population but similar to other students (BeyondBlue, 2013).  The prevalence 
of anxiety in the BeyondBlue study is low compared to others.   Hope and Henderson’s (2014) 
systematic review of studies looked at anxiety amongst medical students in Europe and 
‘English speaking countries outside North America’, they found that prevalence of anxiety 
ranged from 7.7.% to 65.5%.   
In relation to gender and anxiety amongst medical students, one study looking at medical 
students in Brazilian medical schools, found prevalence of state-anxiety was 81.7 % (Mayer et 
al, 2016).  Female students in the study were more likely to score highly for state anxiety but 
there was no difference in anxiety of students from different academic years (Mayer et al, 
2016). This is supported by the Beyond Blue study which found that 8.8% of female medical 
students in Australia who responded had a current diagnosis of anxiety compared to 5.2% of 
male medical students.   
 
1.3.3 Comparison with other students  
Some studies have compared the mental health of different groups of students, with some 
comparing medical students and other students.  A Brazilian study found a high prevalence of 
common mental disorders (CMD) among medical students (42.6%) compared to dental 
students (33.3%), nursing students (31.8%) and physical education students (25%) (Facundes & 
Ludermir, 2005).  A Norwegian study that compared medical students to law, mechanical 
engineering and psychology students  found a prevalence of  44%  for psychological distress in 
medical students   Prevalence of psychological distress among the other student groups were 
58%, 55% and 40% respectively, suggesting medical students had lower prevalence than both 
law and mechanical engineering students (Midtgaard et al 2008).   
A study in a London university compared levels of depression in medical and non-medical life 
sciences students (this included students studying social or pure science) (Honney et al, 2010).   
This study found that the non-medical students showed a higher prevalence of moderate and 
severe depressive symptoms than medical student peers but medical students reported more 
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symptoms of mild depression (Honney et al, 2010).   In their 2016 meta-analysis, Puthran et al 
found no significant difference in prevalences of depression between medical and non-medical 
students in the six studies included in their analysis.   
Two studies have compared the prevalence of depression and anxiety between medical and 
dental students. Knipe et al (2017) compared medical, dental and veterinary students. They 
suggested that there are similarities between these groups of students such as longer course 
duration, longer contact hours and exposure to potentially distressing clinical situations (Knipe 
et al, 2017).  Knipe et al’s study found that medical students had lower levels of moderate 
depression and anxiety compared to dental students.  There was no difference in depression 
and anxiety scores between medical and veterinary students.  Although veterinary students 
had lower levels of wellbeing (Knipe et al, 2018).  In this study prevalence of depression and 
anxiety for medical and dental students was higher in the first few years of study with this 
declining in later years of study (Knipe et al, 2018).  This differed from results from a 2002 
study comparing medical and dental students (Newbury Birch et al, 2002).  Newbury-Birch et al 
found that during the second year of the course a higher prevalence of dental students 
reached the HADS cut off for depressive symptoms (8+) 15% (dentistry) compared to (4%) 
medical students.  During the final year 14% of dental students reached the cut-off compared 
to 5% of medical students.   
For anxiety, 47% of both medical and dental students reached the cut-off for anxiety during 
their second year.  For medical student this decreased to 26% by their fifth year, but for dental 
students, prevalence increased to 67% in their fifth year, (Newbury-Birch et al, 2002).     
In summary, results of studies that looked at depression and anxiety amongst medical students 
and those that compared medical students with other students are mixed.  Depression studies 
suggest prevalences ranging from 1.4% to 73.5%.  In studies comparing medical students with 
other students, some suggest that medical students have similar rates of depression to other 
students, whereas others suggest that medical students have lower rates of depression.  
Similar results are found in relation to anxiety.  Anxiety prevalence in studies ranged from 
7.7.% to 65.5%. One study suggested no difference between medical and dental studies, with 
another suggesting higher rates of anxiety for dental students compared to medical students.   
These differences may reflect the different student groups to which medical students are 
being compared.  Alternatively, other methodological differences may affect the results such 
as the screening tool used, or the timing of the study (eg during exam time).   
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1.3.4.  Resilience 
A growing area of research in relation to mental health and wellbeing is that of resilience.  
‘Resilience is a measure of the ability to cope when faced with adversity’ (Houpy et al, 2017 
p1).  High levels of resilience are linked to higher levels of well-being.  Some studies have 
found that medical students are less resilient than the general population (Houpy et al, 2017; 
Rahimi et al, 2014).  Although Rahimi suggested that in their study it is possible that medical 
students’ lower levels of resilience reflects their higher levels of perceived stress.  It has been 
suggested that resilient medical students are less likely to experience depression (Dyrbye et al, 
2010).  One study found an association between medical students’ higher resilience scores and 
lower scores of anxiety and depression (Tempski et al, 2015).  Tempski et al suggest the 
relationship between resilience and anxiety and depression may be bi-directional; Resilience 
may protect against depression and anxiety symptoms but also an anxious or depressed 
person may be less able to use their coping skills.  Many medical schools now incorporate 
resilience into the medical curriculum (Eg Wright & Mynett, 2019).    
 
1.4 How medical students differ from other students 
Research described in section 1.3 above highlighted possible differences in the levels of mental 
health problems of medical students in comparison to other students.  This section will 
consider ways in which medical students may differ from some other students.  There are a 
number of areas in which differences might occur. One area could relate to the length of the 
course particularly the contrast to those students studying 3-year non-vocational degrees 
which generally have less contact hours than medical students. Section 1.2 highlighted the 
issues facing students in general which may make them more prone to mental health problems 
compared to their peers who do not attend university. These issues included moving away 
from home, financial difficulties, social media, academic demands and worries about future 
careers.  Whilst these issues also affect medical students, there are also a number of other 
factors which medical students face which may affect their mental health.  Some of these 
factors are linked to those discussed above, there are also factors unique to studying medicine 
which may cause medical students additional mental health problems such as exposure to 
death and human suffering.  Factors which will be considered include isolation, financial 
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difficulties, academic demands, career worries, personality, ethical conflicts, role models and 
stigma and support.   
As discussed in section 1.2 above, for many students going to university means moving away 
from their family home and established friends.  This is also the case for medical students, 
many of which move away from home to attend medical school. However, some aspects 
relating to the course may exacerbate feelings of homesickness or loneliness.  In particular, the 
lack of available free time and the shorter holidays.  Lee and Graham (2001) state that “During 
their first year of training, medical students may have marked lifestyle changes such as 
diminished leisure and recreational activity, decreased physical activity and sleep deprivation, 
which can result in a general decrease in physical health and emotional wellbeing” (Lee & 
Graham, 2001, p. 652) The long course contact hours for medical students allow for less time 
to explore leisure activities or join clubs, where new friendships might be formed.  Shorter 
holidays make visiting family and established friendships back home more difficult and less 
frequent.   In addition to the greater number of contact hours at medical school, medical 
students are also expected to attend placements which may mean they have to move to 
different locations for several weeks, taking them away from university friends.  These factors 
may mean there is less time for personal interests and socialising (Yiu, 2005; Holm et al, 2010) 
and may lead to medical students feeling a greater sense of isolation and loneliness.   
 
In addition to potentially contributing to a sense of isolation, long contact hours and attending 
placements may also have a financial implication for medical students (GMC, 2013).   The long 
contact hours and the need for additional studying outside of these hours impact on the 
students’ ability to supplement their income. Attending placements away from their main 
residence may make any type of employment impossible. The financial burden is considerably 
higher for medical students undertaking a 5 year course in comparison to many standard 
university courses which are often only three years.  Some have suggested that this leads to 
many medical students facing significant financial debt (Dyrbye et al, 2005), One UK study 
suggested that if a medical student graduating in 2014 had accepted all student loan and 
maintenance loans available, they could amass debts of £82,000 when they leave medical 
school (Ercolani et al, 2015).  This is compared to students in England studying for a standard 
degree whose debt was predicted to be about £59,000 for students who started in 2012 
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(Richardson & Roberts, 2015).  As stated in section 1.2, financial difficulties and in particular 
worrying about financial difficulties can negatively affect mental health.   
Therefore, the length of the course and the need to attend placements may increase the 
financial burden on medical students and may affect medical student’s mental health and their 
performance at medical school (Ross et al, 2006).   
The academic demands of university can also put a strain on students and for courses which 
may be seen as more academically challenging this strain may be greater. The academic nature 
of medical school training is intense (Yiu, 2005).  Medical students are required to learn, retain 
and recall a wealth of knowledge (Holm et al, 2010, Mahajan, 2010).    Malik (2000) suggests 
that much of medical students’ stress is course related suggesting common problems include 
workload, fear of falling behind and exam failure worries.  In addition to the academic nature 
of the course, medical students are required to be seen as competent doctors/clinicians 
(Chew-Graham et al, 2003) and to uphold the ethics and standards required of a doctor (GMC 
2016).  Medical school also has a competitive nature, students feel the pressure to not only 
pass the course but to be seen as one of the top in the class, their peers being those whom 
they will most likely be up against in the future for jobs (Mahajan 2010).  This may be 
compounded by the shift in position compared to current peers; many medical students are 
likely to have been top in their class at school, in comparison at university they may be average 
or even below average, this in itself may cause stress and anxiety (Dunn et al, 2008).  Holm et 
al (2010) suggest that students may be left feeling anonymous and isolated by the competitive 
nature of the medical course, particularly if the medical school environment is also seen as 
rigid and authoritarian.   
 
The need to be seen as a competent clinician and to be thriving compared to peers is also 
linked to the nature of personal tutors, supervisors, lecturers and other medical school staff.  
These staff may become the people who may be involved in the employment or career 
progression of students in the future (Chew-Graham et al, 2003).  This not only increases the 
pressure of ‘wanting to be seen as having the potential to be a great doctor’ but can also 
increase the worry about admitting that you may be struggling. This along with concerns such 
as stigma, insufficient time to attend appointments (Dunn et al), service issues (long waiting 
lists, access issues, scheduling problems (Stecker 2004)), lack of awareness of the service (BMA 
2019; Stecker, 2004), and confidentiality concerns (Hillis et al , 2010) may prevent medical 
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students from seeking support early.  One study suggests that less than a quarter of first and 
second year medical students who were depressed have used mental health services (Hillis et 
al, 2010). Seeking support early for mental health problems is beneficial as it may improve the 
prognosis of the mental health problem and can reduce the risk of it becoming a chronic 
condition or leading to more severe disorders (Mitchel et al, 2017). As such some have 
suggested that many medical students may not feel comfortable receiving support from their 
own medical school and may prefer to seek help elsewhere (Dyrbye et al, 2005).   
 
Some have suggested that the personality of medical students may put them at greater risk of 
mental health problems.  Historically research has focused on individual personality traits 
(Firth-Cozens et al, (1999), which may predispose medical students to mental health problems, 
such as neuroticism (Mokros et al, 2017). More recent research has suggested that the 
relationship between personality and wellbeing in medical students is more complex and it is 
the combinations of personality traits along with circumstances which may predispose an 
individual to mental health problems (Eley et al, 2016).   Combinations suggested have 
included high neuroticism and high conscientiousness as traits considered to put medical 
students at high risk of stress (Tyssen at al, 2007).   Henning et al (2002) found strong 
associations between current psychological distress, perfectionism and impostor syndrome. 
Other studies have suggested that personality factors which relate to work are more important 
than broad personality types (Chow et al, 2018). Chow et al suggested that students who score 
high on the ‘work-related personality Stability factor’ may be less likely to develop depressive 
symptoms and suicidal ideation (Chow et al, 2018). Chow et al suggested that the students 
with this ‘stability factor’ may be more resilient either naturally or by having developed a 
resilient mindset or attitude.   The Chow study also found that medical students who scored 
high on the dominance factor were more likely to develop depression, possibly because they 
may experience more interpersonal problems due to being more likely to be argumentative 
and confrontational (Chow et al, 2018). Whilst these personality factors may affect medical 
students’ mental health, it is unclear whether these personality factors are more prevalent in 
medical students than other students.  
Eley et al suggest that two main personality types of medical students can be found and that 
the link between personality and mental health is linked to the resilience of the different 
personality types.   The two types are described as: 
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“Students with personality Profile 1 are described as resilient because they combine being 
vigorous (high in Persistence and low in Harm Avoidance), industrious (high in both Persistence 
and Self-Directedness), and versatile (high in Self-Directedness and low in Harm Avoidance).  
Students with personality Profile 2 are referred to as conscientious and may be more anxious 
and less resilient than those with the resilient Profile 1, but both profiles are more mature, 
responsible, and well-organized than the average person in the general population.” 
Other factors which may affect the research looking at personality and mental health include 
differences seen in personality types of different genders (Scott et al, 2007), and also the 
suggestion that the personality of medical students is changing over different generations of 
students (Twenge, 2009).  Consequently, results from research looking at links between 
personality types and mental health problems in medical students, may change over time, 
along with the different generations of students.  
In summary, the personality of medical students and its relation to mental health problems is 
complex.  Although there is some evidence to suggest that some aspects of personalities often 
seen in medical students such as high conscientiousness which may predispose students to 
greater risk of mental health problems.   
 
One aspect of the medical school course which greatly differs from most students’ university 
experience is the ethical conflicts, death and human suffering which medical students are 
exposed to (Mahajan, 2010; Tyssen et al, 2000).  The British Medical Association (BMA) claim 
that medical students often find themselves in traumatic clinical situations that they may be 
unprepared for (BMA, 2018).  One study found that in one UK university 72% of final year 
medical students surveyed had been involved in end-of-life care at some point during their 
course (Jones and Finlay, 2013).  For some students this had taken part overseas during their 
elective period.  The students questioned reported feeling shocked, upset and sad over the 
deaths in the UK.  Some students who witnessed deaths overseas reported feeling angry or 
frustrated.  Only 13% of the students surveyed thought that their medical training had 
prepared them to deal with death (Jones and Finlay, 2013).   
For some students exposure to death at medical school may be their first experience of death 
and that can leave them feeling sad and shocked.  Some students may feel guilty or that they 
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should have done more for the patient (BMA, 2018).  For others who have experienced the 
death of a family member or friend, treating or managing dying patients and their families may 
remind them of their own previous experiences, intensifying emotions and bringing back 
previous trauma (Whyte et al, 2013).   
In terms of ethical dilemmas, a recent study (Monrouxe et al, 2015) suggests that medical 
students and other healthcare students frequently encounter ethical or moral dilemmas.  For 
some students, particularly female students these dilemmas cause them distress (Monrouxe et 
al, 2015).  Monrouxe et al suggest the most common professional dilemmas encountered were 
student abuse, patient dignity and safety dilemmas.   Dyrbye et al suggest that along with the 
formal curriculum of medical school there is an informal or hidden curriculum, based on what 
medical students see doctors doing rather than what they teach (Dyrbye et al, 2005).  This 
informal curriculum can cause ethical dilemmas for students contradicting lessons from the 
formal curriculum and can cause medical students distress (Dyrbye et al, 2005).  Dyrbye 
suggests ethical challenges from the informal curriculum includes ‘demands to write notes 
about patients not personally examined and a dehumanised approach to patients’ (Dyrbye et 
al, 2005 p1615).   
The informal or hidden curriculum can also teach medical students unhealthy behaviours in 
relation to managing their own mental health with some tutors and supervisors providing poor 
role models (Cohen et al 2015).  Some doctors self-manage, prescribing for themselves whilst 
delaying getting external help (Cohen et al, 2015).  Hooper et al (2005) claim self- management 
of illness is learnt early in a medical students career having seen others doing the same.  Other 
have suggested that coping mechanisms learnt at medical school affect students’ long-term 
health, either positively or negatively (Hillis et al, 2010). The hidden curriculum message of the 
need to self-manages illness rather than seeking external support only serves to reinforce the 
view that if you are suffering you must hide it so as not to be seen as weak (Dyrbye & 
Shanafelt, 2011).  This supports the idea that there is a stigma in relation to mental health 
problems which may prevent medical student seeking help early (Dyrbye & Shanafelt, 2011).   
In summary, there are many different aspects which relate to the medical course which may 
impact on medical students’ mental health, over and above the factors which relate to many 
other university students.  The extent to which these affect medical students is not fully 
understood.  In order to understand the effect of these on the mental health of medical 
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students, researchers must be able to accurately measure prevalence of common mental 
health problems such as depression and anxiety in medical students.   
 
1.5 Measuring depression and anxiety in medical students 
As highlighted in section 1.3 the prevalence of mental health problems amongst medical 
students varies in different studies.  A number of reasons have been suggested for this, ranging 
from differences in the characteristics of the samples being tested to differences in aspects 
relating to the methodology used in the studies (Dyrbye, et al, 2006).  These will be considered 
in turn.   
 
1.5.1 Differences in sample characteristics 
Section 1.3 has already highlighted some of the factors which could affect the prevalence of 
mental health problems in medical student studies including gender and year of study.  For 
example, if females experience more depression or anxiety (or are more likely to report having 
these symptoms), then the gender balance of the sample being tested may affect the results 
seen.  Other differences in the specific samples used in studies which might affect prevalence, 
include the medical school which students attend and the age of students.   
A recent study suggests that the prevalence of depression in medical students varies by 
different university and different countries (Gan & Hue, 2019).  Prevalence of depression and 
anxiety in the general population varies across different countries.  One study looking at 
depression across 30 different countries suggested that prevalence of depression was highest 
in countries with a medium human development index (HDI) (Lim et al, 2018). The HDI is 
described as “a tool developed by the United Nations to measure and rank countries' levels of 
social and economic development” (Kenton, 2018).    Lim et al suggested that people living in 
medium HDI countries may have more stressors such as higher cost of living and higher 
expectations and this may affect their mental health (Lim et al, 2018).  It is also likely then that 
medical students attending medical schools in these different countries may also have a higher 
prevalence of depression and other mental health problems.   
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In relation to the differences in universities or medical schools.  Different universities carry out 
their medical training in different way which may have an impact on the mental health of 
students.  For example, some studies have found that medical students report less stress when 
clinical time is increased (Reed et al, 2011). Other medical schools use small group learning, as 
it encourages students to work collaboratively with their peers which can reduce isolation, 
encourage sharing of problems and reduce competition between medical students (Holm et al; 
Kiessling et al, 2004).  One medical school in the US has made extensive changes to their 
medical course such as changing contact hours, scheduling, grading, electives, learning 
communities, and making resilience/mindfulness compulsory (Slavin et al, 2014).  These 
changes were made as the medical school had identified that they were associated with 
significantly lower levels of depression symptoms, anxiety symptoms, and stress (Slavin et al, 
2014).  Other have also suggested that wellbeing programmes should be compulsory for 
medical students as they are associated with lower reported levels of stress and anxiety, and a 
higher tolerance of distress (Greeson et al 2015).  Therefore, students from medical schools 
where some of these interventions and changes have been made may experience less mental 
health problems. As such studies using these medical students may report lower prevalence of 
mental health problems.  In addition, medical schools around the world differ in terms of the 
hidden curriculum as described in section 1.4. The level of stigma students feel about mental 
health problems may affect what they are prepared to disclose (Dyrbye, et al, 2006).   
Dyrbye, et al (2006) suggested that in addition to the location of the students included in 
studies, prevalence can be affected by the age of medical students and the stage of medical 
training.  Section 1.3 highlighted the differences in mental health of medical students as they 
progress through the course, although results from this area of study are mixed. In relation to 
age, some have suggested that older students may not necessarily suffer from fewer mental 
health problems.  One study researching anxiety and stress amongst graduate entry students 
suggested that “anxiety and stress were higher, not lower, with increasing age” (Casey et al, 
2016).  Therefore, whilst age and year of study may affect the prevalence found in studies, the 
effects are not clear.   
Whilst differences between study samples are inevitable and can make comparisons difficult. 
Some differences, such as age or year of study may be more easily quantified and incorporated 
into analysis.  The effect of medical school or country is more likely to be difficult to quantify as 
most studies are only based in one medical school or one country.  
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1.5.2 Differences in methodology 
Prevalence rates may be influenced by study methodology as well as subject characteristics 
(Dyrbye, et al, 2006).  Some have suggested that this may be the result of the different 
instruments used (Chow et al, 2018).  A vast number of instruments are available for 
measuring depression and anxiety in the general population and in student populations, a 
review of these is outlined in section 2.  These tools vary in terms of whether they are self-
report or clinician lead tools.   Tools also vary in terms of sensitivity and specificity for 
diagnosing or screening depression and anxiety (Rotenstein et al, 2016).  For an explanation of 
sensitivity and specificity see section 3.1.6.4. Not all tools used to measure depression and 
anxiety have been validated for use with different groups.  
The most commonly used method to measure depression and/or anxiety in research studies is 
via self-report tools.  Self-report tools are more time and cost effective than tools which 
require a clinician or researcher to administer (Anderson et al 2002).  Self-report tools vary on 
a number of factors, some of these are described in the literature review (see chapter 2).  One 
way in which self-report tools can vary is the point of cut-off for determining caseness.  
Caesness being defined as ’the probably presence of the disorder’. Cut off scores for 
depression and/or anxiety scales are generally determined by comparing scale scores to a 
standard, such a clinical interview.  Participants are asked to complete both the scale and the 
standard.  The standard identifies those participants who reach diagnostic levels of the 
disorder under consideration. The scale scores of those with and without the disorder are then 
compared.  Sensitivity and specificity scores can then be calculated for different cut-off scores 
for the scale.  Sensitivity is the ability of a test to correctly identify positives whereas specificity 
is the ability of a test to correctly identify negatives (Parikh, et al, 2008).  The cut-off score 
which gives optimum balance of sensitivity and specificity is the cut-off score chosen.  
Different groups may require slightly different cut-off points to achieve the optimum 
sensitivity/specificity balance. For some groups the optimum cut off points might not have 
been explored.   
An example of how cut-off scores may affect the prevalence of different studies can be seen 
with the use of the Beck Depression Inventory version 2 (BDI-II).  The BDI-II does not have cut-
off scores which are suitable for all purposes (Smarr & Keefer, 2011).  However, it has been 
suggested that scores of 14–19 suggest mild depression, 20–28 for moderate depression, and 
29–63 severe depression (Smarr & Keefer, 2011).  Some studies with different groups have 
suggested different cut off scores, for example in a study looking at cardiac outpatients it was 
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suggested that the optimum cut off score was 10 for the total sample but for women 13 would 
achieve better sensitivity and specificity (Moullec et al, 2014).  In Rotenstien et al’s (2016) 
meta-analysis of studies looking at depression in medical students 9 studies used the BDI-II.  In 
these 9 studies, 5 different cut-off scores were used (10, 14, 17, 20, 21).  Whilst these may 
reflect differences in the BDI-II used in different countries the differences make it difficult to 
compare results across these studies. The cut-off of 10 was used with Israeli medical students 
(Lupo & Strous, 2011) and the 21 with US medical students (Chandavarkar et al, 2007). As such 
comparing prevalence rates across studies which have used different cut-off points is difficult 
and may explain some of the differences in prevalence seen in studies looking at the mental 
health of medical students. One way to ensure that studies are more comparable 
methodologically is to ensure that instruments used are validated with appropriate cut-off 
points for the sample being tested.   
 
1.5.3 The need to validate self-report tools for use with medical students 
It has been highlighted above that different groups sometimes require different cut-off scores 
for determining possible cases of depression or anxiety when using self-report tools. In the 
example in section 1.5.2 different cut off scores were suggested for patients attending a 
cardiac outpatient clinic.  Possible reasons in this case may be that the physical symptoms 
related to heart related conditions may also be linked to physical symptoms which might relate 
to depression, for example tiredness and difficulty sleeping.   
Other groups have been seen to require different cut-off scores which do not relate to physical 
symptoms, but which relate to the interpretation of some of the items which are used in self-
report tools. In some cases, these are linked to cultural factors when the tools are used in 
different countries (Kerr & Kerr, 2001).  Kerr and Kerr (2001) suggest that when translated into 
some different languages the BDI has limited predictive power and validity due to cultural 
factors.  Kerr and Kerr cite the example of Latino populations who have a strong work ethic 
often taking several jobs to support themselves and their families.  This strong work ethic 
linked with a high stigma associated with mental health problems in this population, lead to 
this group scoring very low on many items including one item in the BDI which asks about an 
individual’s ability to work.  The idea of cultural aspects affecting the validity of self-report 
tools due to interpretation of items is supported by a systematic review of validated screening 
tools for common mental disorders in low and middle income countries (Ali et al, 2016).  The 
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review highlighted that although common mental disorders are prevalent around the world, 
how they present clinically varies.  This affects the use of some tools and in some cases 
optimum cut-off points differ for different countries and cultures (Ali et al, 2016).  Because of 
this, Ali et al recommended that local validation of tools should be carried out, comparing the 
screening tool against a gold standard diagnostic interview.  This validation can also determine 
optimum cut-off scores for the population in question.   
This effect of culture on interpretation of self-report items may also apply to medical students.  
Section 1.4 highlighted the differences seen in medical students compared to some other 
students.  These differences included some personality traits often seen in medical students 
such as conscientiousness.  Section 1.4 also highlighted the difficulties medical students may 
have in admitting they are struggling.  Many students fail to seek support due to the hidden 
curriculum (Dyrbye & Shanafelt, 2011) and the fact that educational tutors and supervisors 
may be the same people who could be involved in their future recruitment or career choices.   
These factors may create a culture amongst medical students which differs from other student 
cultures.  In contrast the culture may be similar to some of the cultures seen in different 
countries where there is a very strong work ethic and stigma associated with mental health 
problems (Ali et al, 2016). Therefore, it is possible that tools which have been validated for 
students in general, with optimum cut-off scores identified, may not be appropriate for 
medical students.  As such, it is suggested that, as advised by Ali et al above, local validation of 
screening tools against a diagnostic interview should be carried out prior to tools being used 
for medical students.   
 
1.6 The need for accurate measurement of depression and 
anxiety in medical students 
Accurately measuring depression and anxiety in medical students is important for identifying 
and supporting students who may require help.  A number of consequences of poor mental 
health amongst medical student have been suggested including impaired academic 
performance, academic dishonesty, substance abuse and suicide (Dyrbye et al, 2005).  It is 
therefore important that medical students who require support are identified and provided 
with the help they require.  As such in 2013 (and updated in 2015) the General Medical Council 
(GMC) in the UK issued guidance for medical schools on supporting medical students with 
mental health conditions. In the guidance the GMC states  
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“A supportive environment in which medical schools openly discuss mental health conditions 
will help students feel happy to ask for support. However, not all students will recognise that 
they have a mental health condition, so schools need processes to identify students who are 
struggling with the course and might need support.”    (GMC, 2015, p36) 
The GMC suggests factors such as a drop in academic performance or non-attendance at 
lectures might indicate developing mental ill health. An alternative would be to screen medical 
students to individually identify students in need, or surveying all students to provide 
information for planning of support.   
 
 1.6.1 Screening to identify those in need of support 
Screening for mental health problems is a contentious issue.  Some have suggested that the 
high prevalence of mental health problems in medical students, along with the potentially fatal 
consequences of not receiving treatment for serious mental health problems, warrants 
screening (Dyrbye et al , 2013).  Others have suggested that screening is not effective and can 
cause other problems (Gilbody et al, 2006). 
The reluctance of medical students to seek support and treatment for mental health problems 
drives the view by some that screening is important.  Some have suggested this increases the 
responsibility of medical schools to identify students who may need help (Silva et al, 2017).  As 
such some advocate the screening of medical students (Dyrbye et al, 2013, Goebert et al, 
2009).  Screening is often seen as a relatively cost and time efficient method of identifying 
students who may be in need.  One study found that having an actual diagnosis of depression 
improves the likelihood of treatment and therefore suggested periodic mental health 
screening of medical students (Tija et al, 2005).  Some have suggested for screening to be 
effective a number of requirements should be fulfilled including amongst others that the 
condition is common in the screened population, that effective interventions should be 
available, that screening results in the condition being recognised early and that the tool used 
must have high specificity and very high sensitivity (Willacy, 2019).   
 
In contrast others claim that screening is not effective and therefore of no use.  A 2005 
Cochrane review found that routine screening for depression had little effect on its detection, 
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management or outcome and as such suggested that it should not be carried out to improve 
the quality of healthcare (Gilbody et al,  2006).  A 2010 report by the National Institute for 
Health and Clinical Excellence (NICE) highlighted that there was a lack of evidence to support 
depression screening in general (NICE, 2010).  Others have acknowledged that screening for 
depression can identify individuals who might otherwise go undetected but have highlighted 
that it could also lead to other issues such as misdiagnosis and over diagnosis (Thombs et al, 
2011).  In the case of medical students, misdiagnosis or over diagnosis (where individuals with 
a mild form of mental health problem are identified as suffering more severe mental health 
problems) could result in labelling and issues related to stigmatisation which could cause 
medical students additional stress, as identified previously.  
 
 1.6.2 Planning for support  
In addition to screening, another possible reason why medical schools or research studies may 
wish to accurately measure levels of depression or anxiety is to assist with planning for support 
and treatment of these mental health problems. It is clear that medical schools have a 
responsibility to support their medical students’ mental health needs, both in terms of 
prevention and in treatment (GMC, 2015). In order for medical schools to plan this support it is 
important that they have reliable estimates of prevalence of mental health problems within 
their student body (Rotenstein et al, 2016).  Reliable estimates ensure that sufficient funding is 
in place to provide sufficient amounts of support that may be required.  As highlighted in 
section 1.3 current estimates of mental health problems vary considerably in the different 
studies, and therefore do not assist medical schools in planning for support.  Medical schools 
may therefore wish to anonymously survey their students to determine prevalence within 
their specific sample.  To ensure this is as accurate as possible, tools validated for use and 
appropriate cut-off points for medical students need to be determined.   
 
 
1.7 HADS and its use in screening Medical Students  
The current study therefore aims to validate one commonly used tool for identifying or 
screening for depression and or anxiety with a medical student sample.  Hope and Henderson 
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(2014) conducted a systematic review of articles looking at depression and anxiety in medical 
students.  The most commonly used tools for identifying depression were the Beck Depression 
Inventory (BDI) (used in 4 studies) and the Hospital Anxiety and Depression Scale (HADS) (used 
in 3 studies).  Similarly, for anxiety the most commonly used scales were HADS (used in 3 
studies) and the Beck Anxiety Inventory (BAI) (used in 1 study).    HADS was therefore one 
widely used scale in the studies reviewed.    
HADS was developed to identify caseness of anxiety and depressive symptoms in non-
psychiatric settings (Zigmond & Snaith, 2015). Caseness being defined as ‘probable presence of 
the mood disorder’.  HADS is a brief, easy to use screening tool which can be used to detect 
depression and anxiety separately or together as a measure of psychological distress (Julian, 
2011).  HADS has been criticised for reduced validity with some populations (Bjelland et al, 
2002).  
An important area related to validity of HADS is the cut-off scores used to determine caseness.  
The original authors of the instrument proposed cut-off scores between 8 and 10 for ‘possible’ 
cases, and scores of 11 or more for ‘probable’ cases in both the anxiety and depression scales 
(Zigmond & Snaith, 2015)  
Since the publication of the original scale many studies have reviewed the cut-off scores which 
give the greatest sensitivity and specificity for detecting clinical cases of anxiety or depression 
symptoms (Mitchell et al, 2010). In a literature review looking at the validity of HADS, cut off 
points ranged from 3+ to 11+ for anxiety and 4+ to 11+ for depression (Bjelland et al, 2002). 
Kendrick et al (2009) suggested that a cut-off point of 9+ is appropriate for GPs to use to 
diagnose depression within the UK.   
As highlighted in the discussion of tools in general in section 1.5 above, this disparity in 
optimum cut-offs between studies may be due to methodological differences such as the 
instrument or interview to which the tool is being compared, alternatively it may also be due 
to characteristics which are inherent in the sample being tested.  Different groups may require 
slightly different cut-off points to achieve the optimum sensitivity/specificity balance when 
compared to a clinical diagnostic interview. It is therefore important that tools are validated 
with the population in question and optimal cut-off scores should be determined.   
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1.8 Andrews et al’s 2006 study.   
The author is not aware of any studies comparing HADS to a clinical diagnostic interview with a 
medical student sample for the purpose of validation and determining optimal cut-off scores.  
One study has compared HADS to a clinical interview with a general student sample (Andrews 
et al, 2006).  Andrews et al (2006) surveyed second year undergraduate students at a 
university in London UK.  As the main focus of the study was student depression, priority was 
given to respondents who scored 8 and above on the HADS depression subscale. 90 students 
were interviewed using the ‘structured interview for DSM-IV axis disorders’ (SCID).  Results 
suggested that for the sample tested a cut-off score of 10 for the HADS depression gave 
optimum sensitivity/specificity balance (Andrews et al, 2006).  The best sensitivity/specificity 
balance for the HADS anxiety scale was at a cut off of 13, although sensitivity and specificity at 
this cut-off were both below .8. The authors thus concluded that students have a tendency to 
over-report levels of anxiety using HADS (Andrews et al, 2006).    The current study aimed to 
carry out a similar study with a medical student sample, comparing HADS to a clinical 
interview. The current study aimed to address one of the main limitations of Andrews et al’s 
study, this being the time between completing HADS and the diagnostic interview taking place. 
In Andrews et al study there was ‘some weeks’ between the two being undertaken which may 
have affected the results of the study.   
 
1.9 Summary 
The prevalence of mental health problems including depression and anxiety in medical 
students is thought to be higher than aged matched peers who are not at University.  A 
number of possible reasons or risk factors for why students may be more likely to experience 
mental health problems have been suggested including moving away from home, financial 
difficulties, social media, academic demands and worries about future careers.    Many studies 
have suggested that medical students experience high levels of depression and anxiety, with 
some finding higher levels than other student groups.   Possible reasons for higher levels of 
depression and anxiety include the length of the course and the resulting financial impact, 
academic demands, career worries, exposure to death, human suffering and ethical conflicts.  
However, the evidence surrounding the mental health of medical students is contradictory.  
Differences found may be methodological and could include variability in the sample being 
tested or the tool used to measure mental health.  A vast number of instruments are available 
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for measuring depression and anxiety in the general population and in student populations, a 
review of these is outlined in section 2.   Not all tools used to measure depression and anxiety 
have been validated for use with different groups.  In addition, cut-off scores used for 
determining caseness have not been determined for different populations. One study has 
compared HADS to a clinical interview with a general student sample (Andrews et al, 2006).   
The author is not aware of any studies comparing HADS to a clinical diagnostic interview with a 
medical student sample for the purpose of validation and determining optimal cut-off scores.   
This thesis aimed to carry out a similar study to the Andrews et al study, making a comparison 
between HADS and clinical interviews with a medical student sample.  This project does not 
aim to address the issue of whether medical students should be screened for mental health 
problems. Instead it aims to validate a tool to determine if it would be effective for screening.  
In addition, it aims to explore whether a tool could fulfil the criteria highlighted previously of 
having high specificity and sensitivity with a specific medical student sample (Willacy, 2019).    
 
1.10 Aims of the current study  
1.10.1 Main aim  
This project aims to investigate the suitability of HADS as a screening tool for anxiety and 
depression in a medical student population by comparing HADS to a structured clinical 
interview (Schedules for Clinical Assessment in Neuropsychiatry) (SCAN).  
 
1.10.2 Research questions 
In order to address the main aim of this project, this project has three research questions 
outlined below: 
• Research question 1 – Is HADS an accurate measure of anxiety and depression in medical 
students? 
 
• Research question 2 – Are the standard cut off scores of 8+ on the HADS-D and HADS-A 
subscales appropriate for a medical student population? 
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• Research question 3 – Do the responses to individual items within the HADS subscales 
truly reflect the presence of anxiety and depression.   
 
In summary, this chapter has discussed the literature around mental health in students and 
medical students and has set out the aims of the current study.  Before describing this study in 
more details (in chapters three to five) chapter two will review the literature specifically 
around tools for measuring depression and anxiety.    
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Chapter 2:  Literature review 
 
2.1 Introduction and rationale  
This chapter presents the findings of a structured review of depression and anxiety tools found 
in psychological and medical literature looking at measuring depression and or anxiety within 
the last 10 years.  An overview of these tools is provided alongside a closer review of the more 
commonly used tools found in the literature.  In addition, differences between tools used with 
students, medical students and the general population will be discussed.   
Chapter one has highlighted the difficulties students and medical students face when 
attending university.  The higher prevalence of depression and anxiety in, student groups and 
specifically amongst medical students compared to the general population was discussed. The 
introduction also highlighted the need for universities and medical schools to identify those 
students who may require support and discussed some of the difficulties and benefits of 
screening students. Screening may include the whole student population or just those who 
present for support by other means.  Services offering help with well-being, such as University 
support services may also wish to screen individuals for the possible presence of depression 
and/or anxiety to allow for them to signpost individuals to the right place.   If students are to 
be screened, appropriate tools for carrying out screening must be identified. There is therefore 
a need for accurate and consistent measurement of the presence or severity of depression 
and/or anxiety.   
 A vast number of tools have been developed to measure the presence or severity of 
depression and or anxiety.  These include clinician-administered scales and clinical interviews 
or self-reported scales or questionnaires which are completed by the individual.  These tools 
vary in their number of items or questions, their time to complete, their recall period (the time 
period in which the individual completing them is asked to consider symptoms over), how they 
are scored and their cut-off periods.  In addition, the scales vary in their reliability and validity 
and in their ability to determine diagnosis or severity of depression or anxiety.  The literature 
on this topic is vast and wide ranging.  There are a number of papers comparing tools, but 
these tend to concentrate on a few tools looking at their reliability or validity, there is less 
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literature providing an overview of the available tools.    In addition, there are few papers 
which compared tools used for different populations groups including the general population, 
students and specifically medical students.    
2.2 Aim  
This review aimed to review the literature to answer the following questions: 
1. What tools have been used for measuring depression and anxiety in studies with 
students, medical students and the general population in the last 10 years? 
2. How do these tools identified differ? 
3. Is there a difference between which tools are used for measuring depression and anxiety 
in studies with students, medical students and general population samples? 
2.3 Method 
2.3.1 Design  
This review used a structured literature review methodology to provide a qualitative summary 
(Higgins & Green, 2011), of the literature on depression and anxiety scales used with the 
general population, students and medical students.  The reviewer chose to look at the 
literature involving the general population, students and medical students to allow for any 
differences in the tools used for these populations to be explored.  
 
The aim of a systematic review is described as “to identify, appraise and synthesise all the 
empirical evidence that meets pre-specified eligibility criteria to answer a given research 
question” (Cochrane definition, 2013). Often a systematic review involves the use of two 
researchers who both conduct the review and assessment of the data.  In addition, a 
systematic review aims to collect precise information and evaluate studies in relation to 
methods used, rigour of conduct of research and strength of evidence (Robinson & Lowe 
2015).  The current review used a structured approach in relation to the search and 
identification of papers included.  In contrast to a systematic review the review was carried out 
by the author alone and aimed to provide an overview of the studies carried out including 
identification of the tools included, rather than evaluating the quality of the research in the 
 33 
 
included studies.  As such the methodology used is considered a structured review rather than 
a systematic review.   
 
2.3.1.1 Overview of method 
An initial search of the literature was carried out using the data sources and search strategy 
outlined below.  Following the searches, papers were reviewed by their title following the 
inclusion and exclusion criteria also set out below.  If any titles were ambiguous as to whether 
or not they might be relevant, they were kept in at this stage.  Following the initial removal of 
papers which did not meet the inclusion criteria, the remaining papers were reviewed by 
reading their abstracts and further papers thought not to be relevant to the aims of the review 
were discarded.  The final set of papers were then resourced and read to identify the tools 
included in the papers.  
 
2.3.2 Data sources and search strategy 
The electronic databases Psycinfo, Medline and Embase were searched. Table 3 outlines the 
search terms for this review.  
Table 3: Literature review search terms. 
Mental health related 
search terms in title and 
combined with OR 
AND 
Tool related search 
terms in title and 
combined with OR 
AND 
Population search 
terms in keywords 
and combined with 
OR 
Depres* Measure* General population 
Anx* Self-report* Student* 
Distress* Questionnaire* Medical student* 
Mental ill-health Scale*  
Mental Illness Clinical interview*  
'Common mental health 
problem' 
Screening*  
CMHP Diagn*  
Psych* Tool  
 Instrument  
 Assessment.  
  Prevalence   
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Search terms relating to mental health were searched for in titles of publications and the 
searches were then combined together using the OR option meaning that any titles with 
depression or anxiety or distress or mental ill-health etc would be included.  The same was 
done with the tool search terms and similar with the population search terms, although these 
were searched for in the keywords of a publication and not in the title.  Once these three 
separate searches had been carried out they were combined with the AND function, meaning 
any publication would need to include a mental health search term and a tool related search 
term in their title and a population search term in their keywords.  
Only English language references from 2007 onwards were included.  Only papers from 2007 
onwards were included to allow the review to consider which tools are being used in current 
research, rather than considering all tools which have been developed but which may not still 
be in use.   
Once the searches had been carried out, papers were initially reviewed by their title using the 
inclusion and exclusion criteria outlined below.   
2.3.3 study selection  
2.3.3.1 Inclusion Criteria 
The inclusion criteria for studies included: 
• Original studies looking at measuring depression or anxiety in general or student 
populations (including medical students) 
• Studies published between 2007 and 2019 
• English language studies 
2.3.3.2 Exclusion Criteria  
A number of exclusion criteria were used, these were: 
• Studies looking at validation or use of the tool with specific medical groups –for example 
cancer, diabetes, pregnancy etc 
• Reviews and meta-analyses 
• Measures for specific demographic groups – for example the elderly, children, pregnant 
• Tools used to identify patients in remission from depression or anxiety 
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• Tools used to assess the functional ability/capabilities of people with depression or 
anxiety 
• Tools for measuring other psychological conditions, other than depression or generalised 
anxiety, unless these tools were specifically being used for the purpose of screening or 
diagnosing depression and anxiety.   
For example, distress scales were not included if the research was looking at distress, but 
where these tools were reviewed for screening for depression they were included.  
 
 
2.3.4 Data extraction  
 
Following the searches, papers were reviewed by their title following the inclusion and 
exclusion criteria also set out above.  If any titles were ambiguous as to whether or not they 
might be relevant, they were kept at this stage.  Following the initial removal of papers which 
did not meet the inclusion criteria, the remaining papers were reviewed by reading their 
abstracts and further papers thought not to be relevant to the aims of the review were 
discarded.  The final set of papers were then resourced and read to identify the tools included 
in the papers. Once the tools had been identified, any details about them were noted.  For 
some tools, not all the information which the review aimed to record was available in the 
literature resourced from the searches.  In these cases, specific searches were carried out to 
find out more specific details about the tool.  This included looking at the following types of 
papers/sources of information: 
• original papers describing the development of the tool/s 
• papers looking at the organisations who hold copyright permissions for the tool  
• looking at papers describing the use of the tool with different groups   
• looking at older research papers not included in the current search.   
Any papers found which provided additional information on the tools but are included in the 
references but not in the ‘number of studies found’ column of tables 5-8 and 13-15.   
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In addition to identifying the tools used in the included studies, information was recorded 
about the nature of the research, which group of participants it involved.   
 
2.3.5 Analysis 
The review aimed to provide an overview about the studies included in the review and as such, 
basic descriptive information about different tools and their uses is presented and discussed.  
In addition, a narrative overview is included for some of the more commonly used tools found 
in the literature. 
2.4 Results 
The current review had three main review questions, these being: 
1. What tools have been used for measuring depression and anxiety with students, medical 
students and the general population in the last 10 years? 
2. How do these tools identified differ? 
3. Is there a difference between which tools are used for measuring depression and anxiety 
in studies with students, medical students and general population samples? 
A structured review methodology was used to search, identify and review studies measuring 
depression and anxiety in the general population, in student populations and specifically in 
medical student samples.  
The numbers of studies identified will be outlined below, following which the results for the 
depression and anxiety reviews will be presented separately as to how they answer the aims of 
the review outlined above.   
 
2.4.1 Number of studies identified  
The initial search yielded 7975 studies.  An initial review of these studies using title alone 
according to the inclusion and exclusion criteria reduced the number to 1000 studies. The 
abstracts for these were then reviewed and further studies removed.   The final set of studies 
included 299 studies, of which 261 were related to measuring depression and 83 related to 
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measuring anxiety (45 of these included the measurement of both depression and anxiety). 
See appendix 1 and 2 for a list of all studies included in the review.  
The depression and anxiety reviews will now be explored separately, and results presented 
under the review questions outlined at the start of this chapter.  
 
2.4.2 Depression review 
261 studies relating to the measurement of depression in the three population groups (general 
population, students and medical students) were identified.  These were made of: 
• 79 studies relating to the measurement of depression in the general population 
• 116 studies relating to the measurement of depression in student populations 
• 74 studies relating to measurement of depression in medical student populations 
Included in these numbers are one study which used both general population and student 
population samples and 3 studies which used both medical student and other student 
samples.   
 
The studies identified in the searches were then resourced and the tools included in them 
were identified.  Information about the tools were collected and compiled into tables (see 
tables 5-8).  This included information about: 
•  when the tool was developed,  
• how many items the tool contains,  
• how long it takes to complete,  
• if the tool is in the public domain or whether it is copyrighted  
• if cut off scores are provided for its use as a screening tool.  
• how many times each tool appeared in the references identified as relevant for this 
review. 
• information about how the tool was used in the identified studies; papers were coded 
against the categories in table 4 according to the stated aims of the studies included.   
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Table 4 Categories for coding the uses of tools within the identified studies 
Category Description  
Comparing groups  Studies comparing two or more population groups in relation to depression and anxiety  
Comparing tools Studies comparing two or more tools for measuring depression or anxiety  
Diagnostic Studies testing the diagnostic ability of tools 
Longitudinal  Studies measuring depression or anxiety over two or more time periods  
Prevalence Studies measuring the prevalence of depression or anxiety 
Psychometric  Studies testing the psychometric properties (often reliability and validity) of a tool 
Screening  Studies using depression and/or anxiety tools to screen individuals for depression or 
anxiety  
Service evaluation  Studies evaluating services/interventions for improving wellbeing (and therefore 
looking at the effect on test scores) 
Technology  Studies looking at using technology to assist in measuring depression or anxiety eg 
online screening 
Tool development  Studies describing the development of new scales.  
Translation  Studies translating tools into different languages or evaluating tools which have already 
been translated.  
 
 
 It was decided that information regarding the reliability and validity of the tools would not be 
included in the review.  This was in part due to the variability in the reliability and validity of 
tools and its dependence on the population with which the tool is being used.  A more in-
depth discussion of the tools which were used most frequently in the identified studies will 
also be presented which will include information of reliability and validity for these tools.  
 
2.4.2.1 Review question 1: What tools have been used for measuring 
depression in studies with students, medical students and the general 
population in the last 10 years? 
54 different tools were identified in the literature for use in determining presence or severity 
of depression itself or symptoms of depression.  The tools could broadly be grouped into 4 
separate categories:  
1. Self-report scales, questionnaires, inventories or checklists – 45 tools identified (see table 
5) 
2. Clinician administered scales or inventories – 3 tools identified (see table 6) 
3. Clinical interviews – 5 tools identified (see table 7) 
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4. Alternative tools – 1 tool identified (see table 8) 
Whilst all of the self-repot scales, clinician administered scales and clinical interviews require 
an individual to report on their symptoms and therefore all use self-report.  For the purpose of 
this review self-report tools will refer to those tools which can be completed by a person with 
no input from an administrator.   
The most common type of tool use in the studies identified were self-report tools and the 
most commonly used tools in the studies were all self-report tools.  Of the 261 studies found in 
the current review, 64 relate to the Beck Depression Inventory (BDI-II).  Other tools which 
were most commonly used in the identified studies included the Physician Health 
Questionnaire (PHQ-9) which featured in 50 studies, The Centre for Epidemiological Studies-
Depression scale (CESD) which appeared in 36 studies and the Hospital Anxiety and Depression 
Scale (HADS) in 24 studies.   
A brief description of each of the four types of tools is presented below, along with tables of 
the identified tools in each category.   This will be followed by a discussion of the 4 most 
commonly used depression tools as identified above (BDI-II, PHQ, CESD, HADS).      
 
2.4.2.1.1 Self-report scales questionnaires, inventories or checklists 
45 tools were identified as being self-report scales, questionnaires, inventories or checklists for 
measuring depression in the literature, a list of these tools is found in table 5.  Whilst there 
may be subtle differences between self-report scales questionnaires, inventories or checklists 
it is difficult to get a clear definition of what these differences are.   
The oxford dictionary defines a scale as: 
“1. In statistics and measurement theory, a rule governing the relationship between numerical 
scores and the magnitudes of the attributes or quantities being measured. 2.A test or 
measuring instrument for implementing a scale (1). scaling n. The development or construction 
of scales (1, 2), often by aggregating or ordering responses of individuals.” (Oxford dictionary 
of English, 2010) 
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A questionnaire is defined as  
“In psychometrics, a set of questions specially designed to provide objective information about 
some characteristic of a respondent, such as attitudes, preferences, interests, values, or 
personality. Also called an inventory, particularly when used to measure abilities, aptitudes, or 
intelligence, such instruments seldom being called questionnaires.” (Oxford dictionary of 
English, 2010) 
An inventory is defined as: 
“Any list or schedule of items. In psychometrics, a questionnaire or checklist usually 
functioning as a self-report test of abilities, aptitudes, or intelligence. Tests designed to 
measure interests, attitudes, personality traits, preferences, and psychological attributes are 
also sometimes called inventories, but tests designed to measure abilities, aptitudes, and 
intelligence are usually called questionnaires.” (Oxford dictionary of English, 2010) 
The dictionary does not define a checklist, but papers using the checklists also refers to them 
as a scale (Lundin et al, 2015).   
From these definitions a scale maybe considered to have a measure of magnitude, which may 
not be found in a questionnaire or inventory.  However, some of the inventories also include a 
scale.  For example, the Beck Depression inventory (BDI) provides scores attached to its items 
which are referred to as a scale (Jackson-Koku, 2016).   in practice the terms scales, 
questionnaires, inventories and checklists are used interchangeably and therefore for the 
purpose of this review we will review them together as self-report tools.   
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Table 5 – Self-report tools identified for measuring depression  
Tool Long name 
When 
developed 
Time to 
complete 
Number 
of items 
Recall 
period 
Cost/copyright Suggested Cut offs 
Number of 
articles 
found 
Uses of the tool in 
the review studies 
ADI 
Adolescent 
Depression 
Inventory  
2003 
Not 
reported 
20 
Past 
month  
Not reported 
≤7 minimal 
8–12 mild depression 
13–18 moderate  
19+ severe depression, 
1 Prevalence = 1 
AKUADS 
Aga Khan 
University Anxiety 
and Depression 
Scale 
1998 
Not 
reported 
25 2 weeks Not reported 
Cut-off of 19 for 
depression  
3 Prevalence =3 
BADS 
Behavioural 
Activation for 
Depression Scale  
2006 
 Not 
reported 
25 
9 for 
short  
past week  In public domain   Not reported 6 
Psychometric = 4 
Translating = 1 
Longitudinal = 1 
BDI – FS 
The Beck 
Depression 
Inventory-Fast 
Screen  
2000 
Less than 5 
minutes 
7 2 weeks 
Available at a cost: 
$67, including manual 
and 50 score forms 
0-3 minimal, 4-8 mild, 
9-12 moderate, and 
13-21 severe  
1 Prevalence =1 
BDI-II 
Beck Depression 
Inventory 
1961 revised 
in 1978 and 
1996 
5 minutes 21 2 weeks 
Available at a cost: 
manual and 25 record 
forms = £108 ec VAT,  
Pack 25 forms = 
£56.50 ec VAT 
0–13: minimal 
depression 
14–19: mild 
depression 
20–28: moderate  
29–63: severe  
64 
Prevalence = 40 
Psychometric = 4 
Screening = 1 
Compare groups = 8 
Translating = 2 
Compare tools = 8 
Longitudinal = 1 
Other = 1 
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Tool Long name 
When 
developed 
Time to 
complete 
Number 
of items 
Recall 
period 
Cost/copyright Suggested cut offs 
Number 
of articles 
found 
Uses of the tool in 
the review studies 
M-BDI 
Modified Beck 
Depression 
Inventory 
2000 
Not 
reported 
21 2 weeks In public domain ≥35 1 Prevalence = 1 
BSI 
Brief Symptom 
Inventory 
1983 
8-10 
minutes 
53 items 
Past 7 
days 
Costs $132.85 for 
manual and 50 answer 
sheets 
Not reported 
2 
 
Prevalence = 2 
CES-D – 
short 
versions 
The Center for 
Epidemiological 
Studies-
Depression scale 
– 10/7/4 
Not reported 
1-2 
minutes 
10/7/4 Last week In public domain 
Originally – 8-10 
optimal for risk of 
depression 
3 
 
Prevalence =1 
Psychometric = 2 
CESD-R 
The Center for 
Epidemiological 
Studies-
Depression scale - 
revised 
1977 
Revised 2004 
2-5 
minutes  
20 Last week In public domain 
Originally – 16 
A meta review 
suggested cut off of 20 
– (Vilagut, 2016) 
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Prevalence = 11 
Screening = 1 
Psychometric = 12 
Comparing groups = 
4 
Translation = 1 
Comparing tools = 3 
Tool development = 
1 
Service evaluation = 
2 
Other = 2 
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Tool Long name 
When 
developed 
Time to 
complete 
Number 
of items 
Recall 
period 
Cost/copyright Suggested cut offs 
Number 
of articles 
found 
Uses of the tool in 
the review studies 
CRSD 
Carroll Rating 
Scale for 
Depression 
1981 
Not 
reported 
17 
Past few 
days 
Via eprovide website 
10 for mild depression 
 
1 
 
 
Comparing tools = 1 
 
DASS-21 
Depression 
Anxiety Stress 
Scale 
1995 3 mins 
21 – 7 for 
each scale 
Past week In public domain 
Depression normal 0-
9, mild 10-13, 
moderate 14-20, 
severe 21-27, 
extremely severe 28+ 
8 
 
Prevalence = 4 
Psychometric = 2 
Comparing tools = 1 
Longitudinal = 1 
DASS-42 
Depression 
Anxiety Stress 
Scale 
1995 – 2nd 
Edition 
7 minutes 
42 – 14 
items for 
each scale 
(depressio
n, anxiety, 
stress) 
Past week In public domain 
Depression normal 0-
9, mild 10-13, 
moderate 14-20, 
severe 21-27, 
extremely severe 28+ 
14 
Prevalence = 6 
Psychometric = 5 
Comparing tools = 1 
Longitudinal = 1 
Comparing tools = 1 
DESC 
Rasch-Based 
Depression 
Screening 
2009 
Not 
reported 
10 items 
Last 2 
weeks 
The DESC is available 
from the principal 
author. 
Not reported 
1 
 
Comparing tools = 1 
DSM 
 Diagnostic and 
Statistical Manual 
of Mental 
Disorders – Self-
Rated Level 1 
Cross-Cutting 
Symptom 
Measure 
 2013 
Not 
reported 
8 
Past two 
weeks  
Free for clinicians 
Less than 55 = None to 
slight 
55.0—59.9 = Mild 
60.0—69.9 = 
Moderate 
70 and over = Severe 
1 
 
Prevalence = 1 
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Tool Long name 
When 
developed 
Time to 
complete 
Number 
of items 
Recall 
period 
Cost/copyright Suggested cut offs 
Number 
of articles 
found 
Uses of the tool in 
the review studies 
GDS 
Goldberg 
depression scale 
1998 
Not 
reported 
Answer 
yes or no 
to 9 
symptoms 
Past 4 
weeks 
Not reported 
Higher scores = 
greater symptoms 
1 
 
Comparing tools = 1 
GHQ-12 
General Health 
Questionnaire 
Not reported 2 minutes 12 Recently 
Royalty fees - 
commercial users 500 
euros per language, 
non-commercial 100 
euros per language.   
2/3 points 
9 
 
Prevalence = 3 
Screening = 2 
Psychometric = 2 
Comparing tools = 2 
GHQ-28 
General Health 
Questionnaire 
Not reported 5 minutes 28 Recently Not reported 5/6 points 4 
Prevalence = 3 
Comparing groups = 
1 
HADS 
Hospital Anxiety 
and Depression 
Scale  
1983 
2–5 
minutes 
14 items: 
7 
depressio
n,  
7 anxiety  
last week 
historically freely 
available.  
Royalty - commercial 
600 euros per 
language.  Non 
commercial 100 euros 
per language 
mild 8-10, moderate 
11-14, Severe 15-21 
24 
 
Prevalence = 6 
Psychometric = 8 
Compare groups = 6 
Translating = 1 
Compare tools = 5 
 
IDAS 
The Inventory of 
Depression and 
Anxiety 
Symptoms  
(IDAS), 
2007 
 Developer 
claim takes 
no longer 
than the 
BDI  
64 items 
Not 
reported 
Not reported Not reported 
2 
 
Comparing groups = 
1 
Tool development = 
1 
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Tool Long name 
When 
developed 
Time to 
complete 
Number 
of items 
Recall 
period 
Cost/copyright Suggested cut offs 
Number 
of articles 
found 
Uses of the tool in 
the review studies 
IDS 
Inventory of 
Depressive 
symptomatology 
1986 
Not 
reported 
IDS  - 30 
items 
short 
version: 
QIDS - 16 
items 
past 7 
days 
IDS and QIDS are 
copyright protected. 
available through 
Mapi’s ePROVIDE 
online platform 
Rush (1996) In the self-
rated version (IDS-SR) 
a cut-off-point of 18 or 
above indicates the 
presence of clinically 
relevant depressive 
symptomatology. 
3 
 
Screening = 1 
Psychometric = 1 
Comparing groups = 
1 
ISR 
ICD-10 Symptom 
rating  
2008 
Not 
reported 
29 items 
total, 4 
for 
depressio
n 
Past 2 
weeks 
In the public domain - 
free 
Not reported 
1 
 
Psychometrics = 1 
KADS - 6 
Kutcher 
adolescent 
depression scale - 
6 
2006 
Not 
reported 
6 Past week In public domain Cut off of 6 1 Prevalence = 1 
K10 
Kessler 10 item 
distress scale 
2003 
Not 
reported 
10 items 
Past 4 
weeks 
In public domain 
Cut off of 20+ for mild  
25-29 moderate, 30-50 
severe 
6 
 
Prevalence = 3 
Screening = 2 
Psychometrics = 1 
K6 
Kessler 6 item 
distress scale  
2002 
Less than 2 
minutes 
6 items 
Past 4 
weeks 
In public domain Cut off of ≥13 
4 
 
Prevalence = 2 
Screening = 2 
LAPS 
the Leuven Affect 
and Pleasure 
Scale 
2017 
 Not 
reported 
16 
 Past 
week  
 Development/validati
on ongoing 
 Development/validati
on on-going 
1 
 
Tool development = 
1 
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Tool Long name 
When 
developed 
Time to 
complete 
Number 
of items 
Recall 
period 
Cost/copyright Suggested cut offs 
Number 
of articles 
found 
Uses of the tool in 
the review studies 
MACL 
Mood adjective 
checklist 
Not reported 
Not 
reported 
Not 
reported 
Not 
reported 
Not reported Not reported 
1 
 
Psychometrics = 1 
MASQ 
Mood and Anxiety 
Symptoms 
Questionnaire  
(short version 
ADDI) 
1995  
 Not 
reported 
Original – 
90 items 
MASQ-
D30 
MASQ-AD 
has 22 
items 
 
Not 
reported 
Not reported Not reported 
3 
 
Screening = 1 
Psychometrics = 1 
Comparing groups = 
1 
MDI 
Major depression 
Inventory 
2001 
Not 
reported 
12 
Last 2 
weeks 
Freely available 
Diagnosis – 1st 3 
symptoms must be 
present most of the 
time and 5 of the 9 
symptoms must have 
been present in past 2 
weeks – These 5 must 
include symptoms 1 or 
2.   
Symptom severity: 
Mild 20-24, moderate 
25-29, severe 30+ 
2 
Psychometrics = 1 
Longitudinal = 1 
MHI-5 
Mental health 
inventory 
1993 
Not 
reported 
5 items 
Last 4 
weeks 
Not reported 
Scores from 0-100, no 
definitive cut off of 70 
suggested 
1 
 
Psychometrics = 1 
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Tool Long name 
When 
developed 
Time to 
complete 
Number 
of items 
Recall 
period 
Cost/copyright Suggested cut offs 
Number 
of articles 
found 
Uses of the tool in 
the review studies 
ODSIS 
Overall 
Depression 
Severity and 
Impairment Scale 
2010  
 
abbreviate
d version - 
2 minutes 
5 past week Not reported 
A cut score of 8 
correctly classified 
82% of outpatients as 
with or without a 
mood disorder;  
2 
 
 
Tool development = 
1 
Comparing tools = 2 
PHQ-2 
Patient health 
questionnaire  2 
2003 
Not 
reported 
2 
Previous 2 
weeks 
In public domain, no 
permissions required 
A cut-off of 3 is 
optimal for screening 
purposes 
6 
 
Screening = 3 
Psychometrics = 3 
PHQ-4 
Patient health 
questionnaire  4 
Not reported 
Not 
reported 
4 
Previous 2 
weeks 
Not reported Not reported 
3 
 
Screening = 1 
Psychometrics = 1 
Diagnostic = 1 
PHQ-8 
Patient health 
questionnaire  8 
Not reported 
Not 
reported 
8 
Previous 2 
weeks 
Not reported Not reported 
3 
 
Psychometrics = 2 
Diagnostic = 1 
PHQ-9 
Patient health 
questionnaire -9 
2001 
Not 
reported 
10  
(9 & 1 on 
impairme
nt) 
Previous 2 
weeks 
In public domain, no 
permissions required 
PHQ-9 scores of 5, 10, 
15, and 20 represents 
mild, moderate, 
moderately severe and  
severe depression 
50 
 
Prevalence = 26 
Screening = 9 
Psychometric = 8 
Comparing groups = 
3 
Technology = 3 
Comparing tools = 2 
 
RRS – 10 
Rumination 
Response Scale 
2003 
Not 
reported 
10 
Not 
reported 
 Freely available if 
work by Hoeksma et al 
is acknowledged 
Not reported 
2 
 
Psychometrics = 2 
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Tool Long name 
When 
developed 
Time to 
complete 
Number 
of items 
Recall 
period 
Cost/copyright Suggested cut offs 
Number 
of articles 
found 
Uses of the tool in 
the review studies 
SCL-90 
Symptom 
checklist 
1994 
12-15 
minutes 
90 items – 
provides 
scores for 
9 domains 
including 
depressio
n  
Past week 
Costs £131.50 for 
manual and 50 answer 
sheets 
Not reported 
 
 
1 
 
Psychometrics = 1 
SDS 
ZUNG self-rating 
depression scale  
1965 
about 10 
minutes 
(WHO 
website) 
 
20 
 past 
several 
days 
in public domain 
•25-49 Normal  
•50-59 Mildly 
Depressed  
•60-69 Moderately 
Depressed  
•70 and above 
Severely Depressed  
10 
 
Prevalence = 3 
Screening = 1 
Psychometric = 3 
Comparing tools = 3 
 
SF-12 
Short-Form 
Health Survey 
1996 
Not 
reported 
12 items 
Past 4 
weeks 
Contact Optum for a 
survey licence  
No generally accepted 
45.6 suggested by 
Vilagut 
3 
 
Screening = 2 
Comparing tools = 1 
SRE-20 
Self-reporting 
questionnaire 
1994 
10 
minutes 
20 items 
Past 30 
days 
Freely available 
7 White Europeans 
6 British Pakistanis 
1 
 
Screening = 1 
SRQ 
The Self-
Reporting 
Questionnaire 
(SRQ) 
1994 
Not 
reported 
20 items 
Past 
month 
In public domain  
A range of cut offs 
have been used in 
studies  
1 Prevalence = 1 
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Tool Long name 
When 
developed 
Time to 
complete 
Number 
of items 
Recall 
period 
Cost/copyright Suggested cut offs 
Number 
of articles 
found 
Uses of the tool in 
the review studies 
ST-DEP 
State trait 
depression scale  
1995 
Not 
reported 
20 : 
10 state 
10 trait 
Not 
reported 
Not reported 
Five items in each 
scale represent the 
presence depression.  
3 
 
Psychometrics = 1 
Translation = 1 
Comparing groups = 
3 
USDI 
University student 
depression 
inventory 
2006 
Not 
reported 
30 
past 2 
weeks 
Not reported 
low – 20-73 
moderate 74-95 
high 96-118 
very high 119-147 
Scores do not 
represent severity of 
depressive disorder or 
a diagnosis, but rather 
the amount depressive 
symptoms weighted 
by frequency of 
occurrence  
1 
•  
Psychometrics = 1 
WHO-5 
World health 
organisation well-
being index 
1998 
Not 
reported 
5 items 
Last 2 
weeks 
Free no permissions 
needed 
≤50 
1 
 
Psychometrics = 1 
ZDS 
 Zagazig 
Depression Scale 
 2010 
Not 
reported 
52 in 
Arabic 
version 
46 in UK 
version 
Not 
reported 
Not reported 
< 10 absence of 
depression symptoms,  
10-19 mild,  
20-29 moderate, 
≥30 severe depressive 
symptoms  
2 
 
 
 
 
Psychometrics = 2 
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2.4.2.1.2 Clinician administered scales or inventories  
Three clinician administered depression scales or inventories were identified in the literature, 
these were the Hamilton depression scale (HAM-d, HRSD), the quick inventory of depressive 
symptomatology (QIDS) and the Montgomery-Asberg depression rating scale (MADRS) (see 
table 6).  Clinician administered depression scales are similar to self-report scales, but they 
require a clinician who has received training in their use to complete them with the participant 
or patient (in clinical settings).   
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Table 6 - Clinician administered scales or inventories for measuring depression 
 
Tool 
Long name 
When 
developed 
Time to 
complete 
Numbe
r of 
items 
Recall 
period 
Cost/copyrig
ht 
Cut offs 
Number 
of 
articles 
found 
Uses 
HAM-
d/HRSD 
Hamilton 
Depression 
Rating scale  
1960 20 
minutes 
17-29 
(depend
ing on 
version) 
Past 
week 
Public 
domain 
For the 17-item version, 
a score of 0–7 is 
considered to be normal 
while a score of 20 or 
higher (indicating at least 
moderate severity) 
6 Prevalence = 1 
Screening = 1 
Psychometrics = 1 
Technology = 1 
Comparing tools = 1 
MADRS Montgomery–
Åsberg 
Depression 
Rating Scale 
(MADRS)  
1979 15-20 
minutes  
 10 Past 
week  
Freely 
available  
0 to 6 – normal/symptom 
absent 
    7 to 19 – mild 
depression 
    20 to 34 – moderate 
depression 
    >34 – severe 
depression. 
3 
 
Psychometrics = 1 
Technology = 1 
Comparing tools = 1 
 
QIDS Quick Inventory 
of Depressive 
symptomatolog
y 
2003 Not 
reported 
QIDS – 
16 
items 
Past 7 
days  
copyright 
protected. 
Available 
through 
Mapi’s 
ePROVIDE 
online 
platform 
mild (6 –10), moderate 
(11–15), severe (16 –20), 
and very severe (≥21) 
depression 
1 
 
Screening = 1 
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2.4.2.1.3 Clinical Interviews 
Five Clinical interview tools were identified in the literature, the Composite International 
Diagnostic Interview (CIDI), the Mini-International Neuropsychiatric Interview (MINI) , the 
primary care evaluation of mental disorders (PRIME-MD), the Schedules for Clinical 
Assessment in Neuropsychiatry (SCAN) and the Structured Clinical Interview (SCID) (See table 
7).   There are fewer clinical interviews than self-report scales use in studies measuring 
depression.  Clinical Interviews are considered by some to be the gold-standard of depression 
measurement (Gelaye et al, 2014).    
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Table 7 – Clinical interviews for measuring depression  
Tool Long name 
When 
developed 
Time to 
complete 
Number 
of items 
Recall 
period 
Cost/copyright 
Clinician 
administere
d only? 
Number 
of articles 
found 
Uses 
CIDI Composite 
International 
Diagnostic 
Interview 
1990 Not 
reported 
276 – 
although 
due to 
screening 
not all 
patients 
will be 
asked all 
questions 
Past 30 
days 
Training required and a 
software licence 
purchased.   
Lay can be 
trained 
8 
 
Prevalence = 3 
Screening = 2 
Psychometrics = 1 
Comparing tools = 2 
MINI  The Mini 
International 
Neuropsychiatri
c Interview  
1998 15 -30 
min 
The MINI 
consists 
of 19 
modules 
that 
explore 
17 
disorders 
of Axis I 
of the 
DSM-IV 
 
Past 2 
weeks 
for 
initial 
sympto
ms  
Any use of the paper/PDF 
versions of the MINI must 
first be licensed by Dr 
David Sheehan. 
A License Agreement 
must be signed 
beforehand by all users 
with Dr Sheehan and fees 
may be requested.  
Lay can be 
trained 
5 
 
Prevalence = 4 
Longitudinal = 1 
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Tool Long name 
When 
developed 
Time to 
complete 
Number 
of items 
Recall 
period 
Cost/copyright 
Clinician 
administere
d only? 
Number 
of articles 
found 
Uses 
PRIME 
MD 
PRIMary care 
Evaluation of 
Mental 
Disorders 
1994 11 
minutes 
(Loerch et 
al 2000) 
Screening 
questionn
aire – 26 
questions
, 
interview 
17 
questions 
Past 
month  
The PRIME-MD PQ and 
CEG are accompanied by 
a 13-page manual, which 
includes information 
regarding reimbursement 
for the evaluation (which 
is under copyright of 
Pfizer, Inc).  
Designed for 
primary care 
(GPs) – 
nurses have 
been trained 
(Preville et al 
2004) 
1 
 
Prevalence = 1 
SCAN Schedules for 
Clinical 
Assessment in 
Neuropsychiatry 
(SCAN) 
1992 Variable 1,872 
items, 
spread out 
over 28 
sections. 
Most 
patients, 
will only 
need parts 
of the 
interview 
Past 
month  
Training required Lay can be 
trained  
1 Comparing tools = 1 
SCID Structured 
clinical 
interview 
1997 30 -60 
minutes  
Not 
reported 
2 weeks  Fee payable based on 
intended use.  
Clinicians or 
trained 
mental 
health 
professional 
1 
 
Prevalence = 1 
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2.4.2.1.4 Alternative tools 
Only one alternative tool for measuring depression was identified in the literature (see table 
8), this is the Rorschach comprehensive system depression index (DEPI) which was included in 
one study.  This category was used for any tools identified which did not fit into the criteria of 
self-report, clinically administered scale or clinical interview.  
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Table 8 – Alternative tools for measuring depression   
Tool Long name When 
developed 
Time to 
complete 
Number 
of items 
Recall 
period 
Cost/copyrigh
t 
Cut offs Number of 
articles 
found 
Uses 
DEPI Rorschach 
Comprehensive 
System 
Depression 
Index 
1991 Not 
reported 
15 
variable
s  
n/a Not reported A DEPI value of 5 
indicates 
depression likely, 6 
or 7 provide more 
certainty 
1 
 
Testing diagnostic 
ability 
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In summary 45 self-report tools, 3 clinician administered scales, 5 clinical interviews and one 
alternative tool were identified in the studies included in this review.  The most common type 
of tool use in the studies identified were self-report tools.  The most commonly used tools 
identified in the studies included in this review were the BDI-II (Beck Depression Inventory) (in 
64 studies), the PHQ-9 (Physician Health Questionnaire)(in 52 studies), the CESD (The Center 
for Epidemiological Studies-Depression scale) ( in 38 studies) and HADS (Hospital Anxiety and 
Depression Scale) (in 25 studies).  A description of each of these tools is provided below. 
 
2.4.2.1.5 Beck Depression Inventory (BDI-II) 
64 studies identified in the review cited use of the Beck Depression Inventory (BDI-II).  
The (BDI-I) was developed in 1979 to measure symptoms and severity of depression (Smarr 
and Keefer, 2011).  After several iterations, the BDI-II (from now on referred to as the BDI) was 
developed in 1996 omitting items relating to weight loss, body image, hypochondria and 
working difficulty in order to better fit the Diagnostic and Statistical Manual of Mental 
Disorders, Fourth Edition’s (DSM-IV) criteria for depression (Kung, 2013).  The BDI includes 
both cognitive (eg feelings of guilt, low mood) and somatic (eg tiredness) aspects of 
depression.  Although developed as a measure of symptom severity in already depressed 
patients it is often used as a screening tool in some clinical settings (Aalto, 2012).  The BDI-II 
has reported high levels of reliability and validity in a range of settings (Kjaergaard et al, 2013; 
Uher, 2012; Aalto,2012).  The BDI is one of the most widely used depression self-rating scales. 
and is one of 3 instruments (along with HADS and the Patient Health Questionnaire (PHQ-9)) 
that are endorsed by the National Institute for Health and Clinical Excellence for use as a 
formal rating scale for in assessing symptom severity for depression (NICE, 2011).    
THE BDI has 21 items and is quick to administer but comes at a cost of £104 for a manual and 
25 forms (from http://www.pearsonclinical.co.uk) .  The need to obtain the BDI from the 
publisher at cost has been seen as a major obstacle against the recommendations of its 
widespread use (Wang & Gorenstein, 2013).   
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The initial structure of the BDI received heavy criticism, though the methods used in the 
evaluation of the structure have since come under fire (Skorikov & Vandervoort, 2003).  More 
recent research suggests that the BDI has a three-factor structure which correspond to Beck’s 
initial subscales of Negative Attitude, Performance Difficulty, and Somatic Elements (Skorikov 
& Vandervoort, 2003).  There has also been much discussion regarding the BDI and it’s 
association with the Beck’s Anxiety Inventory (BAI).  In the same vein, as with the HADS scale 
(see section 2.2.1.5.4), some question whether anxiety and depression are measuring two 
separate constructs or the same construct with anxiety and depression representing different 
measurements on a continuum.  Stultz & Crits-Christoph, (2010) carried out an exploratory 
factor analysis of the 42 BAI and BDI-II items and identified two separate factors indicating that 
the BAI and BDI reflect separate dimensions of anxiety and depression respectively. However, 
Stultz & Crits-Christoph found that in the factor analysis some items affected the factor 
representing the other measure, and therefore they proposed (as has been suggested with the 
HADS questionnaire) that a 3-factor structure is present, these being 1 - anxiety symptoms 
(mostly arousal symptoms such as feelings of tension), 2 - depression symptoms (mostly 
anhedonic symptoms such as loss of interest) and 3 - negative affect.  Others have concluded 
that the correlations between depression and anxiety scales might be linked to underlying 
constructs and characteristics of the instruments or may be due to the overlap of symptoms 
and comorbidity of these conditions (Wang & Gorenstein, 2013).   
 
2.4.2.1.6 Physician Health Questionnaire (PHQ-9) 
The PHQ-9 was used in 50 studies identified in this review.  The PHQ was developed as a self-
administered version of the PRIME-MD interview, a diagnostic interview developed for primary 
care (Kroenke et al, 2010).  Although the PRIME-MD can be administered relatively quickly for 
an interview (11 minutes Loerch et al, 2000) this time can still be a barrier to it’s use in a 15-
minute consultation (Kroenke et al, 2010).  Containing only 9 items the PHQ-9 takes less time 
to complete than the PRIME-MD and can be completed independently.  Despite the PHQ-9 
being originally developed for screening in primary care (Kocalevant et al,2013) it has been 
validated extensively in medical settings (Martin et al, 2006) and has been found to be valid 
and reliable (Soltani et al, 2015) 
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Whilst there has been much support for the PHQ-9 in medical settings and for determining 
severity of depression, some have questioned it’s use in identifying depression in the general 
population (Eack et al, 2006).  Others suggest that there is strong support for the PHQ-9 for 
discriminating between depressed and non-depressed individuals (Martin et al, 2006).  One 
study with 5000 participants found the PHQ-9 to be reliable and valid in both healthcare 
settings and in the general population (Kocalevent et al, 2013).  Furthermore, Lowe et al (2010) 
suggest that the PHQ-9 is able to detect depression outcomes and changes over time and 
encourages its use in both research and clinical practice.  
One reason for the discourse, may be due to the different methods of scoring the PHQ-9.  
Manea et al (2015) describe 2 methods for scoring the PHQ-9, either using a scale and a cut-off 
score, or by the use of an algorithm, looking at the number of symptoms present.  Manea et al 
suggest that the algorithm method leads to low sensitivity for diagnosis.  
As with other depression tools (see BDI, CES-D and HADS), there is some discourse concerning 
whether the PHQ-9 is measuring one uni-dimensional factor, or whether it measures two or 
more factors (Kocalevent et al, 2013; Cameron et al, 2008). However, the PHQ-9 seems to 
attract much less attention in this regard than HADS or the BDI.  Granillo (2012) and Elhai et al 
(2012) suggests a two-factor structure can be identified.  Many others suggest that the PHQ-9 
is unidimensional (Cameron et al, 2008; Kocalevent et al 2013).  This may be because the 9 
symptoms measured by the PHQ-9 map directly onto the 9 criteria required for a DSM-IV 
depression diagnosis (Smarr and Keefer, 2011).   
The PHQ-9 has be translated into many languages and as such is used around the world.  Along 
with the BDI and HADS, the PHQ-9 is endorsed by the National Institute for Health and Clinical 
Excellence for use as a formal rating scale for assessing symptom severity for depression (NICE, 
2011). Of these three tools (HADS, BDI, PHQ-9) the PHQ-9 is the only one freely available in the 
public domain, making it a favourable tool for use in research and clinical settings.   
 
2.4.2.1.7 Center for Epidemiological Studies-Depression scale (CES-D) 
In the current literature review the Center for Epidemiological Studies-Depression scale (CES-
D) was the 3rd most frequently cited depression scale, cited as being used in 36 studies. The 
CES-D was developed in 1977 as a short self-report scale for measuring depressive symptoms 
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in the general population (Radloff, 1977).  The CES-D was initially developed for research 
purposes and has been found to have high levels of reliability and validity for a range of 
populations and languages (Smarr & Keefer, 2011).  It has been suggested that the CES-D 
provides only a rough indication of clinical depression) and that there is a high correlation 
between CES-D and anxiety (Smarr & Keefer, 2011).  As highlighted previously in relation to the 
BDI, the correlations between depression and anxiety scales might be due to the overlap of 
symptoms and comorbidity of these conditions (Wang & Gorenstein, 2013).   
The CES-D is not intended as a diagnostic tool. (Smarr, & Keefer, 2011). Vilagut et al suggests 
that it had acceptable levels of accuracy for screening depression in the general population or 
in primary care but suggests it should not be used as an isolated measure of depression.  One 
reason for this is that when originally developed the CES-D was not designed to reflect the 
diagnostic criteria as determined by the DSM (Carleton et al, 2013). Coupled with this, some 
have questioned the validity and psychometric properties of some of the 20 items contained in 
the CES-D and have questioned the factor structure underpinning the CES-D (Carleton et al, 
2012).     
When developed, the original model identified 4 factors, these being depressed mood, positive 
affect, somatic and interpersonal symptoms (Shean and Baldwin, 2012).   In addition to the 4 
factors originally proposed, studies have suggested a number of different factor structures, 
from one factor to four factors (Arbona et al, 2017).  Carleton et al found support for a 14 item 
(compared to original 20 items), three factor model which is more in line with the diagnostic 
criteria as determined by the DSM (Carleton et al, 2013). Gomez and Mclaren (2015) found 
good support for the original four factor model but also suggest that if researchers wish to use 
a total unidimensional score, that if the PA items are removed, their results support a 
unidimensional structure.  This is supported by Edwards et al (2010) who suggested that if 
required although a one factor model may not be the best fit for the data, it is plausible and 
can effectively be used.  However, Edwards et al also advocated dropping some of the 20 items 
to find a better one factor model.  Fong et al (2016) also suggested that although a four-factor 
model was the best fit, the fact that the correlations between the 4 factors was strong, 
suggesting ‘substantial overlapping among the dimensions’.  Fong et al concluded that the 
overall CES-D score is an approximate unidimensional measure and that the use of CES-D 
overall score as a screening measure of depression is justified.     
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2.4.2.1.8 Hospital Anxiety and Depression Scale 
24 studies were identified that used the Hospital Anxiety and Depression Scale (HADS).  HADS 
was developed by Zigmond and Snaith in 1983. The scale was designed to assess the presence 
and severity of anxious and depressive symptoms in hospital patients (Caci et al, 2003) and as 
such omitted any somatic symptoms such as dizziness or headaches (Brennan et al 2010).  
Whilst the tool was designed for screening for depression and anxiety in hospital settings, the 
tool has been used in the general population and many studies have validated it for this 
purpose (Mykletun et al, 2001).  In addition, the tool has been validated for use in general 
practice (Olsson, et al 2015) and is one of 3 instruments (along with the Beck depression 
Inventory (BDI) and the Patient Health Questionnaire (PHQ-9)) that are endorsed by the 
National Institute for Health and Clinical Excellence for use as a formal rating scale for in 
assessing symptom severity for depression (NICE, 2011).  HADS has been validated for use in 
many different languages and countries (Stern, 2014) 
Despite the popularity of HADS there has been much disagreement in the literature over its 
use.  Many studies have found satisfactory levels of internal consistency, concurrent validity 
and diagnostic ability (Fong et al, 2013), though other studies have questioned the structure of 
HADS (Cosco et al, 2012).  Some studies looking at HADS suggest that the two-factor structure 
(depression and anxiety) is valid (Fong et al, 2013; Bjelland et al, 2002), other suggest that a 
three-factor model fits the data more closely (Cosco et al, 2012).  These inconsistencies and 
disparities have led to some suggesting that HADS should no longer be used (Coyne & Van 
Sonderen, 2012; Zakrewska 2012). It has been suggested that the differences seen in the 
dimensionality results is due to differences in the methods used (and the specific analytic 
strategy employed) to evaluate them rather than different psychological traits (Straat, 2013; 
Cosco et al; Norton 2013).   
A recent article reporting the method and protocol for an upcoming meta-analysis looking at 
the diagnostic accuracy of HADS suggested flaws in many of the existing studies looking at the 
accuracy of HADS (Thombs et al, 2016).  These problems include small sample sizes, inclusion 
of diagnosed and treated patients and selectively publishing accurate results from cut-offs that 
perform well (Thombs et al, 2016).  
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Other criticisms of HADS include the suggestion that it does not sufficiently distinguish 
between anxiety symptoms and depressive symptoms (Andrea, 2004). Some argue that this is 
in part to the comorbidity of the two conditions (Langvik et al, 2016; Cosco et al 2012).   The 
insufficient distinction between anxiety and depression has led some to argue that HADS be 
used as a general measure of distress rather than as depression and anxiety subscales (Cosco 
et al 2012 ; Norton 2013).  Whilst the structural underpinnings of HADS may be in question, 
the tool has been seen to be a valid screening tool and many still consider it to be a valuable 
clinical assessment tool (Cosco et al, 2012) 
 
In summary, 54 different tools were identified in the literature for use in determining presence 
or severity of depression itself or symptoms of depression. The most commonly used were 
self-report tools (BDI-II, PHQ-9, CES-D, HADS). Whilst all four of these tools have received 
criticisms regarding their factor structure, the BDI-II and PHQ-9 have much support in the 
literature.  Three of the tools are endorsed by NICE for assessing symptom severity (BDI-II, 
PHQ-9 and HADS).   
 
2.4.2.2 Aim/Review question 2: How do the depression tools identified 
differ? 
Tables 5-8 above include Information for each of the tools identified in the review.  This 
included information about, when the tool was developed, how many items it contains, how 
long it takes to complete, if the tool is in the public domain or whether it is copyrighted, if cut 
off scores are provided for its use as a screening tool. Finally, it was noted how many times 
each tool appeared in the studies identified as relevant for this review and how the tools were 
used in the studies.    
Each of the types of tools identified above (Self-report, clinician administered scales, clinical 
interview and other) will be considered in turn.   
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2.4.2.2.1 Self-report scales questionnaires, inventories or checklists 
45 self-report tools were identified in the studies included in this review.  The different 
characteristics of these studies (eg age, length of time of administration, recall period etc) will 
now be considered.   
2.4.2.2.1.1 When were the tools developed? 
Of the 45 self-report tools identified, the oldest was the BDI (Beck depression inventory) 
originally developed in 1961 and the newest was the LAPS (Leuven Affect and Pleasure scale) 
developed in 2017 and still undergoing validation and testing with different populations.  
 2.4.2.2.1.2 Completion time 
There was limited information on the length of time it takes to complete the different self-
report scales and inventories with many scales or related articles not providing details.  Of 
those where a completion length was provided the SCL-90 (symptom checklist) was stated to 
be the longest at 12-15 minutes.  The shortest was the short versions of the CES-D (The Center 
for Epidemiological studies depression scale) at 1-2 minutes and the K6 (Kessler distress scale) 
at less than 2 minutes.   
2.4.2.2.1.3 Number of items 
Whilst a number of factors may influence the time it takes to complete the self-report scales, 
the number of items is the predominant factor.  The SCL-90 had the highest number of items 
of all self-report scales (at 90 items) along with the MASQ which also had 90 items, as noted 
above the SCL-90 had the longest report completion length.  The PHQ-2 had the fewest 
number of items, containing only 2 items, no information was found on time to complete the 
PHQ-2.  Once the number of items are reviewed it gives an understanding about the 
completion time which also varied and seemed from the review to correlate with number of 
items.   
2.4.2.2.1.4 Recall period 
The recall period, the time period which individuals are asked to consider their symptoms 
over, varied for the 45 self-report tools found from ‘the past few days’ (CRSD (Carroll Rating 
Scale for Depression) & SDS (Zung Self-rating Depression Scale)) to the past 30 days (eg SRE-20 
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(Self-reporting Questionnaire)).  The recall periods varied across tools as shown in table 9 
below 
Table 9: Number of tools for different recall periods 
 
 
 
The DSM-IV and ICD-10 classification of depression require symptoms to have been present for 
at least 2 weeks (American Psychiatric Association, 2013; World Health Organisation, 1992). 
The scales which asked for symptoms over the last 4 weeks were mostly scales which were not 
originally developed to specifically screen for depression (eg K6 and K10, SF-12) but which may 
be used to screen for other mental health problems such as anxiety which requires symptoms 
to be present for a much longer period of time (WHO, 1992).   The General-Health 
Questionnaires which asks for ‘recent’ symptoms were developed to be sensitive to short-term 
psychiatric disorders and are not designed for long-term assessment.   
 
2.4.2.2.1.5 Public domain/copyrighted tools 
Of the 45 self-report tools, 24 were in the public domain.  Some of these (eg RRS (Rumination 
Response scale) require specific references to be cited for their use (eg RRS – 10).  11 of the 
tools identified required permissions and/or payment for their use.  Payments vary for some of 
the tools (HADS, GHQ-12) dependent on their use.  For example, the GHQ-12 commercial 
royalty fees are €500 (approximately £440) per language for commercial uses and €100 
(approximately £88) per language for non-commercial users.   
 
 
Recall period Number of 
Scales/inventories 
Past few days 2 
Past week/ 7 days 12 
Last 2 weeks 14 
Last 30 days/ 4 weeks 8 
Recently 4 
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 2.4.2.2.1.1 How the tools were used 
The majority of the self-report tools identified were developed to assess symptoms relating to 
depression.  Some of these tools only measure depression symptoms (for example the BDI, 
PHQ), other measure depression symptoms along with other symptoms such as anxiety (eg 
HADS) and/or stress (Eg Depression anxiety and stress scale DASS).  However, some of the 
tools were developed to measure other symptoms but have been found to correlate with 
depression and as such are used for measuring depression in some studies (eg the Kessleer 
distress scales and the World Health organisation wellbeing index – WHO-5).   
In the studies using self-report inventories included in the current review, the tools were used 
to measure depression for a range of purposes.  These include:  
• Measuring prevalence of depression in different populations – 121 studies  
• Review of the psychometric properties of the tool (reliability, validity, factor structure) – 
49 studies 
• Comparing different population groups (eg gender, ethnicity, year of study)- 19 studies  
• Evaluating the effectiveness of the self-report tool for screening depression – 22 studies 
• Comparing different self-report tools – 14 studies  
• Development or evaluation of a tool in a different language – 7 studies  
• Other studies included, incorporating tools into technology (4 studies) tool development 
(4 studies), longitudinal studies (5 studies) 
Table 10 shows how the 4 most commonly used self-report depression tools were used in the 
studies 
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Table 10 How the 4 most commonly used self-report depression tools were used in the studies 
 
BDI 
(in 64 studies) 
CES-D 
(in 36  studies) 
HADS 
(in 24 studies) 
PHQ-9 
(in 50 studies) 
Prevalence 
studies 
40 
(63% of BDI 
studies) 
11 
(31% of CESD 
studies) 
6 
(25% of HADS 
studies) 
26 
(52% of PHQ 
studies) 
Psychometric 
properties 
4 
(6% of BDI 
studies) 
12 
(33% of CESD 
studies) 
7 
(29% of HADS 
studies) 
8 
(16% of PHQ 
studies) 
Comparing 
populations 
8 
(13% of BDI 
studies) 
4 
(11% of CESD 
studies) 
6 
(25% of HADS 
studies) 
3 
(6% of PHQ 
studies) 
Screening 
evaluation 
1 
(2% of BDI 
studies) 
1 
(3% of CESD 
studies) 
0 
(0% of HADS 
studies) 
9 
(18% of PHQ 
studies) 
Comparing 
tools 
8 
(13% of BDI 
studies) 
3 
(8% of CESD 
studies) 
5 
(21% of HADS 
studies) 
2 
(4% of PHQ 
studies) 
Different 
languages 
2 
(3% of BDI 
studies) 
1 
(3% of CESD 
studies) 
1 
(25% of HADS 
studies) 
0 
(0% of PHQ 
studies) 
 
The BDI and the PHQ-9 were most frequently used in prevalence studies and the CES-D and 
HADS were most frequently used in studies evaluating their psychometric properties.   
 
 
2.4.2.2.2 Clinician administered scales or inventories  
Three clinician administered depression scales or inventories were identified in the literature, 
these were the Hamilton depression scale (HAM-d, HRSD), the quick inventory of depressive 
symptomatology (QIDS) and the Montgomery-Asberg depression rating scale (MADRS).  The 
oldest of these was the HAM-D developed in 1960 and the newest was the QIDS developed in 
2003.  Number of items varied from 10 for MADRS to 29 for the longer version of the HAMS. 
The HAMS takes about 20 minutes to complete and the MADRS about 15-20 minutes, no 
information was found on the administration time of the QIDS. All the scales have a recall 
period of one week and whilst the HAMD and MADRS are freely available in the public domain 
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the QIDS is copyrighted.  Of the three scales the HAMD was the most prevalent in the 
literature, being used in 11 studies.  
2.4.2.2.3 Clinical Interviews 
Five Clinical interview tools were identified in the literature, the Composite International 
Diagnostic Interview (CIDI), the Mini-International Neuropsychiatric Interview (MINI), the 
primary care evaluation of mental disorders (PRIME-MD), the Schedules for Clinical 
Assessment in Neuropsychiatry (SCAN) and the Structured Clinical Interview (SCID).   They 
were all developed in the 1990’s with the earliest being the CIDI in 1990.  All five have a large 
number of questions to cover a range of mental disorders, but they acknowledge that not 
everyone would need all questions.  The CIDI, MINI and PRIME-MD have screening questions 
to determine which parts of the interview to use.  The SCAN and SCID have initial questions 
asking about what kinds of problems or symptoms have been experienced to allow the 
interviewers to determine which parts of the interview are required.  Given the all or part of 
the interviews may be used during any given interview, the administration time for the 
interviews vary from individual to individual.  The interview requiring the least amount of 
administration time is the MINII, which on averages takes between 15 and 30 minutes to 
administer.  The MINI is structured so that responders only answer yes or no to questions, 
allowing for a quicker interview.  All of the identified interviews except the SCAN are 
copyrighted and require some permissions and or payment for their use. Training is required 
for all the interviews. The CIDI, MINI and SCAN can be carried out by individuals who are not 
trained clinicians but who have received training.  Although the PRIME-MD is designed for use 
in general practice and as such designed for use by general practitioners, some studies (eg 
Preville et al, 2004) have trained other health professionals such as nurses to use the tool.  The 
SCID is designed for use by a clinician or trained health professional.   
2.4.2.2.4 Alternative tools 
The final tool identified in the literature is the Rorschach comprehensive system depression 
index (DEPI) identified in one study.  The DEPI is a structured version of the Rorschach inkblot 
test (Mondal, 2017). The inkblot test is described by Mihura and Meyer (2015) in their book 
‘The inkblot test’ as follows:   
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“The test including 10 inkblots: 5 are achromatic and 5 include chromatic colors. Respondents 
are asked what the inkblots “might be.” Their responses are coded, tabulated, and compared 
with norms for interpretation. “ 
Use of the Rorschach test in general (not just the depression index) has been controversial and 
had resulted in much discussion in the literature.  In 1999 Garb called for a moratorium on the 
use of the Rorschach Inkblot Test in clinical and forensic settings until the validity of different 
scores had been determined (Garb, 1999). In 2015 a meta-review provided a more detailed 
look at the Rorschach and determine it still had some use in clinical settings.  Specifically 
looking at the DEPI, little support has been given for its use and Mondal et al concluded that 
“DEPI scores should be interpreted with considerable caution when applied for diagnostic 
purposes.” 
In summary the 54 tools identified from the studies included in this review vary on a number 
of aspects.  Differences occur not only between the different categories of tool (eg self-report 
versus clinical interview) but there are also differences in some of the characteristics seen 
within categories, for example in the recall-period of the different self-report tools which vary 
from the past week to the past month.   
 
 
2.4.2.3 Aim/Review question 3: Is there a difference between which 
tools for measuring depression are used in studies with students, 
medical students and the general populations 
 
Out of the 261 studies identified in this review 79 studies used a general population sample, 
116 studies used a student sample and 74 studies used a medicals student sample.  Due to the 
low number of studies using clinician administered scales, clinical interviews and other tools, 
this section will concentrate only on the self-report scales. 
The 79 studies which included a general population sample used 28 different self-report tools.  
The 116 studies which included a student sample used 25 different self-report tools. The 
studies which included a medical student sample used 15 different tools.  Therefore, in the 
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studies included in the review, fewer tools were used with medical students than with the 
general population or other students.   
 
The studies identified in this review were split into categories based on the participants which 
took part and the percentage of studies using the different tools in each category was 
calculated.  The following table highlights for each category the percentage of studies using 
the most commonly used tools overall (as identified in section 2.4.1 above).  I.e. For the 
studies which included a general population sample 7% used the BDI, 25% the PHQ, 17% the 
CES-D and 16% HADS.   
 
Table 11 the percentage of studies in each participant category using the most commonly used 
tools 
 Percentage of all 
General 
Population studies 
identified which 
used this tool 
(n=79) 
Percentage of all 
student studies 
identified which 
used this tool 
(n=116) 
Percentage of all 
medical student 
studies identified 
which used this 
tool (n-74) 
BDI 8% 35% 34% 
PHQ-9 24% 16% 19% 
CES-D 18% 17% 3% 
HADS 17% 5% 9% 
 
 
Table 11 highlights that whilst the BDI was used in about 1/3 of all studies in both the student 
(n=35) and medical student (n=25) participant categories only 8% (n=6) of studies with a 
general population sample used the BDI.  The most commonly used tool with a general 
population sample was the PHQ-9 which was used in 24% (n=19) of studies with a general 
population sample. HADS was used least in studies with a student sample (5%, n=6) and most 
in studies with a general population sample (17% n=13).  Out of the four most commonly used 
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tools overall, the tools used fewest with a medical student sample was the CESD used in only 
3% (n=2) of medical student studies.  
How the tools were used in the studies with the different populations was also evaluated, 
results are shown in table 12 
Table 12 – Uses of the tools in the studies with different populations  
 
General population 
(79 studies) 
Students 
(116 studies) 
Medical students 
(74 studies) 
Prevalence 
studies 
22 
(28% of general 
population studies) 
50 
(43% of student 
studies) 
57 
(77% of medical 
student studies) 
Psychometric 
properties 
25 
(32% of general 
population studies) 
27 
(23% of student 
studies) 
1 
(1% of medical 
student studies) 
Comparing 
groups of 
participants 
5 
(6% of general 
population studies) 
15 
(13% of student 
studies) 
7 
(9% of medical 
student studies) 
Screening 
evaluation 
10 
(12% of general 
population studies) 
10 
(9% of student 
studies) 
3 
(4% of medical 
student studies) 
Comparing tools 
9 
(11% of general 
population studies) 
7 
(6% of student 
studies) 
1 
(1% of medical 
student studies)) 
Different 
languages 
2 
(3% of general 
population studies) 
4 
(3% of student 
studies) 
1 
(1% of medical 
student studies) 
 
In studies with the general populations, the most common use of self-report tools was to 
measure their psychometric properties.  For students and medical students, the most common 
use of the self-report tools was to measure the prevalence of depression, with 77% of medical 
student studies identified being used to measure prevalence of depression among medical 
students.   
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2.4.2.4 Summary of the depression review  
 
54 different tools for use in determining presence or severity of depression itself or symptoms 
of depression were identified in the literature.  The most common type of tool used in the 
studies identified were self-report tools with 45 different self-report tools being identified.  Of 
the 261 studies which measured depression found in the current review, 64 used the BDI, 50 
the PHQ, 36 the CES-D and 24 HADS 
The 45 self-report tools varied in relation to a number of characteristics including the purpose 
for which they were developed and the way in which they are used. The majority of the self-
report tools were developed for measuring depression, however 4 were originally developed 
for measuring other mental health problems.    In relation to the use of the tools, the tools 
were most commonly used for measuring prevalence, reviewing the psychometric properties 
of the tool, comparing different groups, evaluating the effectiveness of the tool for screening 
and comparing different self-report tools.  The most common use was for measuring the 
prevalence of depression in different populations which occurred in 121 studies.    In addition, 
the tools varied according to the length of time they take to complete, the number of items 
they included and the recall period.   3 clinician administered scales for measuring depression 
were identified.   The clinician administered scales take longer to complete than the majority 
of the self-report scales at around 20 minutes and include between 10 and 17 items.  5 clinical 
interviews for diagnosing depression were identified in the literature. They all have a large 
number of items but 3 have screening questions to determine which parts of the interview are 
required.  The clinical interviews between 11 minutes and 60 minutes to complete.  One 
alternative tool was identified for measuring depression which was the DEPi a structured 
version of the Rorschach inkblot test.  Limited information was available for this test and some 
have suggested its use should be treated with caution.   
Some differences were observed between the tools used by studies with general population 
samples and those with student or medical student samples. The PHQ-9 was more commonly 
used with general population samples and the BDI with students and medical students.  
Differences were also seen in the use of self-report tools with the different populations; In 
studies with the general population, the most common use of self-report tools was to measure 
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psychometric properties.  For students and medical students, the most common use was to 
measure the prevalence of depression.   
 
2.4.3 Anxiety review 
 
 83 studies relating to the measurement of anxiety in the three population groups (general 
population, students and medical students) were identified.  These were made of: 
• 26 studies relating to the measurement of anxiety in the general population 
• 42 studies relating to the measurement of anxiety in student populations 
• 16 studies relating to measurement of anxiety in medical student populations 
Included in these numbers is one study which included both student and medical student 
samples.  
The studies identified in the searches were then resourced and the tools included in them 
were identified.  Information about the tools were collected and compiled into tables 13-15.  
As with the depression review information collected included: 
• when the tool was developed,  
• how many items the tool contains,  
• how long it takes to complete,  
• if the tool is in the public domain or whether it is copyrighted  
• if cut off scores are provided for its use as a screening tool.  
• how many times each tool appeared in the references identified as relevant for this 
review. 
• Information about how the tool was used in the identified studies, using categories 
outlined in table 4 above.   
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Again, as with the depression review a closer look at the literature for the most frequently 
used tools for measuring anxiety was carried out and a discussion of these tools will be 
presented.  
 
2.4.3.1 Aim/review question 1: What tools have been used for measuring anxiety in 
studies with students, medical students and the general population in the last 10 
years? 
 
27 different tools were identified in the literature for use in determining presence or severity 
of anxiety itself or symptoms of anxiety (see tables 13-15).   
For the anxiety review, the tools could broadly be grouped into 3 separate categories:  
• Self-report scales questionnaires, inventories or checklists – 21 tools identified 
• Clinician administered scales or inventories – 2 tools identified 
• Clinical interviews – 4 tools identified 
A brief description of each of the three type of tools can be found in the depression review 
above.   
 
2.4.3.1.1 Self-report scales questionnaires, inventories or checklists 
The most common type of tool use in the studies identified were self-report tools.  Of the 83 
studies found in the current review, the most commonly used tools were the Beck Anxiety 
Inventory (BAI) used in 15 studies, followed by the Generalised Anxiety Disorder (GAD-7) scale 
used in 12 studies, the Depression, Anxiety and Stress Scale – 42  items version (DASS-42), 
used in 12 studies and the DASS-21 used in 11 studies.    Table 13 provides an overview of the 
identified self-report scales, questionnaire and inventories for measuring generalised anxiety.   
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Table 13 – Self-report tools identified for measuring generalised anxiety 
Tool 
Self-
report  
Long name When 
developed 
Time to 
complete 
Number 
of items 
Recall 
period 
Cost/copyright Suggested cut offs Number 
of 
studies 
found 
How the tool is used in 
the studies 
ADDQ Anxiety 
Disorder 
Diagnostic 
Questionnaire  
2010 Not 
reported 
4 parts Past 
month  
Public domain 27.5  1 Tool development = 1 
AKUADS Aga Khan 
University 
Anxiety and 
Depression 
Scale 
1998 Not 
reported 
25 2 weeks Used in Pakistan - 
Urdu language 
Cut-off of 19 for 
depression  
1 Prevalence = 1 
BAI 
 
Beck Anxiety 
Inventory 
1988 5-10 
minutes 
21 Past 
month  
Copyrighted 
$138.25 for a 
manual and 25 
forms 
0-9 normal 
10-18 mild 
19-29 moderate 
30+ severe 
15 Prevalence = 8 
Psychometrics = 3 
Comparing groups = 1 
Comparing tools = 2 
Tool development = 1 
BSI-18 Brief Symptom 
Inventory 18 
1993 4 minutes 18 Past week Copyrighted 
$132.85 for manual 
and 50 sheets 
T score of 63 or 
above suggests 
clinical levels anxiety 
1 Tool development = 1 
Cottle 
anxiety 
test 
No information 
found for this 
tool 
 
Not 
reported 
Not 
reported 
Not 
reported 
Not 
reported 
Not reported Not reported 1 Prevalence 
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Tool 
Self-
report  
Long name When 
developed 
Time to 
complete 
Number 
of items 
Recall 
period 
Cost/copyright Suggested cut offs Number 
of 
studies 
found 
How the tool is used in 
the studies 
DASS-21 
 
Depression 
Anxiety Stress 
Scale 
1995 3 mins 21 – 7 for 
each scale 
Past week In public domain Not reported 11 Prevalence = 2 
Psychometrics = 5 
Comparing groups = 1 
Translation = 2 
Comparing tools = 1 
Longitudinal = 1 
DASS-42 Depression 
Anxiety Stress 
Scale 
1995 – 2nd 
Edition 
7 minutes 42 – 14 
items for 
each scale 
(depressi
on, 
anxiety, 
stress) 
Past week In public domain Depression normal 
0-9, mild 10-13, 
moderate 14-20, 
severe 21-27, 
extremely severe 
28+ 
12 Prevalence = 5 
Psychometrics = 4 
Comparing groups = 1 
Tool development = 1 
GAD-7 Generalised 
Anxiety 
Disorder - 7 
2006 Not 
reported 
7 Last 2 
weeks 
Public domain • 0-5 = Mild anxiety 
• 6-10 = Moderate 
anxiety 
• 11-15 = 
Moderately severe 
anxiety 
• 15-21 = Severe 
anxiety 
12 Prevalence = 3 
Screening = 1 
Psychometrics = 3 
Comparing groups = 1 
Technology = 1 
GAD-Q-IV  
 
Generalised 
anxiety disorder 
questionnaire 
2002 Not 
reported 
10 6 months  Public domain  5.7 suggested by 
authors 
1 Tool development = 1 
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Tool 
Self-
report  
Long name When 
developed 
Time to 
complete 
Number 
of items 
Recall 
period 
Cost/copyright Suggested cut offs Number 
of 
studies 
found 
How the tool is used in 
the studies 
HADS Hospital Anxiety 
and Depression 
Scale  
1983 2–5 
minutes 
14 items  
7 
depressio
n,  
7 anxiety  
last week historically freely 
available.  
Royalty - 
commercial 600 
euros per language 
non commercial 
100 euros per 
language 
mild 8-10, moderate 
11-14, Severe 15-21 
9 Prevalence = 4 
Psychometrics = 1 
Comparing groups = 3 
Technology = 2 
K10 Kessler 10 item 
distress scale 
2003 Not 
reported 
10 items Past 4 
weeks 
In public domain Cut off of 20+ for 
mild  
25-29 moderate, 30-
50 severe 
2 Prevalence = 2 
K6 Kessler 6 item 
distress scale  
2002 Less than 
2 minutes 
6 items Past 4 
weeks 
In public domain Cut off of ≥13 2 Prevalence = 2 
MASQ 
 
Mood and 
anxiety 
symptom 
questionnaire  
1995 Not 
reported 
77 Not 
reported 
 
Not in public 
domain available 
from Prosetta 
stone 
Not reported 1 Psychometrics = 1 
OASIS Overall Anxiety 
Severity and 
Impairment 
Scale 
 
2006 2-3 
minutes 
5 Past week Public domain  8 1 Tool development = 1 
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Tool 
Self-
report  
Long name When 
developed 
Time to 
complete 
Number 
of items 
Recall 
period 
Cost/copyright Suggested cut offs Number 
of 
studies 
found 
How the tool is used in 
the studies 
PHQ-
4/GAD-2 
Generalised 
Anxiety 
Disorder-2 
2009 Not 
reported 
2 Past 2 
weeks 
Public domain Greater than or 
equal to 3 
3 Screening = 1 
Psychometrics = 1 
Diagnosis - 1 
 
PSWQ Penn State 
Worry 
questionnaire  
1990 Not 
reported 
16 No time 
period 
Public domain 45 1 Tool development = 1 
SAS Zung self-rating 
anxiety scale 
1971 Not 
reported 
20 Past 2 
weeks 
Public domain  Raw score of 36 cut 
off for clinically 
significant anxiety  
4 Prevalence = 2 
Psychometrics = 1 
Tool development = 1 
 
SCAT Sinha’s 
comprehensive 
anxiety test 
1995 15-20 
minutes 
90 N/A Available in India Not reported 1 Prevalence = 1 
 
STAI 
 
State-Trait 
Anxiety 
Inventory 
1983 10 
minutes 
40 Not 
reported 
Copyrighted $125 
for 50 inventories 
No cut off in 
administration 
materials.  
1 Screening = 1 
STAIS 
 
State-Trait 
Anxiety 
Inventory – 
State scale 
1983 5 minutes 20 Not 
reported 
Copyrighted No cut off in 
administration 
materials.  
1 Translation = 1 
WDQ Worry domains 
questionnaire 
1992 Not 
reported 
25 No time 
period 
Public domain Not reported 1 Psychometrics = 1 
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2.4.3.1.2 Clinician administered scales or inventories  
Two clinician administered scales for measuring generalised anxiety were identified in the 
literature, as seen in table 14 
 
2.4.3.1.3 Clinical Interviews 
Four Clinical interview tools were identified in the literature, the Composite International 
Diagnostic Interview (CIDI), the Mini-International Neuropsychiatric Interview (MINI), the 
Clinical interview schedule revised (CIS-R), and the Structured Clinical Interview (SCID) (See 
table 15).   As with the depression review, there were much fewer clinical interviews than self-
report scales use in studies measuring generalised anxiety.   
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Table 14 – Clinician rated tools for measuring generalised anxiety 
Tool - 
Clinician 
rated 
Long name When 
develope
d 
Time to 
complete 
Number 
of items 
Recall 
period 
Cost/copyright Cut offs Number of 
articles found 
Uses 
GAS Goldberg 
anxiety scale 
1987 Not 
reported 
9 items Past 
month  
public 5+ 1 Comparing tools = 1 
HARS Hamilton 
anxiety rating 
scale  
1959 10-15 
minutes 
14 Not 
reported 
Public <17 mild 
severity, 18–24 
mild to 
moderate 
severity  
25–30 
moderate to 
severe 
 
2 Service evaluation = 1 
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Table 15 – clinical interviews for measuring generalised anxiety 
Tool - 
Interview 
Long name When 
developed 
Time to 
complete 
Number of 
items 
Recall 
period 
Cost/copyright Training Number 
of 
articles 
found 
Uses 
CIDI Composite 
International 
Diagnostic 
Interview 
1990 15 mins 276 – although 
due to 
screening not 
all patients 
will be asked 
all questions 
Past 30 
days 
Copyrighted and a 
software licence 
required 
Training 
required 
6 Prevalence = 4 
Comparing tools = 1 
Diagnosis = 1 
CIS-R Clinical interview 
schedule revised 
1992 30 mins 14 symptom 
groups 
Previous 
month  
Not reported Training 
required 
1 Diagnosis = 1 
MINI  The Mini 
International 
Neuropsychiatric 
Interview  
1998 15 -30 
min 
The MINI 
consists of 19 
modules that 
explore 17 
disorders of 
Axis I of the 
DSM-IV 
Past 2 
weeks 
for 
initial 
sympto
ms  
A License Agreement 
must be signed and 
fees may be 
requested.  
Lay can be 
trained 
3 
 
Prevalence = 2 
Psychometrics = 1 
SCID Structured clinical 
interview 
1997 30 -60 
minutes  
Not reported Not 
reporte
d 
Fee payable based on 
intended use.  
Clinicians 
or trained 
mental 
health 
professiona
l 
3 Diagnosis = 1 
Comparing tools = 1 
Psychometrics = 1 
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2.4.3.1.1 Beck Anxiety Inventory (BAI) 
The BAI was one of the most prevalent anxiety tools used in the literature reviewed, appearing 
in 15 studies.  The BAI was developed as a brief measure of anxiety which aimed to 
discriminate between depression and anxiety (Julian, 2011).  As such the author included items 
specific to the physiological and cognitive symptoms of anxiety, which do not overlap with 
symptoms of depression. Leyfer et al (2006) suggest this focus on physiological symptoms 
extends its use to non-clinical samples and as such the BAI has been used widely.  The BAI has 
been translated into a number of languages and has been used with a range of different 
samples including students (and medical students) and community samples (Julian, 2011).  The 
BAI is considered to have good convergent validity with other measures of anxiety and good 
internal consistency (Julian, 2011).  Although there is some discussion in the literature 
regarding the factor structure of the BAI and whether the BAI is a better measure of symptoms 
of panic rather than general anxiety (Leyfer et al, 2006).  Since its development different factor 
structures have been suggested for the BAI, ranging from 2 to 5 (De lima et al, 2011).  Some of 
these suggested factor structures better reflect the nature of panic disorders rather than 
anxiety disorders (Leyfer et al 2006).  In addition, the BAI also has been found to have better 
convergent validity with measures of panic disorder than with measures of generalised anxiety 
(Leyfer et al, 2006).  Leyfer et al suggest this discord is due to the original aim of the BAI as a 
measure of anxiety which could also discriminate between depression and anxiety.  This aim 
resulted in the exclusion of anxiety symptoms which overlap with symptoms of depression, 
leaving more symptoms which link to panic disorders.  Muntingh et al (2011) suggested that 
the testing of the BAI in settings such as treatment centres might result in participants with a 
greater severity of disorder than in primary care.  Muntingh et al however, concluded that the 
BAI does measure general anxiety in primary care.  Others conclude that if it is to be used as a 
measure of general anxiety, any user should be aware of its limitations,  in particular users 
should consider that the BAI may provide an assessment of one aspect of anxiety and 
therefore may require other forms of assessment alongside (Leyfer et al, 2005).   
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2.4.3.1.2 Generalised Anxiety Disorder (GAD-7) scale 
GAD-7 (Spitzer et al. 2006) was the second most commonly used tool identified from the 
studies include in this review, used in 11 studies.  The GAD-7 was developed from the PRIME-
MD diagnostic interview and measures a range of anxiety disorders including generalised 
anxiety disorder, social anxiety and panic disorder (Maideen et al, 2015).  The tool has 7 items 
which are each scored from 0-3, giving a total score of 21.  A cut off of 10 is suggested for 
detecting generalised anxiety using the GAD-7 scale (Johansson et al, 2013), however a cut-off 
of 8 has been shown to have a better balance of sensitivity and specificity (Kroenke et al., 
2007).  The GAD-7 has been translated into a number of different languages including German 
(Wiltink et al), Swedish (Johansson et al, 2013) and Chinese (Lu et al).  The GAD-7 has been 
found to be a reliable and valid tool for measuring anxiety in the general population (Lowe et 
al, 2008).  Comparisons with the Beck Anxiety Inventory shown a high correlation between the 
2 tools (Kroenke et al., 2010). 
 
2.4.3.1.3 Depression, Anxiety and Stress Scale – 42 (DASS-42) 
The DASS-42 was one of the most prevalent anxiety tools cited in the literature reviewed, 
appearing in 12 studies.  The DASS is a set of three scales designed to measure depression, 
anxiety and stress. Each scale has 14 items, which are scored from 0–3, with higher scores 
indicating greater levels of depression, anxiety, and/or stress (Gale, 2015).  Similarly, to the 
development of the BAI, the DASS-42 was developed with the aim of discriminating between 
depression and anxiety (Ediz et al, 2017).  Items which were considered for inclusion, but 
which were not closely related to depression and anxiety formed a third group which became 
known as the stress scale (Ediz et al, 2017).  studies included in this this review, which 
discussed the factor structure of the DASS-42, supported the three-factor structure (Bilgel & 
Bayram, 2010; Chan et al, 2012).  Both of the DASS scales have been validated against other 
measures and have been found to possess good reliability in both clinical and community 
samples (Beesdo-Baum et al, 2014).  Dunstan et al (2017) compared the DASS-42 with two 
Zung scales; the Zung depression scale (SDS) and the Zung anxiety scale (SAS).  Dunstan et al 
found the DASS-42 to be a stronger predictor of depression and anxiety but also found a high 
correlation between the depression and anxiety subscales.  Dunstan et al suggested this was 
due to the co-morbidity of the two conditions.  
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2.4.3.1.4 Depression, Anxiety and Stress Scale – 21 (DASS-21) 
The DASS-21 is a shortened version of the DASS-42.  Whilst the DASS-42 contains 14 questions 
for each subscale, the DASS-21 contains 7 questions for each subscale.  Both of the DASS scales 
have been validated against other measures and have been found to possess good reliability in 
both clinical and community samples (Beesdo-Baum et al, 2014).  Antunez & Vinet (2012) 
found that the DASS-21 was valid for use with Chilean students and supported a 3-factor 
structure. Alfonsson et al (2017) were looking at the Swedish version of the DASS-21, whilst 
they found adequate support for a 3 factor model their results also support a bi-factor 
structure with depression, anxiety, stress and a general factor.  Alfonsson et al suggest that the 
stress and anxiety symptoms overlap which can make specific screening difficult.  Osman et al 
(2012) also found evidence of a general distress factor and stated their findings are consistent 
with the co-morbidity of mood and anxiety disorders.  Ruiz et al (2017), investigated the 
Spanish version of the DASS-21 and found support for a hierarchical factor structure, 
containing 3 ‘first-order’ factors (depression, anxiety and stress) and one ‘second order’ factor 
which they stated were ‘emotional symptoms’.  Whilst the discord between the factors may 
make screening difficult Alfonsson et al conclude that “In practice, it seems that the DASS-21 
can be used to measure both specific psychiatric domains and general psychological distress”.   
 
In summary, 27 different tools were identified in the literature for use in determining presence 
or severity of generalised anxiety itself or symptoms of generalised anxiety.  The most 
common type of tool used in the studies identified were self-report tools (BAI, GAD-7, 
DASS42/21).  Whilst the GAD-7 is considered by most to be a reliable and valid tool.  The BAI 
and DASS scales have been criticised for their structure and overlap between the depression 
and anxiety scales (the BAI being compared to the BAI).  The BAI has also received criticism for 
measuring more aspects of panic disorder than generalised anxiety.   
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2.4.3.2 Aim/Review question 2: How do these anxiety tools identified 
differ? 
 
Information for each of the tools was collated and can be found in tables 13-15 above. A 
discussion of the differences between tools will be presented below, each of the types of tools 
identified above (Self-report, clinician administered scales and clinical interview) will be 
considered in turn.   
 
2.4.3.2.1 Self-report scales questionnaires, inventories or checklists 
 
23 self-report tools were identified in the studies included in this review.  The different 
characteristics of these studies (eg age, length of time of administration, recall period etc) will 
now be considered.   
2.4.3.2.1.1 When were the tools developed? 
Of the 23 self-report tools identified, the SAS has been in use the longest, having been 
developed in 1971. The tool most recently developed was the SQ-48 developed in 2012. 
2.4.3.2.1.2 Completion time 
There was limited information on the length of time it takes to complete the different self-
report tools.  Of those where a completion length was found the SCAT was stated to be the 
longest at 15-20 minutes and the K6 was found to be the quickest to complete, taking less than 
2 minutes. As with the depression review, one factor affecting the length of completion is the 
number of items contained within the tool. 
2.4.3.2.1.3 Number of items 
The SCAT contains the greatest number of items, at 90 items which may explain why it takes 
longer to complete than the K6 which contains only 6 items.  The tool with the fewest number 
of items was the GAD-2 (part of the PHQ-4) which contains only 2 items.   
 85 
 
 
2.4.3.2.1.4 Recall period 
The recall period, the time period which individuals are asked to consider their symptoms 
over, varied for the 23 tools found, from the past week (BSI, DASS-21&42, HADS, OASIS) to the 
past 6 months (GAD-IV).  4 tools asked about symptoms over the last 2 weeks (GAD-7, GAD-2, 
SAS), 4 tools asked about symptoms over the past month or 4 weeks (ADDQ, BAI, K10 & K6, 
AKUADS).  6 did not mention any time frame  but just asked how often the if the individual had 
these symptoms for example: always, sometimes or never (MASQ, PSWQ, STAI, STAIT, STAIS, 
WDQ).  The DSM-IV and ICD-10 classification of generalised anxiety requires symptoms to have 
been present for at least 6 months (American Psychiatric Association, 2013; World Health 
Organisation, 1992).  Only 1 tool asked about symptoms going back that far.  There may be a 
number of reasons why this might be the case for example many of these tools are developed 
for screening for anxiety and not diagnosing generalised anxiety disorder.  In the case of 
screening for the purposes of providing help, it may not be necessary to wait for 6 months for 
a diagnosis of generalised anxiety disorder prior to starting support.   
 
2.4.3.2.1.5 Public domain/copyrighted tools 
 
Of the 21 self-report anxiety tools identified, 12 are in the public domain and 6 require some 
permission and/or payment for their use.  For some of these tools payment varies depending 
on use for example, research verses commercial use (see HADS).  Of the tools which require 
payments, these varied from 600 euros (£539) for HADS commercial use to $138.25  (approx. 
£107) for a BAI manual and 25 forms.  
 
In summary, the 21 self-report scales for measuring anxiety varied on a range of characteristics 
including number of items, completion time and the recall period.  The clinician administered 
scales and clinical interview will now be considered.   
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 2.4.3.2.1.6 How the tools were used 
The 23 self-report anxiety tools which were identified from the studies included in this review 
differed in terms of their purpose and usage.  19 of the tools were developed to measure 
anxiety, 2 of the tools were developed as distress scales (K6 & K10) and 2 as worry scales 
(PSWQ, WDQ).  These 4 tools however have since been used to measure general levels of 
anxiety in studies.   
 
In the studies using self-report inventories included in the current review, the tools were used 
to measure anxiety for a range of purposes.  These include:  
• Measuring prevalence of anxiety in different populations – 40 studies  
• Review of the psychometric properties of the tool (reliability, validity, factor structure) – 
17 studies 
• Comparing different population groups (eg gender, ethnicity, year of study)- 6 studies  
• Evaluating the effectiveness of the self-report tool for screening depression – 4 studies 
• Comparing different self-report tools – 3 studies  
• Development or evaluation of a tool in a different language – 4 studies  
• Other studies included, incorporating tools into technology (1 study) tool development (4 
studies), testing diagnostic ability (2 studies).   
The following table shows how the 4 most commonly used self-report anxiety tools were used 
in the studies 
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Table 16 How the 4 most commonly used self-report anxiety tools were used in the studies 
 
BAI 
(in 15 studies) 
GAD-7 
(in 12  studies) 
DASS-21 
(in 11 studies) 
DASS-42 
(in 12 studies) 
Prevalence 
studies 
8 
(53% of BAI 
studies) 
6 
(50% of GAD7 
studies) 
5 
(45% of DASS21 
studies) 
2 
(17% of DASS42 
studies) 
Psychometric 
properties 
3 
(20% of BAI 
studies) 
3 
(25% of GAD7 
studies) 
4 
(36% of DASS21 
studies) 
5 
(42% of DASS42 
studies) 
Comparing 
groups 
1 
(7% of BAI 
studies) 
1 
(8% of GAD7 
studies) 
1 
(9% of DASS21 
studies) 
1 
(8% of DASS42 
studies) 
Screening 
evaluation 
0 
(0% of BAI 
studies) 
1 
(8% of GAD7 
studies) 
0 
(0% of DASS21 
studies) 
0 
(0% of DASS42 
studies) 
Comparing 
tools 
2 
(13% of BAI 
studies) 
0 
(0% of GAD7 
studies) 
0 
(0% of DASS21 
studies) 
1 
(8% of DASS42 
studies) 
Different 
languages 
0 
(0% of BAI 
studies) 
0 
(0% of GAD7 
studies) 
0 
(0% of DASS21 
studies) 
2 
(17% of DASS42 
studies) 
 
The BAI, GAD-7 and DASS-21 were most frequently used in prevalence studies, in contrast the 
DASS-42 was most frequently used in studies reviewing the psychometric properties of the 
tool.   
 
 
2.4.3.2.2 Clinician administered scales or inventories  
Two clinician administered anxiety scales were identified in the literature, these were the 
Hamilton anxiety rating scale (HARS), and the Goldberg anxiety scale (GAS) The oldest of these 
was the HARS developed in 1959 and the most recently developed was the GAS in 1987.  The 
HARS takes around 10-15 minutes to complete, no information was found for the 
administration time of the GAS.  The number of items included in the scales range were 9 for 
the GAS, and 14 for the HARS.  No information was found on the recall periods of the HARS, 
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the GAS asks about symptoms during the past month.  Both of the clinician-administered 
scales are available in the public domain.   
 
2.4.3.2.3 Clinical Interview 
Four clinical interview tools were identified in the literature for use in diagnosing anxiety these 
being the Composite International Diagnostic Interview (CIDI), the Clinical Interview Schedule 
(CIS-R), the Mini International Neuropsychiatric Interview, (MINI) and the Structured Clinical 
Interview (SCID).  All the interviews were developed in the 1990s with the earliest being the 
CIDI in 1990 and the most recent the MINI in 1998.  The CIDI contains 276 items but has 
screening questions to determine which parts of the interview to use.  The CIS-R contains 
questions asking about 14 symptom groups and the MINI included 19 modules that explore 17 
disorders. The administration time for the different clinical interviews varied from 15 minutes 
for the CIDI up to 60 minutes for the ADIS.  All of the identified interviews are copyrighted and 
require some permissions and or payment for their use. Training is required for all the 
interviews, but the training and administration can be completed by non-clinicians.   
In summary 27 different tools were identified in the literature for use in determining presence 
or severity of generalised anxiety.  23 of these were self-report tools, 3 were clinician 
administered scales and 4 were clinical interviews. The anxiety tools identified varied on a 
number of aspects.  Differences occur not only between the different categories of tool (eg 
self-report versus clinical interview) but there are also differences in some of the 
characteristics seen within categories, such as the mental health condition for which the tools 
were developed.   
   
2.4.3.3 Aim/Review question 3: Is there a difference between which 
tools for measuring depression are used in studies with students, 
medical students and the general populations 
 
The 27 anxiety tools identified in the literature have been developed and validated for use 
with different populations. This review searched for papers which had included the general 
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population, students and/or medical students as keywords.   Out of the 83 studies identified in 
this review which used anxiety measures, 26 studies used a general population sample, 42 
studies used a student sample and 16 studies used a medical student sample.  Due to the low 
number of studies using clinician administered scales, clinical interviews and other tools, this 
section will concentrate only on the self-report scales. 
The 26 studies which included a general population sample used 18 different self-report tools.  
The 42 studies which included a student sample used 20 different self-report tools. The 16 
studies which included a medical student sample used 9 different tools.  Therefore, in the 
studies included in the review, fewer tools were used with medical students than with the 
general population or other students.   
The studies identified in this review were split into categories based on the participants which 
took part and the percentage of studies using the different tools in each category was 
calculated.  The following table highlights for each category the percentage of studies using 
the most commonly used tools (as identified in section 2.4.1 above).   
Table 17 the percentage of studies in each participant category using the most commonly used 
tools 
 Percentage of all 
General 
Population studies 
identified which 
used this tool 
(n=26) 
Percentage of all 
student studies 
identified which 
used this tool 
(n=42) 
Percentage of all 
medical student 
studies identified 
which used this 
tool 
(n-16) 
BAI 0% 26% 31% 
GAD-7 27% 10% 6% 
DASS-42 9% 19% 13% 
DASS-21 4% 19% 13% 
HADS 8% 10% 19% 
Table 17 highlights the difference between the tools used with general population samples and 
those with student and medical student samples.  27% (n=7) of studies which involved general 
population samples used the GAD-7 scales, no studies with a general population sample used 
the BAI.  In contrast the BAI was the most commonly used tool in studies which involved 
students (11 studies – 26%) and medical students (5 Studies – 31%). HADS was used in 2 
general population studies (8%), 4 student studies (10%) and 3 medical student studies (19%).    
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How the tools were used in the studies with the different populations was also evaluated, 
results are shown in table 18.  
 
Table 18 – Uses of the tools in the studies with different populations  
 
General population 
(26 studies) 
Students 
(42 studies) 
Medical students 
(16 studies) 
Prevalence 
studies 
11 
(42% of general 
population studies) 
18 
(43% of student 
studies) 
12 
(75% of medical 
student studies) 
Psychometric 
properties 
6 
(23% of general 
population studies) 
11 
(26% of student 
studies) 
0 
(0% of medical 
student studies) 
Comparing 
groups of 
participants 
1 
(4% of general 
population studies) 
3 
(7% of student 
studies) 
2 
(13% of medical 
student studies) 
Screening 
evaluation 
0 
(0% of general 
population studies) 
2 
(5% of student 
studies) 
2 
(13% of medical 
student studies) 
Comparing tools 
1 
(4% of general 
population studies) 
1 
(2% of student 
studies) 
1 
(6% of medical 
student studies)) 
Different 
languages 
2 
(8% of general 
population studies) 
2 
(5% of student 
studies) 
0 
(0% of medical 
student studies) 
 
For all study populations the most common use of self-report tools was to measure the 
prevalence of anxiety.    
 
 
2.4.3.4 Summary of the anxiety review  
 
27 different tools were identified in the literature for use in determining presence or severity 
of anxiety itself or symptoms of anxiety. 23 self-report anxiety tools, 3 clinician administered 
scales and 4 clinical interviews were identified for measuring anxiety.  Within the 83 studies 
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which measured anxiety in the current review, 15 used the BAI, 12 the GAD-7, 12 the DASS-42 
and 11 the DASS-21.   
The 23 self-report anxiety tools differed in terms of their purpose and usage.  19 of the tools 
were developed to measure anxiety, however 2 of the tools were developed as distress scales 
(K6 & K10) and 2 as worry scales (PSWQ, WDQ).  In 40 studies the anxiety self-report tools 
were used to measure prevalence of anxiety with 17 studies evaluating the psychometric 
properties of some of the anxiety self-report tools.   Time to complete the scales varied from 2 
minutes to 15-20 minutes and number of items varied from 2 to 90.    As with the depression 
review the recall period varied greatly for the different tools from the past week to the past 
month. 12 of the anxiety self-report tools are available in the public domain and 6 require 
permissions and/or charge for use.   
Three clinician administered anxiety scales were identified in the literature, (HARS, GAS & 
BAS).  The BAS and HARS both take around 10-15 minutes to complete, and number of items 
included in the scales ranged from 9 to 14.  No information was found on the recall periods of 
the BAS and HARS, the GAS asks about symptoms during the past month.  All three of the 
clinician-administered scales are available in the public domain.   
Four clinical interview tools were identified in the literature for use in diagnosing (CIDI, CIS-R, 
MINI & SCID).  The CIDI contains 276 items but has screening questions, the CIS-R contains 
questions asking about 14 symptom groups and the MINI 17 disorders. The administration 
time for the different clinical interviews varied from 15 minutes up to 60 minutes.  All of the 
identified interviews are copyrighted and require some permissions and or payment for their 
use. Training is required for carrying out all the interviews however the training and 
administration can be carried out by non-clinicians.  
Some differences were observed between the tools used in studies with general population 
samples and those with student or medical student samples; The GAD-7 was more commonly 
used with general population samples and the BAI with students and medical students.  With 
each of the different population groups, the tools were most frequently used to measure the 
prevalence of anxiety.   
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2.5 Discussion  
This review asked three questions.  These were: 
1. What tools have been used for measuring depression and anxiety in studies with 
students, medical students and the general population in the last 10 years? 
2. How do these tools identified differ? 
3. Is there a difference between which tools are used for measuring depression and anxiety 
in studies with students, medical students and the general population samples? 
 
Three databases were searched and studies which involved the measurement of depression 
and anxiety with general population, students and medical student samples were identified.  
299 studies were identified, 261 of which included the use of depression measuring tools and 
83 included the use of generalised anxiety measuring tools, 45 studies included the 
measurement of both depression and anxiety. The tools used in these studies were identified 
and their characteristics noted.   
The results found in the review will now be summarised and discussed in relation to the review 
questions above 
 
2.5.1 Review question 1: What tools have been used for measuring 
depression and anxiety in studies with students, medical students and 
the general population in the last 10 years? 
 
2.5.1.1 Summary of findings 
54 different tools for use in determining presence or severity of depression itself or symptoms 
of depression were identified in the literature.  The most common type of tool used in the 
studies identified were self-report tools with 45 different self-report tools being identified.  In 
addition, 3 clinically administered scales were identified along with 5 clinical interviews and 
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one alternative tool.  Of the 261 studies which measured depression found in the current 
review, 64 used the BDI, 50 the PHQ, 36 the CES-D and 24 HADS.  
27 different tools were identified in the literature for use in determining presence or severity 
of anxiety itself or symptoms of anxiety. As with the depression review the most common type 
of tool used in the studies were self-report tools with 23 self-report anxiety tools identified.  3 
clinician administered scales for anxiety were identified along with 5 clinical interviews.  Within 
the 83 studies which measured anxiety in the current review, 15 used the BAI, 12 the GAD-7, 
12 the DASS-42 and 11 the DASS-21.  HADS was the 5th most commonly used tool to measure 
anxiety in the studies identified, having been used in 9 studies.   
 
2.5.1.2 Discussion of findings  
This review has identified a number of different depression and anxiety tools.  The main 
difference seen between the depression and anxiety tools available is the greater number of 
self-report depression tools compared to generalised anxiety self-report tools.  45 depression 
self-report tools were identified compared to 23 anxiety self-report tools. 7 tools were 
identified that were used to measure both depression and anxiety symptoms and, 3 other sets 
of scales were identified which whilst not combined scales were developed by the same author 
or following similar principles, and are often considered in conjunction(eg BDI/BAI, 
OASIS/ODSIS, SDS/SAS. Despite the greater number of self-report tools, the number of 
clinician-administered tools and clinical interviews identified were similar for both depression 
and anxiety (3 clinician-administered tools were identified for both depression and anxiety; 5 
clinical interviews were identified for depression and 4 for anxiety).   
One reason for the differences may be due to this review only searching for anxiety tools 
which measure generalised anxiety, rather than tools for measuring specific types of anxiety 
disorder, such as those looking at panic disorder or social anxiety or those tools measuring 
state anxiety.  Anxiety is a multifaceted condition which can include a range of different 
anxiety disorders with include generalised anxiety, social anxiety, phobias and panic disorders.  
In addition, anxiety can relate to different situations and tools have been developed for 
purposes such as test anxiety, for example Spielberger's Test Anxiety Inventory (TAI) 
(Spielberger, 2010).  Whilst there are some different types of depression such as post-natal 
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depression for which tools have been developed (for example the Edinburgh Postnatal 
Depression Scale (Cox et al, 1987)), the main condition is not made up of as many subtypes as 
is the case with anxiety.   
Differences were also seen in the number of self-report scales compared to clinician-
administered and clinical interviews.   For depression 45 self-report tools were identified 
compared to 3 clinician administered scales and 5 clinical interviews.  For anxiety 23 self-report 
tools were identified compared to 3 clinician administered scales and 4 clinical interviews 
It is unclear from the literature why there are so many self-report rating scales for both 
depression and anxiety.  Clinical interviews are seen by many as the gold standard of 
assessment due to their thorough assessment and relatively positive psychometric evaluations 
(Gelaye et al, 2014).  Therefore, it may be that these tools are accepted, particularly in the 
research community and as such are not seen as requiring significant improvement.  This may 
not be the case with self-report tools.  Researchers may be trying to find or create ‘better’ self-
report tools which have higher predictive values, which are quicker and easier to complete, 
and which could be used for diagnosis.   In 1960 when developing his depression scale 
Hamilton wrote  
“The appearance of yet another rating scale for measuring symptoms of mental disorder may 
seem unnecessary, since there are so many already in existence and many of them have been 
extensively used.  Unfortunately, it cannot be said that perfection has been achieved, and 
indeed, there is considerable room for improvement” (Hamilton, 1960 p56).   
Another reason for the increase use of self-report tools in the literature may be that they are 
easier and cheaper to use.  The use of tools which require clinician or researchers time are 
more time consuming and costly as such they may be a less popular option in research studies.   
 
2.5.1.3 Summary 
In summary, a large number of tools were identified in the literature for measuring both 
depression and anxiety.  More depression tools were identified and for both depression and 
anxiety many more self-report tools were identified in the literature.  Reasons for these are 
unclear but may be due to the current review only including studies looking at generalised 
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anxiety, rather than other types of anxiety.  The large number of self-report tools which have 
been developed may be due to their ease of use, that they are cheaper to use, or due to 
researchers trying to improve on reliability and validity of these types of tool.   
 
2.5.2 Review question 2: How do these identified tools differ? 
 
2.5.2.1 Summary of findings 
2.5.2.1.1. Depression  
54 different tools for use in determining presence or severity of depression itself or symptoms 
of depression were identified in the literature.   45 different self-report tools were identified.  
These 45 tools varied in relation to a number of characteristics.  Firstly, the different self-
report tool varied in both the purpose for which they were developed and the way in which 
they are used. The majority of the self-report tools were developed for measuring depression, 
however 4 were originally developed for measuring distress (K6, K10), general mental health 
(SF-12) and wellbeing (WHO-5).  In addition, 7 tools were identified that were used to measure 
both depression and anxiety symptoms within the same tool these included BSI-18, 
DASS21/42, HADS, K10, K6 and MASQ.  In addition, 3 other sets of scales were identified which 
whilst they are not combined scales were developed by the same author or following similar 
principles, and are often considered in conjunction. These were the BDI and the BAI developed 
by Beck, the OASIS and the ODSIS (the ODSIS was adapted from the OASIS) and the SDS and 
SAS Zung scales.   
In relation to the use of the tools, in 121 studies the tools were used for measuring the 
prevalence of depression in different populations, compared to 49 studies reviewing the 
psychometric properties of the tool and 22 studies evaluating the effectiveness of tools for 
screening. The BDI and PHQ were most commonly used for measuring prevalence and the CES-
D and HADS more commonly used in studies reviewing the psychometric properties of the 
tools.    The self-report tools differed in the number of items they include (from 2 items (PHQ-
2) to 90 items (SCL-90)). The SCL-90 has the longest reported completion length at 12-15 
minute. The recall period for which symptoms are considered varies from 7 days to 4 weeks.  
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24 of the self-report tools are available in the public domain, 11 require payment or for 
specific requirements to be met for their use.  
The 3 clinician administered scales which were identified for measuring depression also varied 
on the recoded characteristics.  The clinician administered scale take longer to complete than 
the majority of the self-report scales at around 20 minutes.  The clinician administered tools 
had between 10 and 17 items.  2 of the clinician administered tools are in the public domain 
and one is copyrighted.   
The 5 clinical interviews for diagnosing depression were identified in the literature. All of the 
clinical interviews were developed in the 1990s and have a large number of questions/items.  3 
of the clinical interviews have screening questions to determine which parts of the interview is 
required.  The clinical interviews take the longest time to complete of all the tools with the 
quickest being the PRIME-MD interview taking about 11 minutes.  The longest interview to 
administer is the SCID which can take up to 60 minutes.   
One alternative tool was identified for measuring depression which was the DEPi a structured 
version of the Rorschach inkblot test.  Limited information was available for this test in relation 
to the characteristics being compared. Its use is controversial, and authors have suggested its 
use should be treated with caution.   
 
2.5.2.1.2. Anxiety  
27 different tools were identified in the literature for use in determining presence or severity 
of anxiety itself or symptoms of anxiety. As with the depression review the most common type 
of tool used in the studies were self-report tools with 23 self-report anxiety tools identified.   
The 23 self-report anxiety tools which were identified from the studies included in this review 
differed in terms of their purpose and usage.  19 of the tools were developed to measure 
anxiety, however 2 of the tools were developed as distress scales (K6 & K10) and 2 as worry 
scales (PSWQ, WDQ).  These 4 tools however have since been used to measure general levels 
of anxiety in studies.  In 40 studies the tools were used to measure the prevalence of anxiety 
compared to 17 studies reviewing the psychometric properties of tools.  The BAI, GAD-7 and 
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DASS-21 were all most frequently used to measure prevalence in studies whereas DASS-42 was 
most commonly used in studies reviewing it’s psychometric properties.   
Less information was available on the length of time to complete the anxiety self-report scales, 
those with a suggested time ranged from 2 minutes to 15-20 minutes. The SCAT self-report 
tool contains the greatest number of items, at 90 items which may explain why it takes longer 
to complete (15-20 minutes) than the K6 which contains only 6 items and takes less than 2 
minutes to complete.  The tool with the fewest number of items was the GAD-2 (part of the 
PHQ-4) which contains only 2 items.  As with the depression review the recall period varied 
greatly for the different tools from the past week to the past month.  The DSM-IV and ICD-10 
classification of generalised anxiety requires symptoms to have been present for at least 6 
months (American Psychiatric Association, 2013; World Health Organisation, 1992).  Only 1 
tool asked about symptoms going back that far.  There may be a number of potential reasons 
for this difference. Many of these tools were developed for screening for anxiety and not 
diagnosing generalised anxiety disorder.  In the case of screening for the purposes of providing 
help, it may not be necessary to wait for 6 months for a diagnosis of generalised anxiety 
disorder prior to starting support.  14 of the anxiety self-report tools are available in the public 
domain and 9 require permissions and/or charge for use.   
Three clinician administered anxiety scales were identified in the literature, (HARS, GAS & 
BAS).  The BAS and HARS both take around 10-15 minutes to complete, no information was 
found for the administration time of the GAS.  The number of items included in the scales 
range were 9 for the GAS, 10 for the BAS and 14 for the HARS.  No information was found on 
the recall periods of the BAS and HARS, the GAS asks about symptoms during the past month.  
All three of the clinician-administered scales are available in the public domain.   
Four clinical interview tools were identified in the literature for use in diagnosing anxiety these 
being the Composite International Diagnostic Interview (CIDI), the Clinical Interview Schedule 
(CIS-R), the Anxiety Disorders Interview Schedule (ADIS) and the Structured Clinical Interview 
(SCID).  Limited information was found regarding the number of items included in the ADIS or 
the SCID.  The CIDI contains 276 items but has screening questions to determine which parts of 
the interview to use.  The CIS-R contains questions asking about 14 symptom groups. The 
administration time for the different clinical interviews varied from 15 minutes for the CIDI up 
to 60 minutes for the ADIS.  All of the identified interviews are copyrighted and require some 
permissions and or payment for their use. Training is required for all the interviews however 
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all can be carried out by individuals who are not trained clinicians but who have received 
training.   
 
2.5.2.2 Discussion of findings  
These findings highlight the wide variation in the tools available for measuring depression and 
anxiety.  The tools vary according to a number of factors including whether they are self-
report, clinician administered or clinical interviews.  In addition, the measures varied according 
to length of time they take to administer, number of items included, recall period, whether 
they are copyrighted ( so need to be purchased) and whether cut-off scores are provided for 
screening purposes.  When determining which tool to use, clinicians or researchers will need 
to consider these differences and make a decision based on their individual need.   
A number of discussion points arise from these differences and these will be considered below.  
These are 
• Criticisms of combined depression and anxiety scales 
• How tools are used 
• Time and cost versus quality of information gathered 
• Recall periods used 
2.5.2.2.1 Criticisms of combined depression and anxiety scales 
7 tools were identified that were used to measure both depression and anxiety symptoms 
within the same tool these included BSI-18, DASS21/42, HADS, K10, K6 and MASQ.  In addition, 
3 other sets of scales which are often considered in conjunction these being BDI/BAI, 
OASIS/ODSIS, SDS/SAS.  It may be considered that the use of these combined tools allow for 
quick and easy screening of both depression and anxiety (and stress in the case of the DASS 
scales) at the same time.  In addition, some of these combined tools (eg BAI, BDI) were 
developed to allow clinicians and researchers to measure one disorder irrespective of the 
other.  However, as discussed previously in the case of the BAI this has possibly led to some 
suggesting that the BAI more closely measures panic disorder rather than anxiety.  The 
combining of depression and anxiety measurement has also contributed to the criticism and 
evaluation of the factor structure of some of these tools, for example HADS (see section 
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2.4.2.1.8).  However, the factor structure of other independent depression and anxiety scales 
have also been questioned/evaluated (PHQ-9 – see section 2.4.2.1.6).  In addition, some have 
suggested that the correlations between depression and anxiety scales might be linked to 
underlying constructs and characteristics of the instruments or may be due to the overlap of 
symptoms and comorbidity of these conditions (Wang & Gorenstein, 2013).   
 
2.5.2.2.2 How tools are used  
The most common use of the self-report tools identified in the studies included in this review 
was to measure the prevalence of depression or anxiety.  121 studies reported on the 
prevalence of depression in studies with general population, student or medical student 
samples.  
The time frame chosen for the current review may have had an impact upon the nature of the 
studies in which scales were included. Only papers from 2007 onwards were included to allow 
the review to consider which tools are being used in current research, rather than considering 
all tools which have been developed but which may not still be in use.  The tools included in 
the study were developed between 1959 (Hamilton anxiety rating scale) and 2017 (Leuven 
Affect and Pleasure Scale).  It is likely that scales included in studies in the current review, 
which were developed many years ago will be included in studies of a different nature to those 
which have been developed more recently.  Scales developed many years ago may have 
already been included in lots of studies prior to 2007 in which their psychometric properties 
are tested.  If their psychometric rigour has already been extensively tested prior to 2007,  
then these scales may be more likely to be used for other purposes in more recent studies. For 
example, these scale maybe used for researching prevalence of depression or anxiety in 
different populations.  Alternatively, these well tested studies, may be used as a standard for 
comparing newly developed tools against.   
In the depression review, the BDI and PHQ-9 were most commonly used to measure 
prevalence of depression whereas the CES-D and HADS where more frequently used in studies 
which reviewed their psychometric properties.  These differences may reflect the weight of 
studies supporting the use of the BDI and PHQ-9.  Many studies have validated these tools for 
screening depression in different populations (Smarr & Keefer, 2011). In contrast HADS and 
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the CES-D have some support for their use as screening tools (Vilagut et al 2016, Mykletun et 
al, 2001). However, their use has received more criticism than the BDI and PHQ-9 (Coyne & 
van Sonderen, 2012 ; Zakrewska 2012). Therefore, the BDI or PHQ-9 may be considered a 
more reliable choice than HADS or the CES-D as a tool for screening for, or measuring 
prevalence of, depression.  In addition, researchers may continue to test the psychometric 
properties of HADS and the CES-D to provide more support for their continued use. 
The tools used in the anxiety review were also most commonly used to measure the 
prevalence of anxiety with 40 studies reporting on the prevalence of anxiety in studies with 
general population, student or medical student samples.   The BAI, GAD-7 and DASS-21 were 
most commonly used to measure prevalence, whereas the DASS-42 was more commonly used 
in studies investigating the psychometric properties of the tool.  The less frequent use of the 
DASS-42 in prevalence studies may be explained by the more common use of the DASS-21.  
The DASS-21 has less items and is therefore quicker to administer than the DASS-42.    
Whilst the tools mostly commonly used in the studies included this review (BDI, PHQ-9, CES-D, 
HADS, BAI, GAD-7, DASS-21, DASS-42) have all been suggested to be valid for screening 
depression or anxiety (Smarr, 2011; Julian, 2011; Thombs, 2016; Nilges & Essau, 2015), they 
were not developed as diagnostic tools (Smarr, 2011; Wang & Gorenstein, 2013).  For a true 
diagnosis, individuals identified by screening tools should be followed up with another method 
of diagnosis, for example a clinical interview (Thombs & Zieggelstein, 2014).  This has 
implications for studies measuring prevalence.  Many studies do not confirm diagnoses with a 
clinical interview but rather report prevalences based on the findings of self-report tools.  Levis 
et al (2019) suggest that this use of screening tests in prevalence studies is problematic.  Levis 
et al state: 
“Theoretically, based on sensitivity and specificity estimates, screening tools would be expected 
to exaggerate prevalence compared to rates based on diagnostic criteria, although the degree 
to which one would expect this to be the case would depend on the specific screening tool and 
cut-off used. Because the false positive rate of screening tools is disproportionately high in 
lower prevalence populations, such as primary health care, estimated prevalence based on 
screening tools would be expected to be exaggerated most when true prevalence is lowest”  
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Therefore, whilst prevalence studies provide an indication of possible numbers of individuals 
within a population who may suffer from a condition, it is likely that true numbers may be 
lower.   
 
2.5.2.2.3 Time and cost versus quality of information 
In many cases administration time and cost must be weighed against the quality of the 
information gained from the tool. This affects not only the choice of type of tool (interview, 
clinician-administered or self-report) but also which individual tool might be chosen. For 
example, the clinician administered HAMD has long been seen as the standard for clinical trials 
(Cusin et al, 2009), however, its use, (and the use of clinician rated scales in general) in routine 
clinical practice is seen as costly and requiring additional clinician time (Uher et al, 2012).  The 
main argument in the literature relating to clinician administered scales relates to whether the 
time taken for their administration provides greater benefits in terms of their use and ability to 
diagnose or determine the severity of depressive symptoms. Cusin et al (2009) claim that there 
is disagreement in research as to the concordance rates of the two methods (Clinician rated 
and self-rated), concluding that the clinicians and patients rate symptoms differently.  Uher et 
al (2012) also conclude that clinician rated, and self-rated scales are not equivalent but suggest 
that each provide information that is relevant to clinical prognosis.   
In terms of self-report questionnaires, it is argued that in general practice, during 
appointments which last on average 9 minutes (Irving et al, 2017), unless key ‘sign-post’ 
symptoms of depression are mentioned by patients, GP may have a low suspicion of 
depression (Michell & Coyne, 2007).  If depression is suspected a screening tool may be used, 
however, even a tool which takes 2 minutes may be considered too lengthy in a 9-minute 
appointment.  This has led to some authors endorsing scales with low item numbers for initial 
screening purposes in general practice (Mitchell & Coyne, 2007).   
Research studies, particularly those paying participants, may not be so concerned with the 
amount of time participants have to spend completing a questionnaire and may be more 
concerned with gaining rich data for analysis.  Clinical interviews are often seen as the gold 
standard to which other tools (eg self-rating scales) are compared (Gelaye et al, 2014).  
However, there is limited research surrounding their use in clinical practice. In one small study 
(with only 40 respondents) it was found that the majority of psychiatrists (72.5%) did not use 
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structured interviews (Aboraya, 2009).  Of the 27.5% that did use structured interviews the 
MINI or SCAN were the most used (Aboraya, 2009).  The time factor involved in their use was 
one reason why clinical interviews were not used.  Other reasons included they are designed 
as research tools, they interfere with establishing rapport with the patients and psychiatrists 
feel they do not need to use any structured interviews to diagnose or manage patients. 
(Aboraya, 2009). One US study suggests that clinical interviews using SCID resulted in more 
accurate diagnoses for new patients and that these could be carried out by trained nurses to 
help manage time and budget constraints (Kashner et al, 2003).    
Linked to the issues of time a measure takes to administer, is the cost of administration.  As 
suggested previously, measures which take longer to administer are considered most costly. In 
addition to the administration time cost, users must consider the potential cost of purchasing 
of some of the measures identified. Whilst some of the tools which require payment, such as 
the BDI, have been found to have high scores for reliability and validity (Jackson-Koko, 2016), 
other tools which are in the public domain have been found to be equivalent (Smarr & Keefer, 
2011), The cost of the BDI has led to some questioning if the cost of the BDI is “prohibitive 
given less expensive public domain assessments are readily available” (Smarr & Keefer, 2011, 
page S136). However, the cost of the BDI does not appear to have restricted the research 
interest in it, of the 261 depression related studies found in the current review, 64 used the 
BDI.   
 
2.5.2.2.4 Recall periods used 
Another factor, which varies for the different measures is the recall period during which 
symptoms are considered.  The DSM-IV and ICD-10 classification of depression require 
symptoms to have been present for at least 2 weeks (APA, 2013; WHO, 1992), however the 
recall period, the time period which individuals are asked to consider their symptoms over, 
varied for the depression measures from ‘the past few days’ to the past 30 days.  In terms of 
generalised anxiety, the DSM-IV and ICD-10 classification of depression require symptoms to 
have been present for at least 6 months (American Psychiatric Association, 2013; World Health 
Organisation, 1992).  The recall period of the anxiety tools identified varied from the past week 
to the past 6 months.  These miss-matches are often due to how the tools are developed, for 
example HADS, as it is assessing both depression and anxiety, asks for both subscale for 
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individuals to consider how they have been feeling over the last week.  Some of the tools were 
developed for other purposes (eg K6/K10) but have since been used to measure depression 
and as such the recall period may not be in line with the classifications for diagnosis.  In 
addition, many of the tools were developed for screening and not for diagnosing depression or 
anxiety.  The time frame for recall of symptoms, particularly for the diagnosing of anxiety is 
under debate in the wider literature.  Many claim a duration of one month should be sufficient 
for the diagnosis of generalised anxiety (Angst et al, 2006; Lee at al, 2008).  Another reason 
why tool developers may not use longer recall periods may be due to recall bias.  Recall bias is 
defined as “a systematic error that occurs when participants do not remember previous events 
or experiences accurately or omit details” (Spencer et al, 2017).  The over-estimating of past 
emotions is also referred to as the memory-experience gap (Urban, 2018).  It is thought that 
the over-estimation of negative emotions tend to be more pronounced than positive emotions 
(Urban, 2018).  Recall bias is greater when recalling events over a long time period (Spencer et 
al, 2017).  Clinical interviews allow participants to consider their symptoms and provide 
prompt questions to try and reduce recall bias, this is not as easy with self-report scales.  This 
may be why self-report scales only ask about symptoms up to a month previously.    
 
 
2.5.2.3 Summary 
In summary, the identified tools vary not only on the administration type but also on a range 
of characteristics.  A number of issues arise out of these differences which have been 
discussed.  These include how the tools are used and in particular the usage of screening tools 
in prevalence studies.  The criticisms of tools which measure both depression and anxiety have 
been highlighted particularly in relation to the overlap in the factor structures of the 
depression and anxiety subscales.  In addition, the need for balancing the cost and time of 
administration of the tests against the quality of information gained has been discussed.  
Finally, aspects relating to the recall period used in the tools have been discussed and reasons 
for the disparity of some of the recall periods with the time periods required for an ICD-10 
diagnosis considered 
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2.5.3 Review question 3: Is there a difference between which tools are 
used for measuring depression and anxiety in studies with students, 
medical students and the general population samples? 
 
2.5.3.1 Summary of findings  
2.5.3.1.1 Depression findings 
 
Out of the 261 depression related studies identified in this review 78 studies used a general 
population sample, 116 studies used a student sample and 74 studies used a medical student 
sample.  The 78 studies which included a general population sample used 28 different self-
report tools.  The 116 studies which included a student sample used 25 different self-report 
tools. The studies which included a medical student sample used 15 different tools.   
Not only were differences seen in the range of tools used in different samples, differences 
were also found in the most commonly used tools with the different samples. Whilst the BDI 
was used in about 1/3 of all studies in both the student (n=35) and medical student (n=25) 
participant categories only 8% (n=6) of studies with a general population sample used the BDI.  
The most commonly used tool with a general population sample was the PHQ-9 which was 
used in 24% (n=19) of studies with a general population sample. HADS was used least in 
studies with a student sample (5%, n=6) and most in studies with a general population sample 
(17% n=13).   
Studies with students and medical student populations most commonly used the tools to 
measure the prevalence of depression.  The majority (57 studies, 77%) of studies with a 
medical student sample used self-report tools to measure prevalence of depression compared 
to only 1 study (1%) reviewing the psychometric properties of self-report tools with medical 
students.  Studies with general population samples most commonly used the tools to evaluate 
the psychometric properties of the tool.   
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2.5.3.1.2 Anxiety findings 
Out of the 83 anxiety related studies identified in this review 26  studies used a general 
population sample, 42 studies used a student sample and 16 studies used a medical student 
sample.  As with the depression review there was a difference in the variety of tools used in 
the studies with these different groups, the 26 studies which included a general population 
sample used 18 different self-report tools.  The 42 studies which included a student sample 
used 20 different self-report tools. The 16 studies which included a medical student sample 
used 9 different tools.   
Not only were differences seen in the range of tools used in different samples, differences 
were also found in the most commonly used tools with the different samples. 27% (n=7) of the 
studies which involved general population samples used the GAD-7 scales, with no studies 
involving a general population sample using the BAI.  In contrast the BAI was the most 
commonly used tool in studies which involved students (11 studies – 26%) and medical 
students (5 Studies – 31%). In relation to HADS, HADS was used in 2 general population studies 
(8%), 4 student studies (10%) and 3 medical student studies (19%).    
The most common type of study across all three populations were studies measuring the 
prevalence of anxiety.  This type of study was most common with medical student populations 
with 75% (12 studies) measuring prevalence of anxiety with medical students.   
 
2.5.3.2 Discussion of findings  
These findings suggest that studies with general population samples, use a wider variety of 
tools relative to the number of studies identified, than students and medical students.   
In addition, the most commonly used tools varied between the studies with a general 
population sample and those with student or medical student samples. The PHQ-9 for 
depression and GAD-7 were most commonly used for general population samples.  Whereas 
the BDI for depression and BAI for anxiety were most commonly used for student and medical 
student samples.   
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While there may be a number of reasons for these differences, it is possible that these 
differences may be explained by the initial development and subsequent evaluation of these 
scales.  The PHQ-9 was first developed for use in primary care, having been designed to be a 
self-report version of the Primary Care Evaluation of Mental Disorders (PRIME-MD) 
(Kroenke,et al, 2001).  Since it’s development it has been widely used in primary care and 
medical settings.  However, studies have also supported its use in the general population with 
some suggesting it has high reliability and validity when used in the general population (Kocal 
event et al, 2013). The GAD-7 was developed by the same authors as the PHQ-9 and was also 
developed for use in primary care (Spitzer et al, 2006). As with the PHQ-9 the GAD-7 has 
received support as a measure of anxiety in the general population (Lowe et al, 2008). 
In contrast the BDI-II when developed was validated with college students and psychiatric 
outpatients (Smarrr & Keefer, 2011).  The BAI has been extensively tested with students (eg 
Smith et al, 2007). However, in studies with older populations, some research suggests that 
the discriminant validity of the BAI may be lower than in younger populations (Julian, 2014).  
This may explain why it is not used as frequently with general population samples which may 
contain older individuals than in student samples.   
The studies using medical student population included in the current review used similar self-
report tools to studies involving other students.  Whilst the use of the same tools across 
studies with different populations allows for more appropriate comparisons of results.  Only 
one study was identified across both the depression and anxiety review which investigated the 
psychometric properties of these tools with medical students (In contrast to 33 studies which 
investigated the psychometric properties of these tools with other students).   The validation 
of the BDI and BAI for use with general student populations may suggest that these tools are 
validated for use with medial students.  However, no studies have been identified (in this 
study, or in wider literature searches) which validated these tools (or any of the self-report) 
tools against a clinical interview to confirm their use with medical students.   
The introduction Section 1.4 highlighted the differences seen in medical students compared to 
some other students, including differences in the individual (eg personalities), the course 
(greater isolation, academic demands, ethical conflicts) and the culture in which medical 
students study (eg role models, career worries).  Therefore, it is possible that tools which have 
been validated for students in general, with optimum cut-off scores identified, may not be 
appropriate for medical students. 
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2.5.4 Strengths and weaknesses 
 
This review benefited from a structured literature review methodology to provide a qualitative 
summary of the literature on depression and anxiety scales used with the general population, 
students and medical students.  This methodology allowed for a wide-reaching review and 
comparison of the different depression and anxiety measures used in studies over the last 10 
years. The review provides an overview of the different features of the tools available to allow 
for comparison at an administration level.  Reviewing both depression and anxiety scales 
allowed for a comparison of measures across the disorders to identify similarities and 
differences in the issues raised by the review.  
 
One weaknesses of the current review is that within the scope of this review, an in-depth look 
at the psychometric properties of the different measures was not possible.  This review aimed 
to provide an overview of a large number of different measures available, rather than an in-
depth look at a few.  In addition, papers were not reviewed for their quality, but rather the 
measures used were identified and the basic scope/aims of the studies considered and 
reported. This review may have benefitted from the use of two researchers shortlisting the 
articles, to allow for consensus and to ensure that all relevant articles were kept, however this 
was not possible due to the nature of the project.   
 
Finally, more information regarding the countries in which the studies took place would again 
provide more details surrounding the use of different tools, for example are different tools 
used in the US to the UK or to China or India.      
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2.5.5 Conclusions  
 
The current review has highlighted the vast number of depression and anxiety tools available 
for use in research and clinical practice.  They vary greatly with regards to many aspects of 
their use and administration.  Whilst all of the most commonly used tools were used in studies 
with students, medical students and the general population, the frequency in which they were 
used with this different groups varied.   The tools used with medical student samples were 
similar to those used with other students, however no validated studies emerged that 
validated any of the self-report tools against a clinical interview to confirm their use with 
medical students.  Given the differences highlighted in the introduction between the groups of 
students and the need for local validation of tools as suggested by Ali et al, (2016), this is still 
an area which requires further research.   
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Chapter 3: Method 
3.1 Overview  
This chapter outlines the research methodology for the present study and explains how this 
methodology supports the aims of the study.  The chapter starts with the rationale for the 
study, an overview of the method, and an explanation over the choice of tools used.  Details of 
the training received by the author and support provided by other researchers will be outlined.  
Finally, a detailed description of the methodology will be presented.   
 
3.1.1 Rationale 
Chapter two described a structured literature review, looking at what is already known about 
measuring anxiety and depression in students generally and specifically in medical students.    
The review highlighted the large number of self-report scales used in studies compared to 
clinical interviews. Whilst the use of self-report scales provides benefits in terms of the time 
and cost taken to administer, clinical interviews are seen as the gold standard for diagnosing 
depression and anxiety (Anderson et al, 2002). Before screening tools can be used to screen 
individuals for a mental health condition it is important to evaluate the accuracy of the tool 
compared to a gold standard interview.  If the tool is able to correctly determine those people 
with a condition compared to those without, the screening tool’s use can be advocated.  
Many different scales have been used to measure depression and anxiety (separately or 
together) in students, however, results from different scales and different populations vary.   
One area where differences may occur, are the cut-off points used to determine caseness 
within different populations for different tools. Caseness being defined as ‘probable presence 
of the mood disorder’.  Some tools have been developed with one population, with norm-
based cut-offs advised, but then following validation with another population revised cut-offs 
have been suggested (Singer et al, 2009).   
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As outlined in the literature review in chapter 2, HADS is one of the four most commonly used 
tools for measuring and screening depression and anxiety in students both in the UK and 
internationally.  Some have questioned if HADS and other similar assessments can provide 
valid approximations of mental health conditions in students (Andrews et al, 2006).  Andrews 
et al validated HADS against clinical interview (using the SCID clinical interview) in a group of 
university students and concluded that the HADS depression scale was an accurate indicator of 
depression in this group using the recommended cut-off of 8 and above.  However, in this 
group the HADS anxiety scale overestimated the levels of anxiety (Andrews et al, 2006).  
Andrews concluded that for the sample tested both depression and anxiety optimum cut off 
scores differed from the recommended 8.  Andrews et al suggested an optimal cut-off of 10 for 
depression and 11 for anxiety.   
 
HADS has been used with medical students in a number of studies however there are limited 
studies looking at comparison of HADS against clinical interview in medical students.   
To address this, this study aimed to investigate the suitability of HADS as a screening tool for 
anxiety and depression in a medical student population by comparing HADS to a structured 
clinical interview (Schedules for Clinical Assessment in Neuropsychiatry) (SCAN).  Three 
research questions were posed: 
• Research question 1 – Is HADS an accurate measure of anxiety and depression in medical 
students? 
 
• Research question 2 – Are the standard cut off scores of 8+ on the HADS-D and HADS-A 
subscales appropriate for a medical student population? 
 
• Research question 3 – Do the responses to individual items within the HADS subscales 
truly reflect the presence of anxiety and depression.   
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3.1.2 Methodology overview 
The methodology was to undertake a pilot study, recruiting medical students from all year 
groups to take part in a face to face meeting where they completed HADS and undertook a 
clinical interview.  HADS was chosen due to it’s use in previous projects with medical students 
and to allow for comparison with the Andrews et al (2006) study.    The clinical interviews used 
the SCAN (Schedules for Clinical Assessment in Neuropsychiatry) interview.  Following the face 
to face meeting a mixed methodology was used for analysis.  Firstly, medical students HADS 
scores were compared to a diagnosis via clinical interview, using quantitative analysis to 
understand if HADS was able to distinguish between medical students who did have 
diagnosable levels of depression and/or anxiety and those who do not.  In addition, optimum 
cut off scores could be calculated.  Secondly, the interview responses of those students who 
had either false positive or false negative results on HADS (using the standard cut off scores of 
8 and above) in comparison to clinical interview were qualitatively reviewed.  This aimed to 
provide a more in-depth review of possible reasons for disparity between HADS scores and 
clinical interview.   
 
3.2 Choice of Tools 
 
The current study used two tools; HADS and SCAN.  Reasons behind the use of these tools are 
outlined below along with a description of each tool.  
 3.2.1 HADS 
HADS (see appendix 3) was chosen for use in the current project due to a number of factors.  
Firstly, the literature review outlined in chapter 2 found HADS was one of the more commonly 
used tools overall and with medical students. In the review HADS was used in 7 studies 
measuring depression with a medical student sample and in 4 studies measuring anxiety 
among medical students.  In addition, use of HADS allowed for a comparison with the Andrews 
et al (2006) study which had compared HADS to a clinical interview diagnosis with a general 
student sample (see section 3.1.1).   
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The hospital anxiety and depression scale was developed by Zigmond and Snaith (1983) to 
identify ‘caseness’ of anxiety and depressive symptoms in non-psychiatric settings.  It is a brief, 
easy to use screening tool which can be used to detect depression and anxiety separately or 
together as a measure of psychological distress (Bjelland et al, 2002).  HADS is designed for 
measuring depression and anxiety separately to other medical conditions and as such focuses 
on non-physical symptoms of depression and anxiety (Stern, 2014).   
HADS comprises two subscales HADS-A (anxiety) and HADS-D (depression) each with seven 
questions. Each question has four possible answers rated from zero to three.  Higher scores 
indicate higher levels of symptoms.   The scales were developed to ensure that the scale could 
distinguish between anxiety and depression (Zigmond and Snaith, 1983).  In addition, to 
prevent symptoms from other conditions such as somatic disorders affecting the depression 
and anxiety scores, all physical symptoms eg dizziness and headaches were excluded from the 
scales (Bjelland et al, 2002).   
HADS has been used extensively with a range of different populations but has been criticised 
due to inconsistencies in its factor structure (Coyne & van Sonderen 2012).  These 
inconsistencies and disparities have led to some suggesting that HADS should no longer be 
used (Coyne & van Sonderen 2012; Zakrewska 2012).   However, a comprehensive review of 
HADS stated that HADS has good levels of reliability and validity and is effective at screening 
for caseness of anxiety disorders and depression in patients (Bjelland et al, 2002).  It claimed 
that “HADS seems to have at least as good screening properties as similar, but more 
comprehensive, instruments used for identification of anxiety disorders and depression” 
(Bjelland et al, 2002).  In addition, it was concluded that HADS has the same properties when 
used in different samples including the general population, general practice, and with 
psychiatric patients (Bjelland et al, 2002).    Since the publication of the original scale many 
studies have reviewed the cut-off scores which give the greatest sensitivity and specificity for 
detecting clinical cases of anxiety or depression symptoms (Mitchell et al, 2010). In one review 
optimal cut offs were concluded to be 8 for each subscale with a total HADS score of 15+ being 
generally considered to be strongly indicative of psychological distress (Bjelland et al, 2002).  
However, there may be different optimal cut off scores for caseness in different populations.  
For example, Kendrick et al (2009) suggested that a cut-off point of ≥9 is appropriate for GPs to 
use to diagnose depression within the UK.  
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3.2.2 SCAN 
SCAN was chosen for use in the current project as it can be administered by a trained lay 
person and does not require the purchase of a licence for its use (See literature review section 
2.4.2.2.3).   
The Schedules for Clinical Assessment in Neuropsychiatry (SCAN) clinical interview technique is 
a set of instruments and manuals aimed at assessing, measuring and classifying 
psychopathology and behaviour associated with the major psychiatric disorders in adult life 
(Wing et al, 1990).  SCAN was developed by the World Health Organisation and was a 
development of the Present State Examination (Wing et al, 1990).  
Scan is a semi-structured interview technique which allows the interviewer to explore an 
individual’s symptoms whilst providing a glossary and guidance as to the clinical relevance of 
the symptom (Janca et al, 1994).  The technique allows the interviewer to decide the severity 
of a symptom and the length of time that symptom has been present (Janca et al, 1994).   Scan 
has been found to have good reliability and validity and has been used as a standard against 
which the validity of other instruments is tested (Nienhuis et al, 2010).   Although SCAN may 
not be used as frequently as might be expected given its strengths, (Nienhuis et al, 2010), it 
has been suggested this may be due to the length of time it takes to interview using SCAN.  
Alternatively it may be because historically it was designed for use by in clinical settings for 
example by psychiatrists and clinical psychologists (Janca et al, 1994).  More recent studies 
however have suggested that SCAN can give reliable results even when used by less 
experienced (but well trained) interviewers (Rijnders et al, 2000) as in the current study.  In the 
current study SCAN was used to determine clinical diagnoses of depression and generalised 
anxiety disorder (GAD) 
 
3.3 Training and support  
 
To assist with carrying out the interviews, Sarah Winstanley, a PhD student based at Centre for 
Psychosocial Research, Occupational and Physician Health was recruited.  
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Sarah Winstanley and the author received training from an expert (Dr Liz Forty) in 
administering the SCAN interview.  Dr Liz Forty is a psychologist with extensive experience at 
using and training in the use of the SCAN instrument. The training included instruction on how 
to carry out the semi-structured interviews and also in how to interpret the responses given to 
make a diagnosis.  Dr Liz Forty also provided support during the scoring of the interviews and 
determining diagnoses.   
 
3.4 Ethical approval  
The project received approval from Cardiff University, School of Medicine Research Ethics 
Committee.  Permission was granted in April 2014 (MREC 14/19).   
 
3.5  Participant selection  
The project was time limited and had financial constraints therefore a maximum of 50 medical 
students were recruited to take part in the face to face meetings for this project.  Whilst it was 
recognised that to comprehensively test the effectiveness and validity of HADS for a medical 
student sample would require recruitment of more students this was not possible in the 
present study.  However, as the author was not aware of any similar studies carried out with 
medical students it was considered that this study could form a useful pilot project.   
 
3.5.1 Inclusion and exclusion criteria 
Medical students were recruited using the following inclusion and exclusion criteria 
3.5.1.1 Inclusion Criteria 
Inclusion criteria for the project were that participants needed to be current medical students 
studying at Cardiff University, School of Medicine.    
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3.5.1.2 Exclusion Criteria 
Exclusion criteria included: 
• Anyone not currently studying at Cardiff University  
• Students not studying medicine 
 
3.5.3 Sampling  
Calculating the sensitivity and specificity of different HADS scores compared to a clinical 
diagnosis of depression and or anxiety required the recruitment of medical students with a 
range of HADS scores.  Two methods of sampling were considered to achieve this.   
Firstly, consideration was given to sampling students according to their HADS scores prior to 
interviewing. However, to eliminate any bias within the interviews it was decided that the 
interviewers should not know the HADS scores until the student had completed the entire face 
to face meeting.  To sample students according to their HADS scores would have required 
additional staff (who were not undertaking the interviews) and would have required more 
students to be recruited (as not all students recruited would have taken part in the interviews).  
Due to time and financial constraints this was not possible.   
Secondly, in an attempt to recruit medical students with a range of HADS scores, consideration 
was given to sampling according to a medical diagnosis of depression and or anxiety.  
However, it was acknowledged that not all individuals with depression and anxiety will have 
had a formal diagnosis.  Research has highlighted that many medical students and doctors are 
reluctant to seek support (Hillis et al, 2010).  In addition, a previous diagnosis of depression 
and or anxiety would not guarantee that individuals had higher HADS scores.  Those who had a 
previous diagnosis may also have had some treatment for their depression and or anxiety and 
thus may no longer be symptomatic. Therefore, it was decided that medical students would 
not be sampled according to a diagnosis.   
Instead different recruitment strategies were considered, with the aim to recruit medical 
students with a range of HADS scores.  This included specifically targeting recruitment of 
medical students from Medic Support who were likely to be experiencing more mental health 
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problems than the general student population along with recruitment via general email to all 
students (see section 3.1.5.2).    
 
3.5.4 Recruitment  
Recruitment took place between June 2014 and November 2015, this allowed for recruitment 
to take into account timetabling, exam and placement constraints. Students were offered a 
£10 gift voucher for participating as an incentive to assist recruitment. Due to a budget of £500 
this allowed for the recruitment of 50 students.  
Medical students were recruited via three different sources to try and recruit students with a 
range of HADS scores including those with and without a history of mental ill health.  The 
details of the recruitment methods are outlined below.   
 
1. At the end of an online questionnaire  
Between November 2013 and June 2014 Barts and the London Medical School and School of 
Medicine, Cardiff University sent out an online questionnaire to all their medical students.  The 
purpose of the questionnaire was to look at prevalence of mental health problems in the 
medical student populations.  The questionnaire included demographic details, questions to 
assess ‘lifetime’ prevalence of Common Mental Disorders (CMDs) along with two validated 
questionnaires; HADS and the Warwick Edinburgh Mental Well-being Scale (WEMWBS) 
(Tennant, et al, 2007).  The questionnaires were sent out at two time points.  At the end of the 
second questionnaire, medical students from School of Medicine, Cardiff University were told 
that a further study was being carried out looking at comparing self-report and clinical 
interview diagnosis of depression and anxiety.  Students were asked to follow a link if they 
would like more information or to express an interest in taking part.  The link took the students 
to a separate form which was not linked to their questionnaire data. The form provided some 
more information and also asked for their email address so that further information could be 
sent to the provided email address.  
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2. Via Medic Support at School of Medicine, Cardiff University  
Medic Support in Centre for Medical Education, School of Medicine, Cardiff University provides 
support for medical students who have been identified as having issues relating to 
performance or health.  Students referred to the unit may be experiencing physical and mental 
health problems and/or performance related issues such as behavioural or attitudinal 
problems, language or written skills or difficulty with passing exams. During their initial 
assessment with Medic Support students are asked to sign a consent form asking if they are 
willing to be contacted in future with information about research projects.  Only those 
students who had consented and were still attending the unit were provided with information 
about the present study.  Those who were interested in receiving more information or in 
taking part were asked to complete an additional consent form providing contact details to be 
passed to the researcher.  Further details were then sent to the contact details provided.  
 
 
 
3. Via an email 
All medical students at Cardiff Medical School were invited to take part via email. The email 
was sent out via the C4ME Medical School office and provided the student with information 
about the project.  Students who were interested in receiving more information or in taking 
part were asked to contact the researcher directly.   
Medical students who responded to the emails were sent a participant information sheet (see 
appendix 4) and invited to a face to face meeting at a convenient time in a confidential setting 
at Cardiff University.   
 
3.6 Face to face meeting  
The face to face meetings took place between July 2014 and November 2015.  The face to face 
meetings were undertaken by one of two researchers (Naomi Marfell and Sarah Winstanley).    
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The purpose of the face to face meetings was to allow comparison between diagnoses derived 
from clinical interview data with self-reported data using the HADS questionnaire. After 
providing consent, students were asked to first complete the HADS self-report scale before 
undertaking the SCAN interview.  Student’s HADS questionnaires were not studied or scored 
prior to the commencement of the clinical interview.  The HADS scale and the clinical interview 
data were linked using responses to three unique identifier questions.  
The unique identifier questions were taken from ones previously used in another study 
(Reisbig et al, 2007). The students were asked to give the first two letters of the answers to the 
three questions: 
1. What was the name of your primary (or first) school? 
2. What is your mother’s first name? 
3. Name of town where you were born? 
 
This produced a six letter identifier which enabled the matching of the HADS questionnaire 
and the interview response whilst maintaining anonymity.  The six-letter code was stated at 
the start of audio recording of the interview.  
 3.6.1 Consent  
At the start of the face to face meeting, the researchers reiterated the purpose of the research 
and the meeting which had been included in the information sent to all medical students who 
had shown an interest in taking part.  Medical students attending the face to face meeting 
were also told that the interviews would include asking them questions about symptoms 
relating to depression and anxiety and that they were not obliged to answer all questions.  
Participants were given the opportunity to withdraw from the study.  If the students were 
happy to proceed, they were asked to sign a consent form (see appendix 5).   
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3.6.2 Time frames  
Consideration was given for the time frames students would need to reflect on their symptoms 
over in the SCAN interview.   
HADS required respondents to consider how they have been feeling over the previous week.   
For the clinical interviews data, a clinical diagnosis of depression ICD-10 classification requires 
that symptoms are present for at least a month.   
For a clinical diagnosis of GAD the ICD-10 classification requires that symptoms are present for 
at least six months.  However, this requirement of a period of six months has been debated in 
the literature with many claiming a duration of one month should be sufficient (Angst et al, 
2006; Lee at al, 2008).  The National Comorbidity Survey carried out in the US suggested that in 
terms of onset, persistence, impairment, and comorbidity, patients who experience anxiety 
symptoms of between 1 and 5 months do not differ greatly from those with symptoms of 
greater than six months (Kessler et al, 2005).  As such it is claimed that there is little evidence 
for excluding those with symptoms of at least a month from a diagnosis of GAD (Kessler et al, 
2005).  
It was decided that asking participants to consider their symptoms over the last month for 
both depression and anxiety would prevent confusion due to switching time frames during the 
SCAN interview.  Especially given that in the present study student’s diagnoses were being 
compared to their HADS scores and HADS required respondents to consider how they have 
been feeling over the previous week.    
 
3.6.3  Protocol for distressed students  
 
Given the subject matter of the face to face meeting and specifically the SCAN interview it was 
recognised that students may experience psychological distress whilst talking about their 
symptoms and past experiences.  The researchers took every precaution to ensure students 
experienced as little psychological distress as possible during the interview.  In order to 
 120 
 
minimise psychological distress and to fully support students the researchers followed the 
protocol outlined below.  
 
• The face to face meetings were held in a suitable and confidential room and where 
possible at Medic Support Unit to ensure further support would be available if needed.  
• The face to face meetings were held at a convenient time for the students.   
• The interviews lasted no longer than 60 minutes.   
• The interviews were carried out by Naomi Marfell and Sarah Winstanley, researchers at 
the Centre for Psychosocial Research, Occupational and Physician Health (based at the 
same premises as Medic Support).  The researchers received training in carrying out the 
SCAN interviews.  
• Before students agreed to take part in an interview, and at the start of the interview the 
researchers ensured that the students were fully aware of what the study was about and 
that they would be asked questions about symptoms relating to depression and anxiety 
during the interview.   
• Students were informed and reminded that they were not committed to answer any 
questions that they did not feel comfortable answering.    
• If there was any sign of distress the interview was paused, and the student asked 
whether they would like to stop the interview completely. 
• At the end of the interview students were provided with a debrief sheet which outlined 
where they could seek support if they had queries or were distressed about the study. 
This included information about Medic Support and the student counselling service.  
Students were also reminded that they should contact their GP if they have any physical 
or mental health concerns.   
 
If during or following the interview the researcher had serious concerns about the mental 
health of a student, the following protocol was followed: 
• The researcher stopped the interview. 
• The researcher informed the student that they were concerned about them. 
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• The researcher suggested that the student should seek appropriate help. The researcher 
also suggested they may want to see their GP or contact student counseling service or 
another psychiatric service if appropriate. 
• If necessary, the researcher would support the student in contacting appropriate help.   
• If the researcher felt that there was immediate risk of harm, the researcher would 
accompany the student to an emergency service such as their GP, Accident and 
Emergency or local psychiatric crisis services (e.g. via Crisis Resolution and Home 
Treatment Teams).  The researcher would ensure that the student is not left on their own 
and at risk.   
 
 
3.6.4 Debrief. 
At the end of the face to face meeting participants were thanked for taking part and given a 
debrief sheet (see appendix 6).  This sheet thanked the participants for taking part and 
outlined places where they could seek support if they felt they needed it following the face to 
face meeting. The Interviewers explained to participants what the sheet included to ensure 
participants were fully aware of where they could receive support should it be required.   
  
3.7 Data collection  
All interviews were carried out face to face.  The interviews were audio recorded to allow for 
scoring of the SCAN interview after the interviews.  Interviews were carried out by Naomi 
Marfell and Sarah Winstanley.  Neither interviewer had any prior relationship with any of the 
participants.  
HADS questionnaires were completed via paper and pen and then inputted into excel.   
A number of different verification checks are suggested in the literature to ensure that the 
data is entered accurately. The most popular check for reducing inputting errors, found in the 
literature is ‘double entry’.  This is the process of entering the data twice into two separate 
databases and comparing the two data sheets, any discrepancies are highlighted, and the 
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original data referred to and the correct response recorded. Many suggest that double entry 
can result in a data set with fewer errors compared to single entry data (Reynolds-hartle et al, 
1992) and as such this type of verification is considered important with particularly high value 
data, where a mistake in the data input could affect patient care or safety (Goldberg et al, 
2015). Double entry is often criticised for being time consuming, however for the present 
study, only 50 HADS scales were required to be inputted and as such double entry was 
achievable.   
 There was no missing HADS data and therefore no calculations for missing data were required.   
 
3.7.1 Data Storage  
The audio recordings of the interviews were stored under the students’ unique identifiers on 
password protected computers.  After transfer to the computer, the audio files were deleted 
from the audio-recorder and the audio-recorder’s ‘format’ function used to ensure that data 
could not be retrieved. The HADS data was inputted into excel stored under the students’ 
unique identifiers on password protected computers.  The original HADS sheets and consent 
forms were stored separately in a locked cabinet at Centre for Psychosocial Research, 
Occupational and Physician Health Cardiff University School of Medicine.  Names and email 
addresses used to arrange the interviews, was stored in a password protected file for the 
duration of the study and for three months afterwards. 
 
3.8 Data analysis  
 3.8.1 Scoring HADS 
Once the raw HADS data had been inputted into excel, student’s HADS scores were calculated.  
Each HADS statement is categorised as either HADS-A for statements which relate to 
symptoms of anxiety or HADS-D which relate to symptoms of depression. Each statement has 
4 possible responses, answers to which are scored from 0 to 3.  HADS had both positively and 
negatively scored items to avoid acquiescence bias (Wouters et al, 2012), where a responder 
may just agree or disagree with all statements.  Therefore, each statement must be carefully 
scored according to the instructions.  
 123 
 
For example, one positively scored (ie the more agreement the higher the score) HADS-A items 
is: 
I feel tense or ‘wound up; 
Possible responses include: 
• Most of the time – this scores 3 points 
• A lot of the time – this scores 2 points 
• From time to time occasionally – this scores 1 point 
• Not at all – this scores 0 points.  
 
An example of a negatively scored (the more agreement, the lower the score) HADS-D items is: 
“I still enjoy the things I used to enjoy 
Possible responses include: 
• Definitely as much – this scores 0 points 
• Not quite so much – this scores 1 points 
• Only a little – this scores 2 points 
• Hardly at all  – this scores 3 points.  
 
Once responses to each item have been determined, subscale totals (HADS-A and HADS-D) 
were calculated by adding responses to all the relevant subscale items.   
 3.8.2 Scoring SCAN 
Following the face to face meeting, the clinical interview data was scored as set out in the 
SCAN manual.  Each symptom is given a score as shown in figure 1.  
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Figure 1 – scoring for SCAN symptoms as outlined in the SCAN manual 
 
 
0 This is a positive rating of absence. It does not mean ‘not known’ or ‘uncertain 
whether present or not’. It can only be used if sufficient information is available to 
establish its accuracy. 
 
1 This is a positive rating of presence, but presence of such a minor degree that it is not 
appropriate for use in classification. Like (0) it does not mean ‘not known’ or 
‘uncertain’. Rating of (1) count in scores (but not for diagnostic purposes), which in 
turn influence the level allocated on the Index of Definition. 
 
2 This rating means that the item is present at a level sufficient to use in classification. 
For this purpose it is equivalent to (3), but it contributes less to scores. In general, it is 
used when symptoms are of moderate severity during most of the period being 
assessed. 
 
3 A rating of (3) is similar to (2) except that the symptom is present in severe form for 
most of the period under review. 
 
5 The presence of psychotic symptoms can make the rating of Part One items very 
difficult, because of problems in interpreting the meaning of what R says, or because the 
symptoms (for example, anxiety or a phobia about leaving one’s house) may themselves 
be based in psychotic experiences. The rating should be only made when there is doubt 
about the nature of the symptom or the balance is in favour of the symptom being 
psychotic. 
 
8  If, after an adequate examination, the interviewer is still not sure whether a symptom 
is present (rated 1-3) or absent (rated 0), the rating is (8). This is the only circumstance in 
which (8) is used. It should not be used to indicate a mild form of the symptom. 
 
9 This rating is only used if the information needed to rate an item is incomplete in 
some respect, for example because of language or cognitive disorder, or lack of co-
operation, or because the interviewer forgot to probe sufficiently deeply. It is 
distinguished from (8) because the examination was not, for whatever reason, carried out 
adequately. 
 
 
For duration ratings, duration less than 1 week/month should be rated 1. A rating of 0 
thus means that the phenomenon has been totally absent. 
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Once all symptoms had been scored as per the SCAN manual, these were used to establish 
whether each of the symptoms required for an ICD-10 diagnosis of depressive disorder and 
generalised anxiety disorder were present at clinically significant levels and for the required 
duration as outlined in the ICD-10 classifications (see figures 2 & 3).  Those students who had 
the required number of symptoms present were considered to have a clinical diagnosis of 
either depression or generalised anxiety disorder.    
 
SCAN can be used to make clinical diagnoses using the Diagnostic and Statistical Manual of 
Mental Disorders (currently in its fifth edition, DSM-V) or the International Statistical 
Classification of Diseases, (currently in its 10th edition, ICD-10) (Janca et a, 1994).  DSM was 
developed by the American Psychological Association (APA, 2009) to offer standard criteria for 
the classification of mental disorders.  ICD was developed by the World Health Organisation 
(WHO) to improve the diagnosis and classification of mental health disorders (WHO, 1992).  
When first developed the two classification systems were quite different, however as 
approaches to diagnosing mental disorders has changed over the years and the two systems 
have been updates, they have become very similar with some claiming that “there is little 
justification for maintaining the DSM as a separate diagnostic system from the ICD in the long 
run” (APA, 2009, p63). The DSM is popular in the US and produces much revenue for the APA 
(Khoury et al, 2014), whereas the ICD-10 can be produced at much less cost and is used more 
widely in Europe and in the rest of the world (APA, 2009).  Given this and the location of the 
present study the SCAN clinical interview data was used to derive clinical diagnoses according 
to ICD-10 (WHO, 1992). 
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Figure 2 – Symptoms required for an ICD-10 classification of generalised anxiety disorder 
 
 
 
Generalised anxiety disorder classification  
Prominent tension or worry along with at least 4 of the symptoms listed below at least one 
of which must be from items 1-4 
 
Category Symptoms 
  
Autonomic arousal 
At least 1 of these 
1 - Palpitations pounding heart 
2 - Sweating 
3 - Trembling/shaking 
4 - Dry mouth 
  
Chest & abdomen Difficulty breathing 
Feeling of choking 
Chest pain or discomfort 
Nausea or abdominal distress 
  
Mental state Dizzy, unsteady, faint, lightheaded 
Derealisation/depersonalisation 
Fear losing control, going crazy 
Fear dying 
  
General  Hot flushes, cold chills 
Numbness or tingling  
  
tension Muscle tension/aches and pains 
Restlessness & inability to relax 
Feeling keyed up on edge, tense 
Sensation of a lump in the throat 
  
Other non-specific Exaggerated response to minor surprise 
Difficulty concentrating  
Persistent irritability  
Difficulty getting to sleep  
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Figure 3: Symptoms required for an ICD-10 classification of depressive disorder 
 
Once any diagnoses had been determined, student’s scores on the anxiety and depression sub-
scales of the HADS were compared with clinical diagnosis (ICD-10) of depressive or anxiety 
disorder obtained via the SCAN clinical interview.   
Basic descriptive statistics were calculated along with sensitivity, specificity and positive and 
negative predictive value calculations.  
ICD-10 Classification – Depressive disorder 
Main symptoms, for diagnosis at least 2 of these symptoms must be present most days, most of 
the time for at least 2 weeks  
▪ Persistent sadness or low mood 
▪ Loss of interest or pleasure 
▪ Fatigue or low energy 
Associated symptoms 
• Disturbed sleep 
• Poor concentration or indecisiveness 
• Low self-confidence or self-esteem  
• Poor or increased appetite 
• Suicidal thoughts or acts 
• Agitation or slowing of movements 
• Guilt or self-blame  
Diagnostic Criteria: 
• Sub clinical - Fewer than 4 symptoms in total 
• Mild – 4-5 symptoms (2 of which must include main symptoms below) 
• Moderate –6-7 symptoms (2 of which must include main symptoms below) 
• Severe – 8+ (2 of which must include main symptoms below) 
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3.8.3 Inter-rater reliability  
To ensure reliability of the interviewer’s scoring and diagnoses, a sample of 10 interviews were 
randomly selected for review by both interviewers and inter-rater reliability was then 
calculated. Inter-rater reliability was calculated for the main symptoms for depression and 
anxiety and for the diagnoses.   
 
The symptoms compared are outlined in table 19 below 
Table 19 – symptoms compared for IRR 
Depression symptoms 
Persistent sadness or low mood 
Loss of interest or pleasure   
Fatigue or low energy  
  
Anxiety symptoms 
Prominent tension worry   
Palpitations pounding heart   
Sweating    
Trembling/shaking    
Dry mouth 
 
For those where there was a discrepancy diagnoses were determined via discussions between 
the interviewers and a supervisor (LF) to ensure accurate diagnoses  
 
3.8.4 Sensitivity/Specificity  
For any screening test to be of use it needs to be able to identify as accurately as possible the 
presence or absence of a condition (Trevethan, 2017).  When determining the ability of a test 
to predict the presence or absence of a condition, one method is to compare the screening 
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test results to a diagnostic test result (Trevethan, 2017).  In the present study the screening 
test – HADS, was compared to the diagnostic test – SCAN, at different cut-off points for HADS.  
The comparison of these tests produces four possible responses in individuals. These are: 
1. True positive (HADS score above cut off and positive diagnosis according to SCAN) 
2. False positive (HADS score above cut off but no diagnosis according to SCAN) 
3. True negative (HADS score below cut off and no diagnosis according to SCAN) 
4. False negative (HADS score below cut off but positive diagnosis according to SCAN) 
The following table highlights these different responses. 
 
Table 20: Possible responses when comparing HADS scores to diagnosis using SCAN data 
  Diagnosis according to SCAN 
  Diagnosis according to 
SCAN 
No diagnosis according to 
SCAN 
Sc
re
e
n
in
g 
vi
a 
H
A
D
S 
HADS 
above 
cut off 
True positive 
  
False positive 
a b 
HADS 
below 
cut off 
 
False negative 
c d  
  True Negative 
 
Any screening test aims to have high numbers of true positives and true negatives and aims to 
have few false positives and false negatives.  Sensitivity is the ability of a test to correctly 
identify positives – reported as a proportion of actual positives that are correctly identified as 
such (Parikh, et al, 2008).  Using the above table sensitivity is calculated as a/(a+c)*100 
 130 
 
Specificity is the ability of a test to correctly identify negatives, reported as the proportion of 
negatives that are correctly identified (Parikh, et al, 2008). In the above table specificity is 
calculated as d/b+d*100.  
In addition to sensitivity and specificity the negative predictive value (NPV) must also be 
considered.  The NPV estimates the probability that subjects with a negative screening test 
truly do not have the disease (Maxim et al, 2014).  In the above table NPV is calculated as 
d/(c+d)*100.  
Finally, positive predictive value (PPV) can also be considered.  The PPV estimates the 
probability that subjects with a positive test result, will truly have the disease. In the above 
table PPV is calculated as a/(a+c)*100 
Sensitivity, specificity PPV and NPV were calculated for different cut-off scores.    
Any screening tool should have high sensitivity and specificity (Maxim et al 2014).  Optimum 
specificity, sensitivity and NPV levels would all be 100 % (or 1.0) where all cases were 
identified, there were no false negatives and all negative results were truly negative.  This 
however, is rarely achieved and as such studies need to consider an optimum balance.  This is 
particularly difficult with sensitivity and specificity.  As general rule you cannot increase both 
simultaneously, one will be increased at the expense of the other (Hazibzadeh et al, 2016).  
This relationship between sensitivity and specificity, of a specific test can be represented 
graphically as a receiver operating characteristic curve.   
 
3.8.5 Receiver operating characteristic curve (ROC curve) 
A ROC curve was produced using the data from the present study.  A ROC curve is a graphical 
representation of the trade-off between sensitivity and specificity (Hazibzadeh et al, 2016).  
The curve is a plot of true positives (sensitivity) against true negatives (1-specificity).  An 
example of a ROC curve can be seen below in figure 4 
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Figure 4: Example of a ROC curve 
 
 
 
 
 
 
The red line would represent a test in which at each cut off point there were as many false 
positives as false negatives and as such is a test which is only as good as chance (eg flipping a 
coin).  The blue line would represent a test in which there was 100% accuracy ie when it has 
any positives there are no negatives and vice versa.  In reality, a typical ROC curve falls 
somewhere between these – an example might be the grey curve.   
As such the ROC demonstrates the ability of a test to discriminate between those with a 
disease and those without a disease (Akobeng, 2007). The curve also allows for determining 
the optimal cut off point for the screening test (see below).   
The use of ROC curves have been used extensively in research.  Advantages of using a ROC 
curve in addition to calculating sensitivity and specificity are its ability to provide graphical 
representation of the accuracy of all cut-off values.  In addition, the ROC curve is not affected 
by the prevalence of the disease/condition in question.  Finally, it allows for comparison of 
different screening tests (Halligan et al, 2015).   
However, some have criticised the use of ROC curves, in particular some have suggested that 
the data produced is not understood or effectively interpreted by clinicians (Halligan et al, 
2015).  In addition, it assumes that sensitivity and specificity are of equal importance (Halligan 
et al, 2015).  Sensitivity and specificity are not always of equal importance, for example 
sensitivity may be more important, particularly if there are serious consequences of not 
Tr
u
e 
p
o
si
ti
ve
s 
True negatives 
Chance line 
Ideal test 
point 
Typical ROC curve 
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identifying someone with the disease (Hazibzadeh et al 2016). Alternatively, specificity may be 
more important if the consequence of treating an individual might itself bring risks (e.g. side 
effects of treatment).  In addition, ROC curves require a broad spectrum of responses on the 
screening test to ensure the curve is accurate.  Despite these criticisms some have concluded 
that the ROC curve is useful in the early stages of diagnostic test assessment (Halligan et al, 
2015).  Given this project aimed to test the effectiveness of HADS as a screening tool with a 
previously untested sample and it aimed to review a range of possible cut-off values it was 
decided that a ROC curve would be of help in this situation.  
There are a number of methods for identifying optimal cut off points using the curve 
(Akobeng, 2007). Two of the most commonly used are: 
• Identifying the point on the curve closest to the ideal test point (Also known as 
the Euclidian’s index). As described above a perfect test would have all positives 
and no negatives or vice versa and as such would only have one threshold which 
would fall at the o,1 point on the plot (at the star), (0 negative and 1 positive).  
The optimal cut off point for any other screening test using this method, is to 
identify the point on the curve closest to this ideal test point.   
• The Youden Index.  This method involves identifying the cut-off point furthest 
away from the line of chance (ie the red line on the above curve).   
Whilst both of these methods provide similar optimal cut off point and receive similar criticism 
and recommendations for use. It has been suggested that the Youden index provides a slightly 
more sensitive cut-off threshold (ie a slightly lower cut-off) (Hajian-Tilaki, 2017).  Given the 
sensitive nature of the conditions being tested, it was decided that a test which produced a 
slightly more sensitive threshold may be of more value and as such the Youden Index method 
for calculating the optimum cut-off score was used.   
In addition to calculating the optimum cut off score the ROC was also used to calculate an area 
under the curve value (AUC).  The AUC is a calculation of how good the test is at distinguishing 
between patients with disease and those without. It is a single measure which allows for 
comparison of different tests.  AUC values can vary between 0.5 which represents a poor test 
and 1 which is a perfect test.   
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3.8.6 Qualitative analysis  
Following the quantitative analysis of the data, the interview responses of those students who 
had either false positive or false negative results on HADS (using the standard cut off scores of 
8 and above) in comparison to clinical interview were qualitatively reviewed.  This aimed to 
provide a more in-depth review of possible reasons for disparity between HADS scores using 
the standard cut off and clinical interview.   
 
3.8.7 False positives 
Those students who scored 8 and above on HADS but who did not reach the threshold for 
clinically significant levels of depression or anxiety as determined by SCAN, were identified as 
false positives.  Responses to the HADS items of these participants were then explored further.  
In particular, items in which these participants scored particularly highly were identified. 
Responses to equivalent SCAN questions were reviewed and compared to their HADS 
responses.   
 
3.8.8 False negatives 
Those students who scored 7 and below on HADS but who reached the threshold for clinically 
significant levels of depression or anxiety as determined by SCAN, were identified as false 
negatives.  Responses to the HADS items of these participants were then explored further.  In 
particular, items in which these participants scored particularly low were identified. Responses 
to equivalent SCAN questions were reviewed and compared to their HADS responses.   
 
3.9 Summary 
 
In summary, this study set out to investigate the suitability of HADS as a screening tool for anxiety 
and depression in a medical student population by comparing HADS to a structured clinical 
interview (Schedules for Clinical Assessment in Neuropsychiatry) (SCAN).   The methods used for 
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this study have been described. Medical students were recruited via a range of methods and 
invited to attend a face to face meeting.  During the face to face meeting students completed 
HADS and took part in a clinical interview using SCAN.  Students HADS scores were calculated and 
any depression or anxiety diagnoses determined by scoring the SCAN data. Individual students’ 
results from HADS and SCAN were then compared.  The results of these comparisons will be 
outlined in the next chapter.   
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4. Results  
 
This chapter outlines the results from the study in which medical students were recruited and 
asked to attend a face to face meeting where they completed HADS and then undertook a 
SCAN interview to assess clinical levels of anxiety and depression.  The face to face meetings 
took place between July 2014 and November 2015.   
The interviews lasted between 6 minutes 15 seconds and 61 minutes 50 seconds, with a mean 
time of 21 minutes 28 seconds.  The students were engaged and willing to discuss their 
experiences and aspects relating to their mental health.  One interview was stopped due to the 
student being upset but was then restarted at the request of the student, once they had 
composed themselves. Four students talked about feeling very down and the interviewer 
checked that they had support in place and ensured they were aware of the support offered by 
Medic Support.  One student was interested in finding out more about Medic Support and was 
introduced to the Medic Support administration team following the face to face meeting.  The 
interviewers were not worried about the safety of any of the students interviewed.  
The demographic information collected from the students will be described to provide an 
overview of the sample who took part. Results of the inter-rater reliability calculated to ensure 
reliability of the interviewer’s scoring and diagnoses will also be reported.  The research 
questions for the current study will then be answered by reporting firstly on the depression 
related data and then on the anxiety related data.  The analysis of both the depression and 
anxiety data included two steps.  
Firstly, quantitative analysis was carried out comparing the HADS data with SCAN diagnoses.   
This quantitative analysis included calculating the sensitivity and specificity, negative and 
positive predictive values.  In addition, the optimum subscale cut-offs for this cohort will be 
determined, by plotting a ROC curve and the area under the curve will be calculated to give an 
indication of how good the test is at distinguishing between patients with disease and those 
without.  Results from this quantitative analysis will answer research questions 1 and 2.   
The second step of analysis involved reviewing the interview responses of those students who 
had either false positive or false negative results on HADS (using the standard cut off scores of 
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8 and above) in comparison to their clinical interview results. Those students who scored 8 and 
above on HADS but who did not reach the threshold for clinically significant levels of 
depression or anxiety as determined by SCAN, were identified as false positives.  Those 
students who scored 7 and below on HADS but who reached the threshold for clinically 
significant levels of depression or anxiety as determined by SCAN, were identified as false 
negatives.   
The interview responses of students identified as false positives or natives at the original cut-
off were compared to the responses given to related HADS items.  This aimed to provide a 
more in-depth review of possible reasons for disparity between HADS scores (using the 
standard cut off) and clinical interview diagnoses.  This analysis aimed to answer research 
question 3.     
4.1 Demographics 
50 medical students from School of Medicine Cardiff University were recruited to the study 
and took part in a face to face meeting between July 2014 and November 2015.  To increase 
recruitment and respond to concerns regarding the need for anonymity of medical students 
taking part, minimal demographic details were collected about the students.  In addition, these 
demographic details were not linked to participants’ data but were only collected to provide 
an overview of the sample.  The only demographic information reported will be gender and 
year of study.  
Of the 50 students who participated, 7 (14%) were male and 43 (86%) were female. In C4Me in 
the School of Medicine Cardiff University at the time of the project total student population 
were 37% male and 63% female.  
 The following graph shows the years of study of participants.  
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Figure 5: Distribution of years of study of participants.   
 
 
42% (21) of students were from year 2.  This was believed to be due to many medical students 
in years 3-5 being away on placement during the year and as such may have found it harder to 
attend a face to face interview in Cardiff.   
 
4.2 Inter-rater reliability  
 
The interviews used the Schedules for Clinical Assessment in Neuropsychiatry (SCAN) clinical 
interview technique.  From the SCAN interview symptoms were rated as to whether they were 
not present, present but to not clinical significance or present to a clinically significant level.  
The SCAN clinical interview ratings were used to establish whether each of the symptoms 
required for an ICD-10 diagnosis of depressive disorder and generalised anxiety disorder were 
present.   
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10 interviews (20%) were randomly sampled from the 50 interviews and independently rated 
by the two researchers who had carried out the interviews (Naomi Marfell & Sarah 
Winstanley).   
Each symptom was rated either not present (0) or present (1) or unknown (9) or unsure (8).  
Cohen's Kappa was then calculated for the main symptoms for depression and anxiety to test 
inter-rater reliability for the symptoms.  
The symptoms compared are outlined in table 19 below. 
Table 1 – Symptoms used for IRR 
Depression symptoms 
Persistent sadness or low mood 
Loss of interest or pleasure   
Fatigue or low energy    
Anxiety symptoms 
Prominent tension worry   
Palpitations pounding heart   
Sweating    
Trembling/shaking    
Dry mouth 
 
For the depression symptoms 30 symptom ratings were compared (3 main symptoms X 10 
interviews).  The cross tabulation for the comparison of the depression symptoms are shown 
in table 21. 
Table 21 – Cross tabulation of the comparison of ratings of the depression symptoms 
 Rating of depression 
symptoms – Rather 2 Total 
Not present Present 
Rating of depression 
symptoms – ratter 1 
Not present 25 0 25 
Present 1 4 5 
Total 26 4 30 
Kappa statistics for the level of agreement between the rating of depression symptoms are shown 
in table 22.   
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Table 22 – Kappa statistics for inter-rater reliability of rating of depression and anxiety 
symptoms  
 Kappa Value Approx. Sig. 
Depression symptoms .765 0.000 
 
For anxiety symptoms 50 symptom ratings were compared (5 main symptoms X 10 interviews).  
The cross tabulation for the comparison of the anxiety symptoms are shown in table 21. 
Table 23 – Cross tabulation of the comparison of ratings of the anxiety symptoms 
 Rating of anxiety 
symptoms – Rater 2 
Total 
Not 
present 
Present 
Rating of anxiety 
symptoms – Rater 
1 
Not Present 41 1 42 
Present 2 6 8 
Total 43 7 50 
 
Kappa statistics for the level of agreement between anxiety rating of symptoms are shown in 
table 24.   
Table 24 – Kappa statistics for inter-rater reliability of rating of anxiety symptoms 
 Kappa Value Approx. Sig. 
Anxiety Symptoms .870 0.000 
 
There was a high level of inter-rater reliability between the two raters with respect to 
symptom rating.   
Cohen's Kappa statistic were also calculated for the overall ICD-10 diagnostic ratings of 
depressive disorder and generalised anxiety disorder to determine level of agreement 
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between raters (20 diagnoses in total).  Cohen’s kappa was significant There was moderate 
agreement between the two rater’s judgements, κ = .643, p < .0005. Cross tabulation for this 
calculation is shown in table 25.  
 
Table 25 - Cross tabulation of the comparison of ratings of the diagnoses 
 Diagnosis ratings – Rater 
2 
Total 
Not 
present 
present 
Diagnosis ratings 
– Rater 1 
Not 
present 
18 0 18 
Present 1 1 2 
Total 19 1 20 
 
The remaining interviews were rated by the interviewer who conducted the interview (NM & 
SW) and the symptoms scored according to the ICD-10 criteria for diagnosis for depression and 
anxiety.   
 
These diagnoses were then compared to students’ HADS depression and anxiety scores.  
Results relating to depression and anxiety will be presented separately.   
 
4.3 Depression  
As outlined above analysis of the depression data involved two steps.  The first step involved 
the quantitative analysis of the HADS and SCAN data.  Step two took a qualitative approach to 
reviewing the interview responses of those students who had either false positive or false 
negative results when their HADS scores were compared to their clinical interview data.  The 
results of these two steps will be reported in turn.  
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4.3.1 Quantitative analysis  
The quantitative analysis involved firstly identifying those students who reached the diagnostic 
criteria for depression.  This data was then used to compare individual students HADS scores 
to their diagnosis and then calculate sensitivity and specificity at different HADS cut-offs. The 
data was also used to create a ROC curve and the optimum cut-off score for this sample 
identified.  Finally, the area under the curve was calculated to give an indication of how good 
HADS is at distinguishing between medical students with depression and those without.   
 
Using the ICD-10 criteria 3 students reached the diagnostic criteria for depression 
Figure 6 shows the distribution of HADS depression scores as completed by students 
immediately prior to their interviews, broken down by those who following interview were 
determined to have reached the ICD-10 criteria for depressive disorder and those who did not 
reach the ICD-10 criteria for depressive disorder.   
Figure 6 - Comparison of individual student’s HADS-D scores to ICD-10 criteria for depressive 
disorder
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Figure 6 highlights that the HADS-D scores for students who meet the ICD-10 diagnosis for 
depressive disorder ranged from 7 to 12, whereas the HADS-D scores for those who did not 
meet the criteria ranged from 0 to 11.   
 
In order to consider how effective HADS-D is at determining whether medical students have 
depression, the sensitivity and specificity of HADS-D was calculated.  
 
4.3.1.1 Sensitivity and specificity of the HADS-D subscale 
The sensitivity, specificity, positive and negative predictive values were calculated for different 
cut off points.   
 
• Sensitivity being defined as the proportion of people with disease who have a positive 
test result (Altman & Bland, 1994).  
• Specificity is defined as the proportion of people without disease who have a negative 
test result (Altman & Bland, 1994).   
• The negative predictive value estimates the probability that subjects with a negative 
screening test truly do not have the disease (Maxim et al, 2014).   
• Finally, the positive predictive value estimates the probability that subjects with a 
positive test result, will truly have the disease. 
One systematic review suggested that for depression tools used for case finding, sensitivity should 
be at least 85% and a specificity at least 75% (Gilbody et al, 2006).   
Table 26 shows the difference in sensitive and specificity calculations for different cut off points 
for the HADS depression scores using the ICD-10 depression diagnoses as a basis for comparison.  
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Table 26 – Sensitivity and specificity values for different HADS-D cut off points using the ICD-10 
depression diagnoses.  
 HADS 
cut off 
≥7 
HADS 
cut off 
≥8 
HADS 
cut off 
≥9 
HADS 
cut off 
≥11 
HADS 
cut off 
≥12 
Sensitivity 1.00 0.67 0.67 0.33 0.33 
Specificity 0.83 0.87 0.96 0.98 1.00 
Positive predictive value 0.27 0.25 0.50 0.5 1.00 
Negative predictive value 1.00 0.98 0.98 0.96 0.96 
 
Using the accepted HADS-D cut-off point of 8, the sensitivity in the current sample is 0.67 with 
a specificity of 0.87. This implies that of those students with a HADS score of 8 or more, 67% 
were correctly classified as having a diagnosis of depressive disorder. 87% of cases were true 
negatives, meaning that 87% of students who scored below the cut off of 8, did not have a 
diagnosis of depressive disorder. The NPV would be high at 0.98.  
 
If the cut-off was reduced to 7, the sensitivity of the test would rise to 1.00. The specificity 
however would reduce to .83. The NPV would be optimum at 1.00.  By applying a  cut off to 7 
would provide a test with higher level of accuaracy although not quite ‘optimum’ levels with 
specificty of .83 being below optimum of .9 
 
An ROC curve was then plotted and youden’s index calculated for different cut offs to 
determine the optimum cut-off for this sample.  
 
4.3.1.2 ROC curve 
The ROC curve for the HADS-D and SCAN data was plotted in SPSS.  The ROC curve is a plot of 
true positives (sensitivity) against true negatives (1-specificity) and is a graphical 
representation of the trade-off between sensitivity and specificity (Hazibzadeh et al, 2016).   
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In the graph below (figure 7) the blue curve shows the plot for the depression data for the 
present study.  The red line would represent a test in which at each cut off point there were as 
many false positives as false negatives and as such is a test which is only as good as chance.   
Figure 7 – ROC curve for the depression data 
 
 
To determine the optimim cut-off point for the current sample the youden index was 
calauclated.  This method involves identifying the cut-off point furthest away from the line of 
chance.  Table 27 shows the different Youden values for different cut-off values. 
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Table 27 – Youden values for different HADS-D cut-off scores 
Cut 
off 
Sensitivity 
1 - 
Specificity 
specificity 
Youden 
(sens+spec-
1) 
0 1.000 1.000 0.000 0.000 
1 1.000 0.894 0.106 0.106 
2 1.000 0.702 0.298 0.298 
3 1.000 0.553 0.447 0.447 
4 1.000 0.447 0.553 0.553 
5 1.000 0.340 0.660 0.660 
6 1.000 0.213 0.787 0.787 
7 1.000 0.170 0.830 0.830 
8 0.667 0.128 0.872 0.539 
9 0.667 0.043 0.957 0.624 
10 0.333 0.043 0.957 0.291 
11 0.333 0.021 0.979 0.312 
12 0.333 0.000 1.000 0.333 
14 0.000 0.000 1.000 0.000 
 
The youden index is greatest for a cut-off of 7 and above at 0.830.  This suggests that for this 
sample a HADS-D cut-off of 7 would be optimum for determining those students who are likely 
to suffering fom depression .   
 
4.3.1.3 Area under the curve  
In addition to detemining the optimum cut-off score the ROC curve was used to calculate the 
area under the curve (AUC) to provide an indication of how good the test is at distinguishing 
between medical students with depression and those without. AUC values can vary between 
0.5 which represents a poor test and 1 which is a perfect test.   
 
For the HADS-D data the area under the curve equalled 0.936 (p<0.05 Confidence intervals: 
0.847-1.0) suggesting that the HADS-D subscale was very good at distingusing between 
medical students with depression and those without in the current sample.  
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4.3.1.4 Summary of the quantitiative analysis 
In summary the HADS-D quantitative data demonstrated that three students reached the 
diagnostic criteria for depression.  The HADS-D scores for students who met the ICD-10 
diagnosis for depressive disorder ranged from 7 to 12, whereas the HADS-D scores for those 
who did not meet the criteria ranged from 0 to 11.  The AUC data suggsted that HADS-D 
subscale was very good at distingusing between medical students with and without 
depression.  The original cut off score of 8 and above had relatively high levels of specificity at 
0.87, however sensitivity at this cut off was lower at 0.67.  A lower cut-off of 7 is suggested as 
it had a better balance of sensitivity and specificity for the current sample, with sensitivity of 
1.0 and specificity of 0.83.   
 
To understand why there might be differences between the original cut-off of 8 and the 
optimal cut-off for the current sample.  the items which make up the HADS-D scale were 
explored and compared to medical students’ responses given in the clinical interviews.   
 
 
4.3.2 Exploration of the HADS-D items  
Following the quantitative analysis of the data, the interview responses of those students who 
had either false positive or false negative results on HADS (using the standard cut off scores of 
8 and above) in comparison to clinical interview were qualitatively reviewed.  This aimed to 
provide a more in-depth review of possible reasons for disparity between HADS scores using 
the standard cut off and clinical interview.  These factors may influence why alternative cut-off 
scores are more appropriate for medical students.   
Eight of the 50 students interviewed (16%) scored 8+ on the HADS-D scale, but only 2 reached 
the diagnostic threshold for depression as determined by SCAN.  At the original cut off of 8, 
the 6 students who scored above 8 but did not reach the threshold for depression as 
determined by SCAN would be considered false positives.  I.e. they scored positive on the test 
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(HADS-D) but did not have depression.  The responses to the HADS-D items of the 6 students 
who scored highly on HADS-D but did not reach diagnostic threshold for depression as 
determined by SCAN are explored below.   
Only 1 student scored 7 on HADS but reached the diagnostic threshold for depression as 
determined by SCAN, this would be considered a false negative if the original cut-off score of 8 
was being used.  With only 1 student in this category patterns and themes in the responses of 
students identified as false negatives at the original cut-off was not possible.   
 
 
4.3.2.1 HADS-D false positives  
Those students who scored 8 and above on HADS but who did not reach the threshold for 
clinically significant levels of depression or anxiety as determined by SCAN, were identified as 
false positives. At the original cut off of 8, the 6 students who scored above 8 but did not reach 
the threshold for depression as determined by SCAN.  Responses to the HADS items of these 
participants were explored further.  In particular, items in which these participants scored 
particularly highly were identified. Responses to equivalent SCAN questions were reviewed 
and compared to their HADS responses.   
 
Responses to each HADS item are rated between 0-3. 0 suggesting the symptom is not present 
and 3 suggesting the symptom is present to a significant level.   
The responses given to HADS-D items by the 6 students identified as false positives on HADS-D 
at the original cut off can be seen in figure 8 below.  
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Figure 8 - Responses to the HADS-D items of those students who scored above 8 on HADS-D 
but did not reach the threshold for depression as determined by SCAN 
 
 
This graph highlights that only two HADS-D items elicited a response that scored 3 in this group 
of 6 medical students who score above 8 on HADS-D but did not reach diagnostic criteria for 
depression.  These items were ‘I feel as if I am slowed down’ and ‘I can enjoy a good book or 
radio or TV Programme’.  These items are explored below.   
 
4.3.2.1.1 ‘I feel as if I am slowed down’ 
3 students responded on HADS that they felt slowed down ‘nearly all the time’ (a score of 3 on 
the HADS item) and 1 student reported that they felt slowed down ‘very often’ (a score of 2 on 
the HADS item).  None of the students said they ‘did not feel slowed down at all.’  
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During the SCAN interviews these students were asked: “Over the past month have you felt as 
though you were slowed down in your movements, as though everyone and everything else 
was moving much faster?”.  This SCAN question determines whether someone is suffering 
from "psychomotor retardation" where their thoughts and/or physical movements are slowed 
down.  Psychomotor retardation can be a symptom of depression.   
 
5 of the 6 students stated that they felt slowed down in their movements.  When asked to be 
more explicit only 1 student felt that they were moving physically slower to an extent that was 
clinically significant.  Some students answered this question in relation to how they feel about 
their progress on the medical course. 
 
“Only in the sense of relating it back to work, if you don’t understand something then you feel 
that you are behind everyone else and everyone’s like oh have you done this and you are like 
no I haven’t had time for that yet”  
“I feel that everyone is doing things faster and more efficient than me.” 
 
4.3.2.1.2 “I can enjoy a good book or radio or TV Programme” 
In response to the HADS-D item “I can enjoy a good book or radio or TV Programme” 3 of the 
6 students under consideration, answered ‘Very seldom’ (HADS score of 3 for this item) and 2 
answered ‘not often’ (HADS score of 2 for this item).   
During the SCAN interview students were asked if they could still find enjoyment in things, a 
loss of interest being one symptom of depression. 3 of the 6 students under consideration, 
mentioned not enjoying things as much as they normally do, but this did not reach a significant 
level for any of the students. For some who felt that they could no longer enjoy activities that 
they used to enjoy they stated this was due to time restraints and the feeling of guilt if they 
spent time not working.  
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 “Little things like watching the TV, I just wont do it I’ll just go to sleep. …. I see my family and 
my boyfriend and that is all the free time I have.” 
“No… lack of time, because I’m on an intensive course I feel bad if I don’t work even though I 
know I shouldn’t work all the time..” 
“I haven’t done them (leisure activities) because I haven’t had time” 
 
4.3.2.2 Summary of the HADS-D qualitative analysis 
Exploration of the HADS-D items of those students who scored above 8 on HADS-D but did not 
reach diagnostic criteria for depression (n=6) highlighted that these medical students scored 
very highly on two items.  These items were ‘I feel as if I am slowed down’ and ‘I can enjoy a 
good book or radio or TV Programme’.  Although 4 students scored high on the HADS-D item ‘I 
feel as if I am slowed down’, when retardation was explored via SCAN only 1 of these students 
felt that they were moving physically slower to an extent that was clinically significant.  Some 
of these students talked instead about feeling behind on the course.  In terms of ‘I can enjoy a 
good book or radio or TV programme’, 5 of the 6 students scored high on this HADS-D item.  
However, none of the students who talked about not enjoying activities during their SCAN 
interviews had a loss on interest to a clinically significant level.  Some talked about not having 
the time to do these activities, suggesting their lack of enjoyment of activities may be due to 
their circumstances and not their mental health.   
 
4.4 Anxiety 
As with the depression data, the analysis of the anxiety data involved two steps. The first step 
involved the quantitative analysis of the HADS and SCAN data.  Step two took a qualitative 
approach to reviewing the interview responses of those students who had either false positive 
or false negative results when their HADS scores were compared to their clinical interview 
data.  The results of these two steps will be reported in turn. 
 151 
 
 
 
4.4.1 Quantitative analysis 
As with the depression data the quantitative analysis involved identifying those students who 
reached the diagnostic criteria for anxiety, comparing this data with the HADS-A scores and 
calculating sensitivity and specificity.  The data was then used to plot a ROC curve and the 
optimum cut-off score for this sample identified.  Finally, the area under the curve was 
calculated to give an indication of how good HADS is at distinguishing between medical 
students with and without generalised anxiety.   
Following the SCAN interviews, 4 medical students’ symptoms for the month prior to interview 
reached the threshold for ICD-10 diagnostic criteria for generalised anxiety disorder.   
Figure 9 shows the distribution of HADS anxiety scores as completed by students immediately 
prior to their interviews, broken down by those who following interview were determined to 
have reached the ICD-10 threshold for generalised anxiety disorder (if the symptoms had 
persisted for a period of six month) and those who didn’t reach the ICD-10 threshold for 
generalised anxiety disorder.   
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Figure 9 - Comparison of individual student’s HADS-A scores to ICD-10 criteria for generalised 
anxiety disorder 
 
 
25 medical students (50%) of those interviewed had a HADS-a score of 8 and above and 13 
students (26%) had a HADS-a score of 11 and above,  but only 4 (8%) of these reached the 
threshold for generalised anxiety disorder  as determined by clinical interview (if the 
symptoms had persisted for a period of six month).   
In order to consider how effective HADS-A is at determining whether medical students have 
generalised anxiety, the sensitivity and specificity of HADS-A was calculated.  
 
4.4.1.1 Sensitivity and specificity of the HADS-A subscale 
The sensitivity and specificity for different cut off points for anxiety caseness  were calculated 
for the HADS-a scores. Table 28 shows the difference in sensitive and specificity calculations 
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for different cut off points for the HADS anxiety scores using the ICD-10 generalised anxiety 
diagnoses as a basis for comparison.  
 
Table 28 – Sensitivity and specificity calculations for different HADS-A cut off points using the 
ICD-10 anxiety threshold for comparison.  
 HADS 
cut off 
≥8 
HADS 
cut off 
≥11 
HADS 
cut off 
≥13 
HADS 
cut off 
≥15 
HADS 
cut off 
≥17 
Sensitivity 1.00 1.00 1.00 0.50 0.25 
Specificity 0.54 0.80 0.91 0.93 1.00 
Positive predictive 
value 0.16 0.31 0.50 0.40 1.00 
Negative predictive 
value 1.00 1.00 1.00 0.96 0.94 
For this sample, when considering the sensitivity of the scale, a cut-off point of ≥8 (the level 
considered indicative of possible levels of  anxiety in the general population) would mean that 
all students (ie sensitivity of 1.0/ 100%) who have clinical levels of depression as rated by SCAN 
would have a positive HADS-a test.  However, a cut of of ≥8 would results in veru low speficity 
of the test; at this cut off point 54% of students who did not have anxiety having negative 
HAD-a scores, but 46% of students without clinical levels of depression, as rated by SCAN, 
would have a positive HADS-D result (1-0.45).  
At a cut off of 11 (the original cut off for probably cases), the sensitivity would remain at 100% 
(1.0) and specificity would increase to 80%, resulting in 20%  of students who did not have 
anxiety having negative HAD-a scores .   
If a HADS-A cut-off of  ≥13 is used, again all students who had clinical levels of anxiety as rated 
by SCAN had a positive HADS-A result, however specificity increases to 91% resulting in only 
9% of this group without clinical levels of anxiety as rated by SCAN having a positive result on 
HADS-A.   
An ROC curve was then plotted and youden’s index calculated for different cut offs to 
determine the optimum cut-off for this sample.  
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4.4.1.2 ROC curve 
The ROC curve for the HADS and SCAN data was plotted in SPSS.  In the graph below (figure 10) 
the blue curve shows the plot for the anxiety data for the present study.  The red line would 
represent a test in which at each cut off point there were as many false positives as false 
negatives and as such is a test which is only as good as chance.   
Figure 10 – ROC curve for anxiety data 
 
 
 
 
To determine the optimim cut-off point for the current sample the youden index was 
calauclated.  This method involves identifying the cut-off point furthest away from the line of 
chance.  Table 29 shows the different Youden values for different cut-off values. 
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Table 29 – Youden values for different HADS-A cut-off scores 
 
cut 
off 
Sensitivit
y 
1 - 
Specificit
y 
specificit
y 
Youden 
(sens+spec
-1) 
0 1.000 1.000 0.000 0.000 
1 1.000 0.978 0.022 0.022 
3 1.000 0.935 0.065 0.065 
4 1.000 0.848 0.152 0.152 
5 1.000 0.739 0.261 0.261 
6 1.000 0.696 0.304 0.304 
7 1.000 0.565 0.435 0.435 
8 1.000 0.457 0.543 0.543 
9 1.000 0.391 0.609 0.609 
10 1.000 0.348 0.652 0.652 
11 1.000 0.196 0.804 0.804 
12 1.000 0.130 0.870 0.870 
13 1.000 0.087 0.913 0.913 
14 0.500 0.065 0.935 0.435 
16 0.250 0.043 0.957 0.207 
17 0.250 0.000 1.000 0.250 
18 0.000 0.000 1.000 0.000 
 
The youden index is greatest for a cut-off of 13 and above at 0.913.  This suggests that for this 
sample a HADS-A cut-off of 13 would give the optimum balance of sensitivity and specifity for 
determining those students who are likely to suffering from anxiety.   
 
4.4.1.3 Area under the curve  
In addition to detemining the optimum cut-off score the ROC curve was used to calculate the 
area under the curve (AUC) to provide an indication of how good the test is at distinguishing 
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between medical students with generalised anxiety and those without. AUC values can vary 
between 0.5 which represents a poor test and 1 which is a perfect test.   
 
For the HADS-A data the area under the curve equalled 0.948 (p<0.05 std Error 0.032 
Confidence intervals: 0.885-1.0) suggesting that the HADS-A subscale is very good at 
distingusing between medical students with generalised anxiety and those without in the 
current sample.  
 
 
4.4.1.4 Summary of the quantitiative analysis 
In summary the HADS-A quantitative data demonstrated that four students reached the 
diagnostic criteria for generalised anxiety disorder.  The HADS-A scores for students who met 
the ICD-10 diagnosis for GAD ranged from 13 to 17, whereas the HADS-D scores for those who 
did not meet the criteria ranged from 0 to 16.  The AUC data suggsted that HADS-A subscale 
was very good at distingusing between medical students with and without GAD.  The original 
cut off score of 8 and above had very high levels of sensitivity but relatively low levels of 
specificity at 0.54.  The Youden index suggested that the optimum balance of sensitivity and 
specificity was at a cut-off of 13, significantly higher than the original cut off of 8.   
 
To understand why there might be differences between the original cut-off of 8 and the 
optimal cut-off for the current sample the items which make up the HADS-A scale were 
explored and compared to medical students’ responses in the clinical interviews.  This will be 
discussed next.  
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4.4.2 Exploration of the HADS-A items  
 
Following the quantitative analysis of the data, the interview responses of those students who 
had either false positive or false negative results on HADS (using the standard cut off scores of 
8 and above) in comparison to clinical interview were qualitatively reviewed.  This aimed to 
provide a more in-depth review of possible reasons for disparity between HADS scores using 
the standard cut off and clinical interview.   
 
25 of the 50 students interviewed (50%) scored 8+ on the HADS-A scale, of which only 4 
students reached the diagnostic threshold for anxiety as determined by their SCAN interview. 
At the original cut off of 8, the 21 students who scored above 8 but did not reach the threshold 
for generalised anxiety as determined by SCAN would be considered false positives.  Ie they 
scored positive on the test but did not have the condition.  The responses to the HADS-A items 
of the 21 students who scored highly on HADS-A but did not reach diagnostic threshold for 
GAD as determined by SCAN are explored below.   
 
No students who reached the diagnostic threshold for generalised anxiety disorder as 
determined by SCAN had a HADS-A score below 8, there were therefore no false negatives 
using the original cut-off score of 8.   
 
4.4.2.1 HADS-A false positives  
To explore possible false positives the 21 of the students interviewed who scored 8+ on the 
HADS-A scale, but did not reach diagnostic threshold for GAD as determined by SCAN were 
then explored. Items in which these participants scored particularly highly were identified. 
Responses to equivalent SCAN questions were reviewed and compared to their HADS 
responses.   Responses to each HADS item are rated between 0-3. 0 suggesting the symptom is 
not present and 3 suggesting the symptom is present to a significant level.   
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The responses given to HADS-A items by the 21 students identified as false positives on HADS-
A at the original cut off can be seen in figure 11 below.  
Figure 11 - Responses to the HADS-D items of those students who scored above 8 on HADS-D 
but did not reach the threshold for depression as determined by SCAN 
 
 
 
This graph highlights that those HAD-A items which these ‘false positive’ medical students 
responded highly on included ‘Worrying thoughts go through my mind’ and ‘I feel restless as 
if I have to be on the move’. Items which these medical students scored lower on included “I 
get a sort of frightened feeling like butterflies in the stomach’ which 17 out of the 21 students 
said they experienced only occasionally or not at all and ‘I get sudden feelings of panic’ which 
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13 of the 21 students experienced not very often or not at all.  The items which students scored 
highly on will be explored in more detail below.   
 
4.4.2.1.1 Worrying thoughts go through my mind 
In relation to the statement ‘Worrying thoughts go through my mind’ 14 (67%) of the 21 
students responded with ‘a lot of the time’ (HADS score 3 for this item) and 3 responded with 
‘a great deal of the time’ (HADS score 2 for this item).  (2 responded with ‘from time to time’ 
and 2 responded occasionally).   
In the SCAN interviews the medical students were asked about their worrying, this being one 
of the main symptoms of anxiety.  17 of the 21 students in question talked about having 
worrying thoughts or feeling anxious but only 4 students were worrying to a clinically 
significant level where it was affecting their everyday activities.  
In their responses to the SCAN questions many medical students talked about feeling worried 
about their course and the amount of work that they needed to do, but some felt that this was 
normal for medical students.  
 
“I worry a lot, constantly……. I worry that I won’t pass this year, that I won’t pass finals, that I 
am not improving in any way, instead of improving I am degenerating.  Also, that I haven’t 
done the things I wanted to do.” 
“not doing as well as everyone else, not working as hard as everyone else, not being as 
confident as everyone else.  Feeling a bit behind.  …I worry about them a lot of the time” 
 
“I think I worry more than I should but there is so much pressure on us as medical students, 
pressure to do this work and hundreds of assessments to do… they make it seem to us like it’s 
a big deal, so then we think it’s a big deal then we worry about it, whereas if I stood back and 
took a look at medical students I would say your worrying about nothing, but we are all 
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worrying about the same thing….from any other medical student I am no different… You are 
talking to a ** year medical that is normal” 
“I worry about work, I worked really hard last year and did rubbish so I’m working harder.  But 
I couldn’t have worked harder last year so I’m worrying a lot about that and also because my 
degree is one where you never finish the work, it’s like how much do I do.  When do I give 
myself a break because I could not sleep and work all night and still wouldn’t have done 
enough.  So, I definitely worry about that.   
 
“(I worry about) workload and making enough time to do the things I enjoy.” 
 “(I worry about)   Mainly work related things”   
 
Whilst many were worrying about their course, this worry for most (17 out of the 21 students) 
did not reach clinically significant levels.  
 
4.4.2.1.2  I feel restless as if I have to be on the move 
When answering the HADS-A item ‘I feel restless as if I have to be on the move’ 3 of the 21 
students under consideration  reported they felt restless ‘not very much’ (HADS score 1 for this 
item), 10 said they felt restless ‘quite a lot’ and 8 said they felt restless ‘very much indeed’.   
 
In the SCAN interviews, students were asked if they had been feeling restless over the last 
month, restlessness being a symptom of generalised anxiety.  13 of the 21 students described 
feeling restless but only 2 had restlessness to an extent that was clinically significant where 
they had feelings of restlessness most of the time or were finding themselves often pacing 
around.  During the SCAN interviews some students did talk about being fidgety and restless, 
many said that this was no different to how they normally behaved, some talked about having 
lots to do and some said they feel restless when sat working for long periods.  
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Normal behaviour 
“I’m just like that I’m quite an energetic person” 
 “I like to be physically active” 
“Yes but I do that quite a lot, I’m a bit of a fiddler” 
“Yes I’ve always been like that” 
 
Being busy 
“I’m just a busy bee… I’d rather just be doing something” 
“All the time I feel like I need to be doing something”  
“I’m not pacing for no reason I’ll get up and be busy and active in a purposeful way” 
 
Having been sat for a long time 
“Mainly in terms of concentration, you just want to get up and not… I think it’s more of an 
avoidance thing you don’t want to be sat doing it.” 
“when I’m sat down doing work of an evening” 
“for example if I’m sat down for an hour I completely stretch out my legs,… because I’m in 
lectures do its not appropriate to start running around”  
“In the evenings when I haven’t got enough exercise in… if I’m wanting to do some exercise.   
 
Therefore, whilst many students felt they had been restless during the previous month, most 
(19 out of 21) did not experience this to an extent that was clinically significant.   
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4.4.2.2 Summary of the HADS-A qualitative analysis 
 
Exploration of the HADS-A items of those students who score above 8 on HADS-A but did not 
reach diagnostic criteria for GAD highlighted that responses to two HADS-A items were 
particularly high.  These items were ‘Worrying thoughts go through my mind’ and ‘I feel 
restless as if I have to be on the move’.  Although 17 of these students scored high on the 
HADS-A item Worrying thoughts go through my mind’ when worrying thoughts were explored 
in the SCAN interview only 4 had clinically significant levels of worrying.  Some of the students 
were worrying about their course and whether they are working hard enough.   
When exploring the item ‘I feel restless as if I have to be on the move’ 18 students scored 
relatively highly on this HADS-A item.  However, when restlessness was explored during the 
SCAN interviews only 2 students in the ‘false positives’ group had clinically significant levels of 
anxiety.  Others talked about always feeling restless (their normal state), others that they are 
just busy, or like to be busy and some talked about not being able to sit for long periods of 
time without feeling restless.   
 
 
4.5 Summary of interview data  
 
50 clinical SCAN interviews were carried out with medical students.  Prior to starting the 
clinical interviews, the students were asked to complete HADS.  The interviews were rated by 
the interviewers and a diagnosis determined using ICD-10 criteria for depression and 
generalised anxiety disorder.  Results from HADS and the interviews were compared.  To check 
consistency of ratings inter-rater reliability was calculated.  There was a high level of inter-
rater reliability when comparing ratings relating to symptoms and a moderate level of 
agreement relating to diagnosis ratings.   
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Using the ICD-10 diagnostic criteria for depression, three students had clinically significant 
levels of depression.  Using these cases as clinically significant sensitivity and specificity was 
calculated for different cut-off thresholds for HADS-D. These calculations found a cut-off of 7 
gave optimum levels of sensitivity and specificity with depression in the current sample.  At 
this cut-off threshold 11 students in the current sample would reach this threshold compared 
to 3 students who had clinically significant levels of depression as determined by clinical 
interview.   
 
The HADS-D items of those medical students who scored above 8 on HADS but which did not 
reach the threshold for a depression diagnosis were compared to their responses in the SCAN 
interview.    The HADS-D items which students in this sample scored themselves highest on 
were ‘I feel as if I am slowed down’ and ‘I can enjoy a good book or radio or TV Programme’. 
Four of the six students scored high on the HADS-D item  ‘I feel as if I am slowed down’, but 
only 1 was moving physically slower to an extent that was clinically significant as determined 
by the SCAN interviews.  Some of these students talked instead about feeling behind on the 
course, rather than a physical feeling of moving slower.  Five of the six students scored high on 
‘I can enjoy a good book or radio or TV programme’, however, no students in this ‘false 
positives’ group had a loss of interest to a clinically significant level as determined by their 
SCAN interview.  Some talked about not having the time to do leisure activities, suggesting 
their lack of enjoyment of activities may be due to their circumstances/lack of free time and 
not their mental health.   
Using ICD-10 criteria for anxiety 4 medical students in the current sample had clinically 
significant symptoms for generalised anxiety disorder for the month prior to interview.  
Sensitivity and specificity was calculated for different cut-off thresholds for HADS-A. It is 
suggested given these calculation that a HADS-A cut off of greater than or equal to 13 would 
be optimal in identifying medical students with anxiety in the current sample.  At this cut-off 
threshold, 8 students in the current sample would reach this threshold compared to 4 students 
who had clinically significant levels of anxiety symptoms as determined by clinical interview.   
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The HADS-A items of those medical students who scored above 8 on HADS-A but which did not 
reach the threshold for a GAD diagnosis (n=21) were compared to their responses in the SCAN 
interview.    The items which these students scored high included ‘Worrying thoughts go 
through my mind’ and ‘I feel restless as if I have to be on the move’.  17 students scored high 
on the HDAS-A item worrying thought go through my mind but only 4 of this group of students 
had significant levels of worry.  Many of the students were worrying about their course but not 
to a clinically significant level.  18 students in this ‘false positives’ group scored highly on ‘I feel 
restless as if I have to be on the move’ although only two students in the group have 
restlessness to a clinically significant level as determined by the SCAN interviews.  Students 
talked about a range of aspects relating to restlessness including being a restless person, being 
busy or not finding it easy to sit for long periods when working or in lectures.  
 
4.6 Responses to research questions 
 
This project aimed to answer three research questions, these are described below with an 
explanation of how the above results answer each question.   
The research questions for this project were: 
Research question 1: Is HADS an accurate measure of depression and anxiety in medical 
students? 
The area under the curve for both the depression (AUC= 0.936) and the anxiety (AUC = 0.948) 
ROC curves suggest that in the current sample both the HADS depression and anxiety 
subscales can distinguish between medical students  who are likely to be suffering from 
depression or anxiety and those that are not.   
 
Research question 2: Are the standard cut off scores of 8+ on the HADS-D and HADS-A 
subscales appropriate for a medical student population? 
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Results from this study suggest the HADS-D cut off should be 7 and the HADS-A cut off should 
be increased to 13.   
For the HADS-D subscale the cut-off score which resulted in the best balance between 
sensitivity and specificity was 7 for this medical student sample.  Sensitivity at the original cut-
off of 8 was 0.67 for this sample with a specificity of 0.87.  Thus the original cut-off would have 
a sensitiviy below what is considered an acceptable level (Gilbody et al, 2006) suggesting that 
the original cut off may not be appropriate for a medical student population.   
For the HADS-A subscale the cut-off score which resulted in the best balance between 
sensitivity and specificity was 13 for this medical student sample. Sensitivity at the original cut-
off of 8 was excellent at 8 for this sample.  However specificity was very low at 0.54.  Thus the 
original cut-off would have a specificity below what is considered an acceptable level (Gilbody 
et al) suggesting that the original cut off may not be appropriate for a medical student 
population.   
 
Research question 3: Do the responses to individual items within the subscales truly reflect 
the presence of anxiety and depression? 
Exploration of the responses of the students who scored highly on the HADS subscales but 
which did not reach the threshold for clinical diagnosis, suggests that some HADS items are 
scored more highly by the medical students in these groups.  These were I feel as if I am 
slowed down’ and ‘I can enjoy a good book or radio or TV Programme’ for the depression 
subscale and ‘Worrying thoughts go through my mind’ and ‘I feel restless as if I have to be on 
the move’ for the anxiety subscale.  For all of these items, only a small number actually 
experienced these symptoms to a clinically significant level as determined by their SCAN 
interviews.  Some of the medical students talked in their interviews about other aspects 
broadly relating to these symptoms.  These students did not interpret and answer the 
questions in a way in which would suggest that they were experiencing the symptoms to a 
clinically significant level as described in the ICD-10.   This may explain why, in the case of 
anxiety, the cut-off for the HADS-A subscale may require a change for this particular cohort.  
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Chapter 5: Discussion 
The preceding chapters have detailed the rationale, design, methodology and results of a 
project which had the primary aim of investigating the suitability of HADS to screen for 
depression and anxiety in a medical student population.   
This chapter will review the results of the study and discuss these in the context of the wider 
literature.  The strengths and limitations of the study will also be reviewed.  Finally, the 
implications of the study will be highlighted along with conclusions which can be drawn from 
the study.     
 
5.1 Key findings and contributions 
This project had 3 specific research questions: 
• Research question 1 – Is HADS an accurate measure of anxiety and depression in medical 
students? 
 
• Research question 2 – Are the standard cut off scores of 8+ on the HADS-D and HADS-A 
subscales appropriate for a medical student population? 
 
• Research question 3 – Do the responses to individual items within the HADS subscales 
truly reflect the presence of anxiety and depression.   
To answer these questions 50 medical students were recruited and took part in a face to face 
meeting.  During the face to face meeting the medical students completed the HADS 
questionnaire and then undertook a clinical interview using the SCAN clinical interview 
technique.  Of the 50 students who participated, 7 (14%) were male and 43 (86%) were 
female.  The proportion of male students who took part in the project was lower than the 
proportion of male medical students studying at Cardiff at the time which was on average 37% 
male. A summary of how the results from the study answer each of these research questions is 
detailed below.  The cut-off scores for the depression and anxiety subscales (Research 
question 2) will be considered separately.  
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5.1.1 – Is HADS an accurate measure of anxiety and depression in 
medical students? 
 
This project aimed to determine if HADS is able to distinguish between medical students who 
are suffering from depression and/or anxiety and those who are not. The current study was 
concerned with the two separate subscales of HADS, these being the depression subscale and 
the anxiety subscale. These subscales are used to screen for anxiety and depression.  In order 
to establish how valid these subscales were for screening for depression and generalised 
anxiety, within a medical student sample, the medical students HADS results were compared 
to clinical interview data.  Clinical interviews are seen as the gold standard for diagnosing 
depression and anxiety.  Interviews allow the interviewer to explore the responses provided to 
establish if a symptom has been present, for how long and the effect that the symptom has 
had on the individual’s quality of life.  To test the validity of HADS, students undertook a SCAN 
clinical interview to determine if they meet the criteria for depression or generalised anxiety.  
An individual’s diagnosis could then be compared to their HADS subscale scores.  Sensitivity 
and specificity were then calculated for different HADS cut-off points and a ROC curve plotted.  
The area under the curve (AUC) was then calculated.  The AUC score is defined as “the 
probability that a randomly sampled respondent will be correctly assigned to the appropriate 
group” (Hanley & McNeil, 1982).  AUC is the probability that individuals who score above the 
cut-off for depression on HADS also reach the threshold for a diagnosis of depression 
according to SCAN.  The AUC value is therefore considered to represent the overall accuracy or 
validity of the instrument (Balsamo & Saggino, 2014).  AUC scores vary from 0.5 to 1, a score of 
1 suggests that the test is perfect and a score of 0.5 suggests a worthless test.  
In the current sample 3 students reached the diagnostic criteria for depression (from their 
SCAN interviews).  The HADS-D scores for students who meet the ICD-10 diagnosis for 
depressive disorder ranged from 7 to 12, whereas the HADS-D scores for those who did not 
meet the criteria ranged from 0 to 11.  The area under the curve for the HADS depression 
subscale was 0.936.   
For the anxiety subscale 4 medical students’ symptoms for the month prior to interview 
reached the threshold for ICD-10 diagnostic criteria for generalised anxiety disorder.  The 
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HADS-A scores for students who meet the ICD-10 diagnosis for generalised anxiety ranged 
from 13 to 17, whereas the HADS-A scores for those who did not meet the criteria ranged from 
0 to 16.   The area under the curve for the HADS anxiety subscale was 0.948.   
The high AUC scores for both subscales suggest that in the current sample both the HADS 
depression subscale and the HADS anxiety subscale were relatively good at distinguishing 
between medical students who were and were not suffering from depression or anxiety 
respectively.  Therefore, for the current sample of medical students, HADS would be 
considered a suitable tool for identifying students who may be suffering from depression 
and/or anxiety.   
 
5.1.2 Is the standard cut off scores of 8+ on the HADS-D subscale 
appropriate for a medical student population? 
 
The original authors of the instrument proposed cut-off scores between 8 and 10 for ‘possible’ 
cases, and scores of 11 or more for ‘probable’ cases in both the anxiety and depression scales.  
Since then studies have used values between 8 and 11 when using HADS, with the majority 
using a single cut-off value of 8.  For the current study comparisons will be made to the 
standard cut-off score of 8 for ease of comparison.   
To establish if the standard cut-off score of 8+ for the HADS-D subscale is appropriate for a 
medical student population, the sensitivity and specificity of different cut-off scores was 
calculated.  These were then plotted on a ROC curve and Youden’s index was calculated to 
determine the optimum cut-off for the current sample.   
Using the standard accepted HADS-D cut-off point of 8 for possible cases, the sensitivity in the 
current sample was 0.67 with a specificity of 0.87. This implies that of those students with 
depression, 67% had a HADS score above 8, however, 33% of students with depression would 
go undetected at this cut-off.  87% of cases who did not have a diagnosis of depressive 
disorder had a score below 8. Negative predictive value is the probability that a person with a 
negative (normal) test result is truly free of disease.  The NPV for the current sample at a cut 
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off of 8+ was high at 0.98, suggesting 98% of those whith a negative result would not not have 
depression but 2% of those with a negative result would have depression.   
The youden index values suggested that a cut-off of 7 and above for the HADS depression scale 
would be optimum for this sample. If the cut-off was reduced to 7, the sensitivity of the test 
would rise to 1.00, suggesting at this cut-off all students with depression would be idenfiied. 
The specificity however would reduce to .83, suggesting 17% of students who did not have 
depression would reach the cut-off for depression.   
In summary, results from the current study suggest that the standard cut-off score of 8+ would 
mean that not all medical students with depression would reach the HADS cut-off, suggesting 
that this cut-off score is not optimum for medical students.   A optimal cut-off would be 7+ for 
the current sample.  Reducing the cut-off for medical students may identify those students 
who would reach the threshold for depression at an earlier stage.  Earlier detection of 
depression would allow for earlier support and treatment if required.   
 
5.1.3 Is the standard cut off scores of 8+ on the HADS-A subscale 
appropriate for a medical student population? 
 
As with the depression subscale to establish if the standard cut-off score of 8+ for the HADS-A 
subscale is appropriate for a medical student population, the sensitivity and specificity of 
different cut-off scores was calculated.  These were then plotted on a ROC curve and Youden’s 
index was calculated to determine the optimum cut-off for the current sample.   
At the original suggested cut of point of 8+ for the HADS anxiety subscale, for the current 
sample, sensitivity was 1.00 suggesting that all students who have clinical levels of depression 
as rated by SCAN would score positively on the HADS-A subscale.  However at this cut-off 
specificity was very low at 0.54 suggesting only 54% of students who did not have anxiety had 
a negative HAD-A score (ie below the cut-off), and 46% of students without clinical levels of 
depression, as rated by SCAN, would have a positive HADS-D result 
The Youden Index was calculated for all cut-off and was greatest for a cut-off of 13 and above 
at 0.913.  This suggests that for this sample a HADS-A cut-off of 13 would give the optimum 
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balance of sensitivity and specifity for determining those students who are likely to suffering 
from anxiety.   
At a HADS-A cut-off of  ≥13 , again all students who had clinical levels of anxiety as rated by 
SCAN had a positive HADS-A result, however specificity increases to 91% resulting in only 9% of 
this group without clinical levels of anxiety as rated by SCAN having a positive result on HADS-
A.  If the HADS cut-off was increased beyond 13, whilst specificity would increase the 
sensitivity would decrease meaning that not all students with anxiety would have a positive 
HADS-A result.   
 
In summary, results from the current study suggest that the standard cut-off score of 8+ would 
mean that nearly half of students who did not have anxiety would have a positive HADS-A 
score and thus this cut-off would not appear to be appropriate for medical students.   A more 
optimal cut-off would be 13+ for the current sample.   
 
5.1.4 Research question 3: Do the responses to individual items within 
the HADS subscales truly reflect the presence of anxiety and depression.   
 
In order to answer this research question students who scored above the standard cut-off 
points on the HADS subscales but did not reach the diagnostic criteria for depression or anxiety 
(false positives) were explored.  For the HADS-D subscale 6 students scored above the 
standard cut-off and did not reach the diagnostic criteria for depression.  Exploration of these 
6 students HADS-D responses highlighted that these medical students scored very highly on 
two items.  These items were ‘I feel as if I am slowed down’ and ‘I can enjoy a good book or 
radio or TV Programme’.  Further exploration was carried out on responses to these two items 
and responses were compared to responses to similar questions asked in the SCAN interviews.  
Although 4 students scored high on the HADS-D item ‘I feel as if I am slowed down’, when 
retardation was explored via SCAN only 1 of these students felt that they were moving 
physically slower to an extent that was clinically significant.  Some of these students talked 
instead about feeling behind on the course and feeling that others were doing more work or 
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were better than them.  In terms of the HADS-D item ‘I can enjoy a good book or radio or TV 
programme’, 5 of the 6 students scored high on this HADS-D item.  Though, none of the 
students who talked about not enjoying activities during their SCAN interviews had a loss on 
interest to a clinically significant level.  Some talked about not having the time to do these 
activities, suggesting their lack of enjoyment of activities may be due to their circumstances 
and not their mental health.   
A similar exploration was carried on the HADS-A items of those students who score above 8 on 
HADS-A but did not reach diagnostic criteria for GAD.  21 students score above the standard 
cut-off of 8 on HADS-A but did not reach diagnostic criteria for GAD.  Exploration of these 
students’ HADS-A responses highlighted that responses to two HADS-A items were particularly 
high.  These items were ‘Worrying thoughts go through my mind’ and ‘I feel restless as if I 
have to be on the move’.  Although 17 of these students scored high on the HADS-A item 
Worrying thoughts go through my mind’ when worrying thoughts were explored in the SCAN 
interview only 4 had clinically significant levels of worrying.  Some of the students were 
worrying about their course and whether they are working hard enough.  When exploring the 
item ‘I feel restless as if I have to be on the move’ 18 students scored relatively highly on this 
HADS-A item.  When restlessness was explored during the SCAN interviews only 2 students in 
the ‘false positives’ group had clinically significant levels of anxiety.  Others talked about 
always feeling restless (their normal state), others that they are just busy, or like to be busy 
and some talked about not being able to sit for long periods of time without feeling restless.   
In summary, exploration of the responses of the students who scored highly on the HADS 
subscales, but which did not reach the threshold for clinical diagnosis, suggests that there 
were some patterns particularly in the items in which these students scored particularly high.  
When these high scoring items were further explored, only a small number of students actually 
experienced these symptoms to a clinically significant level as determined by their SCAN 
interviews.  In all cases, some of the medical students talked in their interviews about other 
aspects broadly relating to these symptoms.  These students did not interpret and answer the 
questions in a way in which would suggest that they were experiencing the symptoms to a 
clinically significant level as described in the ICD-10.   This may explain why, in the case of 
anxiety, the cut-off for the HADS-A subscale may be different to the original cut-off.   
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5.1.5 Summary of findings 
 
Results from this study found that in the current sample both the HADS depression subscale 
and the HADS anxiety subscale were relatively good at distinguishing between medical 
students who were and were not suffering from depression or anxiety respectively.  Suggesting 
that for the current sample of medical students, HADS would be considered a valid tool for 
identifying students who may be suffering from depression and/or anxiety.  However, 
optimum cut off scores for the depression and anxiety subscales, for the current sample varied 
from the standard cut-off score of 8+.  Optimum cut-off scores were 7+ for the depression 
subscale and 13+ anxiety subscale,   
Exploration of the responses of the students who scored highly on the HADS subscales, but 
which did not reach the threshold for clinical diagnosis, suggests that there were some 
patterns particularly in the items in which these students scored particularly high.  Items 
scored highly were I feel as if I am slowed down’ and ‘I can enjoy a good book or radio or TV 
Programme’ for the depression subscale.  For the anxiety subscale Worrying thoughts go 
through my mind’ and ‘I feel restless as if I have to be on the move’ were scored highly.   Only 
a small number of students experienced these symptoms to a clinically significant level as 
determined by their SCAN interviews.  The remaining students did not interpret and answer 
the questions in a way in which would suggest that they were experiencing the symptoms to a 
clinically significant level as described in the ICD-10.    
 
5.2 Findings in the context of wider literature  
 
The results from this study have been summarised in Section 5.1 above.  The results for each 
research question will now be discussed in relation to the wider literature.    
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5.2.1 Is HADS an accurate measure of anxiety and depression in medical 
students? 
Results from this study suggests that HADS is a valid tool for use with a UK medical student 
population.  Whilst HADS has been criticised for reduced validity with some populations 
(Bjelland et al, 2002) many studies have used HADS with a medical student sample.  Many of 
the studies using HADS with a medical student population are either using it to determine the 
prevalence of depression and or anxiety in different medical student populations around the 
world (eg Rab et al, 2008, Ibrahim et al, 2013).  Other studies using HADS with medical 
students have looked at factors which affect medical student’s health wellbeing (eg Voltmer et 
al, 2012, Kotter et al, 2014). However, the author is not aware of any other studies which 
compare HADS results to a clinical interview diagnosis for determining its validity for use with 
this population.  Ali et al (2016) suggest that any tools (especially if used for screening for 
depression and anxiety) should be validated locally against a gold standard diagnostic 
interview to confirm its validity for the study population.    
Therefore, this study provides new support for HADS with this population. This study was 
concerned with the criterion validity of HADS, determining its ability to identify students who 
may be suffering from depression or anxiety, again a gold standard diagnostic interview.   
Nevertheless, other aspects relating to the use of HADS with this population also need to be 
explored, before users can be fully confident in using HADS as a screening took for depression 
and anxiety in medical students.  These include, exploring the factor structure and construct 
validity of HADS and ensuring HADS provides reliable results with this population.  As outlined 
in the literature review (see section 2) many studies have questioned the structure of HADS 
(Cosco et al, 2012).  However, it has been suggested that the differences seen in the 
dimensionality results may be due to methodological differences and the specific analytic 
strategy employed to evaluate them rather than different psychological traits (Straat, 2013; 
Cosco et al; Norton 2013).  Determining if a two factor (depression and anxiety) structure is 
found when HADS is used with a medical student sample would provide additional support for 
its use with this population.  
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5.2.2 Are the standard cut off scores of 8+ for the subscales appropriate 
for a medical student population? 
 
The original authors of the HADS instrument proposed cut-off scores between 8 and 10 for 
‘possible’ cases, and scores of 11 or more for ‘probable’ cases for both the anxiety and 
depression subscales (Zigmond & Snaith, 1983).  Since the publication of the original scale 
many studies have reviewed the cut-off scores that are likely to give the greatest sensitivity 
and specificity for detecting clinical levels of anxiety or depressive symptoms (Bjelland et al, 
2002). In a literature review looking at the validity of HADS, cut off points ranged from 3+ to 
11+ for anxiety and 4+ to 11+ for depression (Bjelland et al, 2002).   
Studies using HADS with medical students have used cut-off scores for the depression scale 
ranging from 7+ to 12+ (Rotenstein et al, 2016).  Reasons for these differences are in part due 
to the interpretation of the original cut-off range of between 8-10 for possible cases and 11+ 
for probable cases, meaning some use 8+ as a cut off, others 11 and one study 12 (Rab et al, 
2008; Prinz et al, 2012; El-Gilany at al, 2008).  Other reasons are due to validation of HADS in 
specific languages, hence Turkish studies used a cut-off of 7 (Akvardar et al, 2004) as this was 
the cut off suggested when the tool was validated for a Turkish population (Aydemir et al. 1997)   
The use of different specific cut-off points makes comparison of results across studies difficult.  
In addition, none of these cut-offs are based on a validation study specifically involving medical 
students.   
Studies comparing self-report to clinical interviews are sparse, no studies of this nature were 
found for HADS with a UK medical student population. In a study involving a UK general 
student population, Andrews et al (2006), compared HADS to clinical interviews (using the 
Structured Clinical Interview for DSM-IV Axis 1 disorders).  The authors noted that students 
tended to over-report levels of anxiety using HADS (11).  They concluded that for the HADS-D 
subscale a cut-off score of 10 gave optimum sensitivity/specificity balance. For the HADS-A 
subscale the best sensitivity/specificity balance was a cut-off of 13.  At this cut off however for 
both scales the sensitivity and specificity values were both below 8 and only half of students 
with HADS-A scores of 13 and over had clinical levels of anxiety. 
Results from the current study suggest that for the HADS-D subscale the standard cut-off score 
of 8+ (original score for possible cases) would mean that not all medical students with 
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depression in the current sampple would reach the HADS cut-off.  A optimal cut-off would be 
7+ for the current sample.  For the HADS-A subscale the standard cut-off score of 8+ (for 
possible cases) would mean that nearly half of students who did not have anxiety would have a 
positive HADS-A score.   At the cut off of 11+ (the original cut off for probably cases) whilst all 
those who had anxiety would have a positive score, 20% of those who did not have anxiety 
would also have a positive score.  A optimal cut-off for the HADS-A subscale would be 13+ for 
the current sample.   
Therefore, both the current study and Andrews et al suggest that a cut off of 13+ for the HADS-
A subscale would give the best sensitivity/specificity balance for students and medical 
students. In contrast,  Andrews et al suggest a cut off of 10+ for the HADS-D subscale whereas 
in the current study found an optimal cut off of 7+ for the HADS-D subscale.   
Andrews study (11) examined anxiety and depression in a general student population whereas 
the current study specifically looked at a medical student cohort. Both these studies suggest 
that students when completing HADS report high levels of anxiety which is not supported by 
clinical interview data. The current study used the Youden Index to determine the optimum 
cut-off score for probable cases.  It has been suggested that the Youden index provides a 
slightly more sensitive cut-off threshold (ie a slightly lower cut-off) (Hajian-Tilaki, 2017).  Given 
the sensitive nature of the conditions being tested, it was decided that a test which produced a 
slightly more sensitive threshold may be of more value and as such the Youden Index method 
for calculating the optimum cut-off score was used.  Andrews et al, used a measure of overall 
efficiency to determine optimum cut off which was the percentage of cases correctly classified 
as having or not having a diagnosis.   
Thus, the disparity in sensitivity, specificity and optimum cut-offs between the current study 
and Andrews et al study may be due to methodological differences. This could relate to the 
instrument or interview to which the HADS tool was compared to. Andrews in his study made 
comparisons using DSM IV for diagnostic criteria whereas our study used ICD 10 criteria. 
Differences in outcomes across the two studies may also be due to characteristics which are 
inherent in the sample being tested.  Medical students are recognised as having high levels of 
neurotic perfectionist traits which is a risk factor for common mental health conditions such as 
anxiety and depression (Lessin, & Pardo, 2017).  Medicine also recruits a high percentage of 
woman to the course. Woman are more likely to self-report anxiety than men. The current 
sample consisted of 84% female, whereas the sample used in Andrews et al’s study was 70% 
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female   It could be that for accurate assessment of self-report symptoms different student 
groups may require slightly different cut-off points to achieve the optimum 
sensitivity/specificity balance.  
 
5.2.2.1 Effect of cut-off values on prevalence 
The cut-off values which are used for HADS will affect the prevalence found in studies using 
HADS.  For example, in the current study, true prevalence of depression as determined by the 
scan interviews was 6%.  However, prevalence as determined by HADS-D would be 16% at a 
cut-off of 8+ and 22% at a cut-off of 7+.  As cited in the introduction a 2016 meta-analysis of 
studies suggested a global prevalence of depression amongst medical students of 28.0% 
(Puthran et al, 2016).  Another 2016 meta-analysis identified prevalence rates from 1.4% to 
73.5% (Rotenstein et al, 2016). Of the seven studies identified in the Rotenstein analysis, which 
were based in the UK, prevalence ranged from 4.4 % (Newbury-Birch et al, 2001) to 48.8%.  
(Honney et al, 2010). Of these seven studies, four used HADS to measure prevalence and all 
used a 8+ cut off value.  Prevalence of these four studies were 4.4% (Newbury-Birch et al, 
2001), 9.6% (Picjard et a, 2000), 1.6% (Ashton and Kamali 1995) and 6.6% (Quince at al, 2012).  
Whilst these values are not dissimilar to the 6% true prevalence (as determined by SCAN 
interviews), they are lower than the prevalence found in the current sample as determine by 
HADS-D with a 8+ cut-off. The true prevalence found in the current study is similar to that 
found in the general population of a similar age: A National survey of mental health in the UK 
suggests that the prevalence of depression amongst 16-24 year olds is 2.3% (Stansfeld, et al, 
2016) suggesting that medical students may have a slightly higher prevalence of depression 
(6%) than the general population of a similar age (2.3%).   
 
For anxiety in the current sample true prevalence (as determined by the SCAN interviews) of 
generalised anxiety disorder was 8%.  However, prevalence as determined by HADS would be 
50% at a cut-off of 8+ and 16% at a cut-off of 13+.  Andrews et al, found prevalence of anxiety 
at a cut-ff of 8+ in their general student sample of 76%.  In a systematic review of studies 
looking at anxiety amongst medical students in Europe and English speaking world outside 
North America prevalence of anxiety was very variable between studies, ranging from 7.7.% to 
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65.5% (Hope & Henderson, 2016).  In one study using HADS with a UK medical student sample 
found prevalence of 39.2% for anxiety using an 8+ cut-off value (Ashton and Kamali, 1995).  
Newbury-Birch et al (2001), found prevalence levels of 47% for second year medical students 
which dropped to 26% by final year again using 8+ as the cut-off. Given the variable level of 
anxiety in medical students from these studies it is difficult to determine how typical the 
prevalence of anxiety found in current study is compared to other samples of medical 
students.  The true prevalence  of anxiety in the current sample of medical students (as 
determined by the SCAN interviews) of 8%  is not dissimilar to that seen amongst 16-24 years 
as seen in the 2014 Adult Psychiatric Morbidity Survey (APMS) (prevalence amongst UK 16-24 
year olds was 6.3%)  (Stansfeld, et al, 2016).  This may suggest that prevalence of anxiety in 
medical students may only be slightly higher than the general population of similar age.   
 
 
5.2.3 Do the responses to individual items within the HADS subscales 
truly reflect the presence of anxiety and depression.   
A further area considered in the present project is interpretation of the individual items of the 
scales or instruments. For both HADS subscale item responses there was disparity, for students 
who scored highly on the HADS subscales, but which did not reach the threshold for clinical 
diagnosis, between the responses given on the HADS items and the answers given by the same 
medical students in clinical interview. The HADS-D subscale items in which it seemed students 
tended to report highly were ‘I feel as if I am slowed down’ and ‘I can enjoy a good book or 
radio or TV Programme’. Within the HADS A subscale items students seemed to report highly 
on the items ‘‘Worrying thoughts go through my mind’ and ‘I feel restless as if I have to be on 
the move’.  When these high scoring items were further explored, for all the items, only a small 
number of students actually experienced these symptoms to a clinically significant level as 
determined by their SCAN interviews.   
Andrews et al (2006) also explored the interview responses of some of their ‘non-cases’ 
(according to their diagnostic interviews) who had high anxiety HADS scores (11+). Andrews et 
al, do not report qualitatively on the types of responses given, instead they identified the 
symptoms which were present in these students and the length of time the symptoms were 
present for.  Andrews et al found that a third of these non-cases with high HADS-A scores, had 
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high levels of worry and difficult controlling worry. In addition, Andrews et al found that these 
symptoms were not present for more than a month.   Andrews et al conclude, given these 
students’ responses that “much of the high anxiety that students endorse on questionnaires 
may reflect transient feelings and responses to transient situations. Examples of such 
situations are likely to include coursework deadlines, and relatively short-lived relationship 
problems”.   
Analysis of the interview responses in the present study found that students who were non-
cases but had high HADS-A scores, as with the Andrews study, reported excessive worrying but 
not to a clinically significant level.  These symptoms did not reach a clinically significant level 
either due to the symptoms not being present for more days than not and/or for not being 
present for at least a month.  Whilst as Andrews et al suggests this may suggest that students’ 
anxiety is transient or linked to transient situations, qualitative examination of the current 
students interview responses suggest otherwise.  Whilst the medical students in the current 
study talk about worrying about work, their worry appears to not be about an individual 
deadline but a greater feeling that they are not doing enough or that they won’t pass the 
course.  Whilst this worry may not be present continually or to a significant level, neither does 
it appear for medical students to be linked to a transient situation such as a coursework 
deadline. This may reflect the differences between medical students and other students.  
Medical students have a much more academically demanding course than many other 
students and may have many deadlines and exams (Yiu, 2005).  Wider literature has also 
suggested that much of medical students’ stress is course related suggesting common 
problems include workload, fear of falling behind and exam failure worries (Malik, 2000).   
Results from the current study suggest that for many of the medical students interviewed this 
is true, though, for the majority of students these worries do not reach a clinically significant 
level.   
Also, in contrast to Andrews et al’s students, the medical students in the present study who 
were non-cases but had high HADS-A scores also reported symptoms of restlessness and 
described finding it difficult sitting working for long periods. Again, these findings may be the 
result of the demanding nature of the course, combined with the high contact hours 
experienced by medical students, meaning medical students may end up working into the 
evening resulting in feelings of restlessness.  
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Andrews et al did not look at the responses of students who were non-cases for depression 
but had high HADS-D scores.  In the present study some of the medical students in this 
category interpreted feeling slowed down with feeling behind with work.  In the introduction 
for this study, the competitive nature of the medical course was discussed.  Medical students 
feel the pressure to not only pass the course but to be seen as one of the top in the class, their 
peers being those whom they will most likely be up against in the future for jobs (Mahajan 
2010). In addition, the shift in position compared to current peers (going from being one of the 
top achievers at school to average at medical school) may cause stress and anxiety (Dunn et al, 
2008).  This shift in class position compared to being at school , or feeling that you are not 
performing as well as your peers, may cause students to feel that they are getting behind on 
the course, which some medical students interpreted as moving more slowly compared to 
their peers. This feeling may explain the high responses to this HADS-D item.  However, on 
exploration of this symptom with the students many did not feel that they were physically 
moving more slowly suggesting that the students’ interpretation of this symptom is not in line 
with what the item is designed to measure.  
 
The other HADS-D item scored highly by students who were non-cases for depression but had 
high HADS-D scores was ‘I can enjoy a good book or radio or TV Programme’.  Some students in 
this category talked about time restraints and the feeling of guilt if they spent time not 
working. As discussed in the introduction on attending medical school, students may 
experience many lifestyle changes resulting from a lack of leisure time (Graham, 2001).  
Spending time on leisure and recreational activities may cause medical students to feel guilty 
and finding a beneficial work-life balance is something many doctors still haven’t achieved 
(Rich et al, 2016).  However, whilst these students are not able to enjoy these things, it does 
not appear to reach a clinically significant level.  
 
In summary, For both HADS subscale item responses there was disparity, for students who 
scored highly on the HADS subscales but which did not reach the threshold for clinical 
diagnosis, between the responses given on the HADS items and the answers given by the same 
medical students in clinical interview.  When these high scoring items were further explored, 
for all the items, only a small number of students actually experienced these symptoms to a 
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clinically significant level as determined by their SCAN interviews.  In all cases, some of the 
medical students talked in their interviews about other aspects broadly relating to these 
symptoms. In many cases these aspects were things relating to their course such as feeling 
behind with work, not having time for leisure activities, worrying about the course and feeling 
restless when sitting for long hours.  In many cases these students did not interpret and 
answer the HADS items in a way in which would suggest that they were experiencing the 
symptoms to a clinically significant level as described in the ICD-10.   Whilst these aspects may 
make medical students more likely to interpret the HADS questions differently it does not 
necessarily mean that these aspects cause medical students to suffer more depression and 
anxiety.  This may explain why some medical students may score highly on HADS when they 
are not experiencing anxiety or depression.   Andrews et al reach a similar conclusion, although 
only in regard to anxiety stating that “students' self-reports of anxiety symptoms might have a 
different significance or meaning to that of other groups in the population” (Andrew et al, 
2006 p33).   
 
 
5.2.4   Summary of findings in the context of wider literature.  
 
This study provides new support for HADS with this population.  However, additional 
psychometric properties of HADS need to be explored with this population, including the 
factor structure which has been questioned with other populations.  A range of HADS subscale 
cut-off scores have been used in other studies.  The optimal anxiety subscale score for medical 
students as identified in the current study matches that found by Andrews et al (2006) in their 
study with other students.  In contrast, Andrews et al suggest a cut off of 10+ for the HADS-D 
subscale whereas in the current study found an optimal cut off of 7+ for the HADS-D subscale.  
The use of different cut-off scores could affect the prevalence of depression and anxiety found 
in research studies.  Prevalence found in the current study using the SCAN data suggests that 
suggesting that medical students may only have a slightly higher prevalence of depression and 
anxiety than the general population of a similar age.    
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The disparity between the responses given on some HADS items and the answers given by the 
same medical students in clinical interview were discussed.  Aspects relating to such as feeling 
behind with work, not having time for leisure activities, worrying about the course and feeling 
restless when sitting for long hours, were highlighted.  These aspects have been highlighted in 
other studies as potential factors which may cause increases in depression and/or anxiety.  
Results from the current study suggest they may not cause increase in depression and/or 
anxiety but rather influence how medical students interpret some of the items on self-report 
scales.  This is supported by Andrews et al who suggest students may place a different 
significance to items on self-report scales.   
 
 
5.3 Strengths and limitations 
 
This study has a number of strengths and limitations, these will now be explored.   
 5.3.1 Strengths 
 
The main strengths in the present study are the contribution of new data to the study of 
measurement of depression and anxiety in medical students.  This study is the first that the 
author is aware of which compares medical students’ depression and anxiety self-report 
responses to clinical interview data.  In order to make this comparison two validated tools 
(HADS and SCAN) were used.  Whilst HADS has been criticised for use in some studies it has 
been validated for use in different settings including general practice and community settings 
and is one of the National Institute for Health and Care Excellence (NICE) recommended tools 
for diagnosis of depression and anxiety (Stern, 2014).  SCAN and has been used as a standard 
against which the validity of other instruments is tested and has good reliability and validity 
(Nienhuis et al, 2010). Use of the standardised SCAN technique provides confidence in the 
diagnoses of depression and anxiety which were used to compare to HADS. In addition, 
interviewer’s data was checked and validated between the two researchers and supported by 
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a psychologist with extensive experience at using and training in the use of the SCAN 
instrument. Thus, two validated instruments were used, including a gold standard test and one 
endorsed by NICE (for determining severity of depression) providing high face validity and 
more confidence in the results of the study.   
The two tools, were completed during the same face to face meeting, providing further 
strength to the analysis and comparison.   This is in contrast to the Andrews et al study where 
there was ‘some weeks’ between HADS being completed and the interview being undertaken 
which may have affected the results of the study.  This is particularly important, given Andrew 
et al’s conclusion that students high anxiety as recorded by HADS-A but not by interview, may 
be due to students’ anxiety being transient or linked to transient situations.  A delay of several 
week between the two instruments being completed may result in a change of individuals’ 
situation and therefore there may have been a change in the students’ HADS scores during this 
time. This may have contributed to the lower sensitivity and specificity scores seen in the 
Andrew et al study in comparison to the present study.  In the current study medical students 
completed HADS and then immediately undertook the clinical interview.  The interviewer did 
not study or score the HADS questionnaires prior to undertaking the interview to ensure that 
the interview was not influenced by any HADS responses.   Scoring of both HADS and the 
interview data was carried out subsequent to the face to face meeting.  
The study also investigated the items and diagnostic decisions within the two tools to 
understand the potential differences in responses that might be related to interpretation of 
items and thus the efficacy of HADS as a screening tool for medical students.  Whilst Andrews 
et al studied the type and duration of symptoms and how they related to the students’ HADS 
scores they did not explore qualitatively the responses given in the interviews. Qualitative 
exploration of the interview responses in the current study provided further information 
regarding how students might interpret the questions relating to the symptoms of depression 
and anxiety. This is important as it is widely acknowledged that there are a number of 
differences between medical students and other students or the general population as 
discussed in the introduction.  The author believes this is the first time this type of analysis has 
been undertaken and adds strength to interpretation of the results and how these data might 
be used in the future to support students.  
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 5.3.2 Limitations  
 
This study has identified five main limitations these being the small number of participants, the 
small number of medical students with depression or anxiety, the self-selection of students to 
participate, sequencing bias and the limited demographic data. Each of these limitations will 
be discussed and their possible effect on the results of the study will be highlighted.   
The first limitation to the study is the small number of medical students involved in the study; 
only 50 medical students were recruited to the study.  This study was designed as a pilot 
project to investigate the suitability of HADS as a screening tools for medical students.  As this 
was a pilot project with limited funds, the project did not aim to recruit a ‘calculated sample 
size’ of students.  Calculation of the sample size needed for an effective validation of a 
screening tool is difficult.  The sample size calculation requires knowledge of a number of 
factors which are not all know for this sample.  These factors include knowing the prevalence 
of a condition within a population and the sensitivity and specificity of the diagnostic tool used 
(Bujan & Adnam, 2016).  As discussed in the introduction, the prevalence of depression and 
anxiety in medical students varies significantly in different studies.  Of the seven UK studies 
identified in the Rosenstein et al (2016) meta-analysis, prevalence ranged from 4.4 % 
(Newbury-Birch et al, 2001) to 48.8%.  (Honney et al, 2010). In a systematic review of studies 
looking at anxiety amongst medical student prevalence of anxiety ranged from 7.7.% to 65.5% 
(Hope & Henderson, 2016).  The higher the prevalence of the condition in the sample being 
tested the lower the sample size required. Bujan and Adman’s (2016) guide for calculating 
sample size suggests that the minimum sample size required for a screening test validation 
study for a condition with a prevalence of 5% would be 400 participants with 20 having the 
condition.  For a prevalence of 50% minimum sample size would be 40 with 20 having the 
condition.  This suggests that if the prevalence of depression and/or anxiety in medical 
students was as high as the highest prevalence seen in some studies than the whole sample 
size would be sufficient, but the number of students with depression or anxiety would not be 
sufficient. However, it is unlikely that the prevalence of depression or anxiety is as high as 
suggested by some studies.  True prevalence found in the current study was 6% for depression 
and 8% for anxiety, at these prevalences the sample size used in the current study falls 
significantly short.  This information could be used to determine sample sizes for a larger scale 
study.     
 184 
 
The low number of students with depression and anxiety in the current sample, is also a 
limitation to the current study.  Whilst recruitment methods aimed to target students who 
may have had depression and anxiety (e.g. recruiting students via the student support unit), 
few students reached the threshold for depression and or generalised anxiety disorder.  
Andrews et al, pre-screened the students recruited for their study to increase the number of 
students who scored above 8 on HADS.  However, particularly with the HADS anxiety scale, a 
score of 8 and above would not necessarily mean that the individual had anxiety when 
interviewed.  Thus, pre-screening may not have increased the number of students with true 
depression or anxiety.  In addition, this pre-screening in the Andrew et al study resulted in the 
delay between HADS being completed and the interview taking place, which itself brings about 
difficulties as highlighted in section 5.2.1 above. The current study aimed to as much as 
possible ensure that the interviewers were blind to the medical students HADS results and 
therefore screening the students on the day, prior to interview would have proved difficult.   
 
In addition to the low numbers overall and the low number of medical students with 
depression and/or anxiety, the current study is limited by the self-selection of students to take 
part. Inherent in this type of study is selection bias.  Selection bias suggests that those who 
chose to take part in the study may have different characteristics than those who choose not 
to take part.  As discussed in the introduction some medical students may feel that there is 
stigma attached to mental health conditions.  It is possible that students who feel this, may be 
less likely to take part in a project looking at mental health conditions, particularly if they feel 
that they may be suffering from one. In addition, medical students with depression or anxiety 
may be more likely to take part in a project in which they only have to complete a mental 
health tool or scale anonymously, rather than one in which they are required to undertake an 
interview.  This may explain differences in prevalence between the current study and others in 
which students have not had to undertake an interview.   The limited number of students and 
particularly those with depression and or anxiety, coupled with the self-selecting nature of the 
study limits the generalisability of the findings to the full medical student population.  
Another form of bias which may have affected the results of the current study is order-effect 
bias; HADS was always completed prior to the clinical interviews in the face to face meetings.  
Completing HADS prior to the interviews may have influenced how participants then answered 
questions in the interview.  For example, if respondents when asked to make a quick response 
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to a HADS item, responded very negatively, they may have felt that they had to provide a 
similar response in their clinical interview.  However, had they been asked the same question 
in the interview, without having first completed HADS, they may have given the response more 
consideration and not responded as negatively.  The failure to switch the order of completion 
of the two tools would mean that any order effects were not mitigated.   The order of the 
questionnaire and interview completion was not switched due to the instructions provided for 
completion of the two tools; HADS asks responders not to think too long about their responses 
but to try and  give their immediate reaction.  In contrast the nature of the clinical interview 
encourages participants to consider their symptoms and explore their severity, duration and 
impact.  Switching the order would have meant that if the clinical interviews were completed 
first by some participants, they would had given consideration to similar questions to those 
asked in HADS and therefore may have given a more considered response to HADS items, 
which is contrary to the HADS instructions.  In addition, the follow up questions and for the 
SCAN clinical interviews, allows for each symptom to be explored in detail to help prevent bias.   
 
The final limitation identified in the current study is the limited demographic information 
included in the study. Due to the sensitivity of investigating mental ill health in a population of 
medical students who are known to be concerned about disclosing mental ill health, limited 
demographic information was collected to try and increase recruitment. Whilst year of study 
and gender were reported, these were not linked to participants data.   This meant that 
analysis of the data in relation to demographics was not possible. Given the small number of 
participants, it is likely that breaking down the analysis via demographics would have proved 
difficult.  Collection of further demographics such as ethnicity and age would have provided a 
more rounded picture of the sample included in the study.  However, the more demographic 
information collected, the more likely it is that someone could be identified as having taken 
part and may possibly have put students off participating.  As student demographic data was 
not linked to their results, it was not possible to explore the effect in the current study of the 
large number of students who took part from year 2.  If as has been suggested by Newbury-
Birch et al (2001) medical student anxiety decreases from year two to year five, high numbers 
of students recruited from year two in the current study may have increased the prevalence of 
anxiety in this sample.    All years of study were approached in the same way to take part in the 
project, but a higher number of students from year two responded.  This high response may be 
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due to a number of factors including students in higher years of study being away on 
placements.   
In summary, a number of strengths and weaknesses have been identified for the present 
study.  The study is the first to study to examine rates of depression and anxiety in medical 
students comparing self-report responses to clinical interviews. The study strengths were that 
it used well validated tools to make the comparison.  The interviews and self-assessment 
scales were completed within one sitting which gives greater validity to the comparison.  
Interview data was checked and validated between the two researchers, supported by a 
psychologist with extensive experience of using and training in the use of the SCAN 
instrument. The items and diagnostic decisions within the two tools were also examined to 
understand the potential differences in responses that might be related to interpretation of 
items and thus the efficacy of HADS as a screening tool for medical students. It is recognised 
that there are a number of limitations to the study and any results should be interpreted with 
these in mind. The students self-selected to take part in the study and only 50 students were 
recruited.  This may have resulted in students who have a particular interest in mental health 
taking part in the study. This limits the generalisability our findings to the full medical student 
population. We collected limited demographic data on the students. This was to potentially 
increase recruitment, as there is recognised sensitivity in investigating mental ill health in a 
population of medical students who may have concerns about disclosing mental ill health. The 
results are therefore interesting and important but should be interpreted with caution.  
 
 
 
5.4 Implications 
 
Whilst the results of this study should be treated with caution due to the limitations outlined 
above, a number of implications may still be drawn from the results.  If the optimum HADS-D 
cut-off is lower than used in previous studies, prevalence of depression may be higher than 
previously reported.  In contrast if the optimum HADS-A cut-off is higher than previously used, 
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prevalence of generalised may be lower than previously reported.  If amended cut-offs are 
required for the HADS-D and HADS-A scales, consideration needs to be given to how previous 
research studies are interpreted.  In addition, these results have implications for medical 
school, in particular ensuring they do not over pathologise normal responses to stress and 
distress. These implications will now be discussed in more detail under two headings of 
research implications and implications for medical schools/universities/support services.  
 5.4.1 Research implications 
The results from the current study has implications for both the interpretation of previous 
research and possible directions for future research, these will be considered in turn.  
5.4.1.1 Previous research implications  
The current study suggested that whilst HADS may be a valid tool for use with medical 
students, the original cut-off values were not optimum for the medical students in the current 
sample.  Optimum cut-off values for the current medical student sample were 7 for the HADS-
D scale and 13 for the HADS-A scale.  As highlighted in section 5.2.2, a range of HADS cut-off 
values have been used in previous research with medical students.  The use of different cut-off 
values, and the use of cut-off values which may not be optimum may affect the results of 
previous studies.  One way in which different cut-off values may affect the result of studies is 
the effect on prevalence on different cut off values.  For example, in the current study, true 
prevalence of depression as determined by the scan interviews was 6%.  However, prevalence 
as determined by HADS-D would be 16% at a cut-off of 8+ and 22% at a cut-off of 7+.  For other 
studies using HADS with UK medical students, prevalence ranged were recorded as 4.4% 
(Newbury-Birch et al, 2001), 9.6% (Pickard et a, 2000), 1.6% (Ashton and Kamali 1995) and 
6.6% (Quince at al, 2012).  Whilst these values are not dissimilar to the 6% true prevalence (as 
determined by SCAN interviews), they are lower than the prevalence found in the current 
sample as determine by HADS-D with a 8+ cut-off (ie the same as used in the studies cited). If a 
lower HADS-D cut-off value, as suggested by the results of this study, was used in these other 
studies, it is likely that the prevalence rate would have been higher.   
For anxiety in the current sample true prevalence (as determined by the SCAN interviews) of 
generalised anxiety disorder was 8%.  However, prevalence as determined by HADS would be 
50% at a cut-off of 8+ and 16% at a cut-off of 13+. One study using HADS with a UK medical 
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student sample found prevalence of 39.2% for anxiety using an 8+ cut-off value (Ashton and 
Kamali, 1995).  Newbury-Birch et al (2001), found prevalence levels of 47% for second year 
medical students which dropped to 26% by final year again using 8+ as the cut-off. Conclusions 
from these studies therefore suggest that medical students have high levels of anxiety 
compared to their peers.  If a higher cut-off values (e.g. 13 as suggested by this study) was 
used, it is likely that the prevalence found in these studies would be lower.   
If the prevalence’s from these cited studies are being compared to other groups (such as in 
comparison to the general population) then incorrect comparisons and conclusions may be 
made. Therefore, the results and conclusions of previous studies must be read bearing the 
results of the current study and the possibility that the original cut-off values may not be 
optimum, in mind. 
 
5.4.1.2 Future research implications  
In addition to the implications for interpreting previous research, this study has some 
implications for future research.  In discussion of the limitations for the current project, the 
difficulties of the small sample size and small number of medical students with depression 
and/or anxiety were discussed.  It was concluded that these limitations affect the confidence 
that can be placed in the results of the present study.  A larger study should be undertaken to 
verify the results in this study and to confirm the optimum cut offs for caseness.  If a larger 
sample could be recruited and further demographic details collected and linked to results, 
further analysis of different groups would also be possible.  In addition, a larger study would 
allow for other aspects relating to the validity of HADS with medicals students to be tested.  
This could include analysis of the factor structure of HADS as suggested in section 5.2.1.  In 
order to achieve this, consideration would need to be given as to how to increase recruitment.  
Research has suggested that there are a number of things which can increase recruitment 
these include, increasing potential participants' awareness of the health problem being 
studied, its potential impact on their health, and their engagement in the learning process 
(Caldwell et al, 2010). For medical students this might be achieved by spending time going into 
medical students lectures and highlighting the issues surrounding mental health in medical 
students and the need for further research.   
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This study aimed to try and understand potential disparities between interview responses and 
responses to some HADS items. Some of the medical students talked in their interviews about 
other aspects broadly relating to their symptoms but which were not specifically linked to the 
symptom being asked about. In many cases these students did not interpret and answer the 
HADS items in a way in which would suggest that they were experiencing the symptoms to a 
clinically significant level as described in the ICD-10.   The author is unaware of other studies 
looking at this aspect of measuring depression and anxiety and these potential differences in 
how HADS items are interpreted by medical students requires further exploration.  Ali et al 
(2016) advocate that all tools used for screening common mental disorders should be 
validated locally via a pilot study, such as the current study. Whilst Ali et al are discussing the 
use of tools with different countries and in different languages, as highlighted in the 
introduction, this may also be relevant to a medical student population.  In addition to a 
validation study, Ali et al suggest that focus groups should be carried out with representatives 
of the population in question.  The aim of these focus groups would be to ensure that are 
questions are correctly understood and to understand local experience and expression of 
mental illness (Ali et al, 2016).   Focus group study would allow for medical students 
understanding of their own mental health and their interpretation of the items that make up 
HADS to be explored.   
Finally, it would be useful to explore if the results found for the HADS self-report scale are also 
relevant to other depression and or anxiety scales.  This suggestion is also made by Andrews et 
al (2006) who suggest specifically that that an understanding of whether all self-report anxiety 
scales, over report anxiety in students is needed.  A study of this nature would help to clarify if 
prevalence of anxiety in medical students is not as high as previously thought, or whether this 
is an anomaly when using the HADS scale.   Once this is know, further exploration of anxiety in 
medical students can be explored.  Medicine is a highly stressful career with challenging events 
and situations.  More need to be understood about how medical students learn to manage 
these situations and the anxiety symptoms that they may provoke.  
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5.4.2 Implications for medical schools/Universities/support services 
Two aspects of the results of this study may have particular implications for medical schools.  
The first of these is the specific validation and suggestion of optimum cut-offs for a depression 
and anxiety scale for use with medical students.  The second being the conclusion that the 
original cut-off value for the HADS anxiety scale is possibly too low and the implications of this 
for the prevalence of medical student anxiety.  These aspects will be considered in turn.   
The importance of being able to use sensitive and appropriate self-report tools to guide 
support and advice for students cannot be underestimated. Having a tool specifically validated 
for use with medical students is therefore important. A directive from the General Medical 
Council in the UK, who oversee medical education, has acknowledged the increasing level of 
distress and mental ill health in students (GMC, 2015). Poor mental health can have significant 
consequences for medical students including impaired academic performance, academic 
dishonesty, substance abuse and suicide (Dyrbye et al, 2005).  It is therefore of utmost 
importance that medical students who require support are identified and provided with the 
help they require as early as possible.  The GMC (2015) suggests that medical school need to 
have processes to identify students who might need support. As highlighted previously 
(section 1.6) screening for mental health problems is seen as controversial.  However, the 
reluctance of medical students to seek support and treatment for mental health problems 
drives the view by some that screening is important.  Some have suggested this increases the 
responsibility of medical schools to identify students who may need help (Silva et al, 2017). 
Others have acknowledged that screening for depression can identify individuals who might 
otherwise go undetected but have highlighted that it could also lead to other issues such as 
misdiagnosis and over diagnosis (Thombs et al, 2011).  Having a sensitive tool which can be 
used for screening purposes may therefore be of use for those who wish to screen students.  
For those who wish to use alternative methods to identify students who may need support for 
depression and anxiety, self-report tools may still play an important role once a student has 
been identified.  Self-report scales may help to highlight the type of support that students may 
require.   However, these tools are only of use if they accurately measure depression and 
anxiety symptoms.  Receiving a high anxiety self-report score when one has subclinical levels 
of anxiety may cause students additional worry and may lead to signposting to services which 
are not required. Over-diagnosis of anxiety could put additional strain on often stretched 
resources (Brown, 2016).   
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In addition to the benefits of a potentially more accurate tool and cut off for identifying 
students suffering from depression and or anxiety, the current study has implications for the 
planning of support for medical students.  Support for students can broadly fall into two 
categories, support for those currently struggling and preventative support.  Medical schools 
need to understand the true prevalence of mental health conditions to ensure that adequate 
support is in place for those with mental health concerns.  As discussed, if prevalence is 
determined via the use of self-report tool, ensuring these are sensitive and appropriate cut-off 
are used is important for providing accurate data.  In addition to this support, medical schools 
need to consider and implement training to increase the ‘mental resilience’ of the medical 
student population in the UK. However, medical school also need to ensure that they do not 
over pathologise normal responses to stress and distress but support coping strategies to 
everyday events that students might encounter. Medicine recruits a population of high 
achievers with often perfectionist traits, this along with the high anxiety scores on self-report 
questionnaire, has led to the conclusion that medical students suffer from high anxiety.  The 
current study suggests that whilst medical student prevalence of anxiety may be slightly higher 
than age-matched peers, it may not be as high a previously thought.  Over pathologising 
through self-assessment scales that do not take into account the specific population could 
deliver the opposite of what medical education is trying to achieve.  A true understanding of 
the problems facing medical students is required to ensure emotions can be managed 
appropriately and emotional intelligence can be developed.  These aspects have been found to 
be key to building resilience (Haaland et al, 2015) along with providing mental health aware 
environments where emotions such as anxiety are discussed openly and without the fear of 
stigma. 
5.4.3 Summary of implications 
In summary, there are a number of implications resulting from the current study, these have 
been categorised as implications for research and implications for medical schools.  
Implications for research include the need to consider the cut-off scores used in previous 
studies and the impact of these on the prevalence of depression and anxiety reported for 
medical students. If medical students have a tendency to over-report anxiety symptoms on 
self-report tools then prevalence measured by these tools may be inflated, thus results from 
previous studies must be read with this in mind.   A number of suggestions for future research 
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are suggested including a larger scale validation study and a focus group study to try and 
further understand the interpretation medical students give to HADS items. The implications 
for medical schools highlight the benefits of a sensitive and appropriate self-report tool 
validated for use with a medical student population.  These benefits include the ability to be 
able to identify students who may be suffering and to assist in the support of students.  
However, the potential for students who do not reach the threshold for anxiety to report high 
levels of anxiety symptoms via self-report scales, highlights the potential for over-
pathologising symptoms which may be normal responses of medical students to events that 
they might encounter.  Medical schools may choose to explore these ‘normal’ responses with 
medical students to highlight to students some of the feelings that they may experience 
(overwhelmed, guilty) and help students understand the need for self-care and leisure time,  
  
5.5 Conclusions  
Having highlighted the lack of studies validating self-report tools for use with medical students, 
the current study compared medical students HADS scores to their clinical interview data. 
Results suggest that the HADS scale is an appropriate tool to use in a medical student 
population.  However, the cut-off for ‘caseness’ for both anxiety and depression subscales in 
this cohort may need reviewing.  This could relate to how some of the individual HADS items 
are interpreted by the medical student population.  Whilst the study provides some useful 
insights, results must be interpreted with caution due to the small number of students 
recruited and the low numbers of students with depression and or anxiety.  A number of 
implications of the results of the study have been suggested including the implications for both 
the interpretations of past research particularly research using HADS to determine prevalence 
of depression and anxiety in medical students. Suggestions for future studies have been 
highlighted including a larger scale validation study and a focus group study to try and further 
understand the interpretation medical students give to HADS items. Finally, implications for 
medical schools were considered including the possible uses for a depression and anxiety self-
report tool validated for use with medical students and the need to avoid over-diagnosis or 
over pathologising anxiety in medical students.  
Today’s medical students are tomorrows doctors, medicine is a difficult career with many 
challenges. Helping to support medical students to look after their health and wellbeing is a 
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vital aspect of medical education.  This education must be guided by what is known about 
mental health in this group.  Despite the many studies in the area there is still much 
contradiction in what is known about medical students’ mental health.  The current study 
suggests that the use of tools which are not validated for use with the population may fuel 
these contradictions particularly given the possibility of students who do not reach the 
threshold for anxiety to report high levels of anxiety symptoms via self-report scales. More 
research is required specifically to explore medical students’ anxiety and to determine what is 
normal behaviour for this population and what is true pathology.     
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Aalto et al 2012 x x x x x
Abdel Wahed & Hassan 2017 x x x
Abdulahovic et al 2018 x x x
Aghakhani et al 2011 x x x
Ahmad et al 2017 x x x
Ahmed et al 2009 x x x
Akbari et al 2014 x x x
Akin & Bayram 2007 x x x
Al Rashed et al 2019 x x x
Al-Alawi et al 2017 x x x
Al-Faris et al 2012 x x x
AlFaris et al 2016 x x x x
Alfonsson et al 2017 x x x
Al-Ghafri et al 2014 x x x
Alpizar et al 2017 x x x
Alvi et al 2010 x x x
Amarasuriya et al 2015 x x x
Amir & Gillany 2010 x x x
Anderson et al 2011 x x x x
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Aragao et al 2018 x x x
Arbona et al 2017 x x x
Arslan et al 2009 x x x
Badpa et al 2015 x x
Baigent et al 2015 x x x
Baldassin et al 2008 x x x
Barreta Do Carno et al 2018 x x x
Barton 2012 x x x
Basnet et al 2012 x x x
Bassols et al 2014 x x x
Bayati et al 2009 x x x
Baykan et al 2012 x x x
Bayram & Bilgel 2008 x x x
Beiter et al 2015 x x x
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Bilgel & Bayram 2010 x x x
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Chen et al 2013 x x x x
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Coentre et al 2016 x x x
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Dahlin et al, 2005 x x x x
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Djukanovic et al 2017 x x x
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Ediz et al 2017 x x x x
Edwards et al 2010 x x x
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Farahangiz et al 2016 x x x
Fawzy & Hamed 2017 x x x
Fernandes et al 2018 x x x
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Fong & Ho 2013 x x x
Fong & Ho 2014 x x x
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Geethanjali & Adalarasu 2014 x x x
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Goebert et al 2009 x x x
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Gonzalez & Jenkins 2014 x x x x x x
Gress-Smith  et al 2015 x x x
Gulec et al 2012 x x x
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Hannan et al 2013 x x x x
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Hinz & Brahlerr 2011 x x x
Hinz et al 2014 x x x
Hong & Min 2007 x x x
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Kebede et al 2019 x x x
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Khaled 2019 x x x
Khubchandani 2016 x x x x
Kiely & Butterworth 2015 x x x x x x
Kim et al 2015 x x x
Kim et al 2015 x x x
Kivrak et al 2016 x x x
Kjaergaard et al 2013 x x x x
Kjaergaard et al 2014 x x x
Kobak et al 2008 x x x x
Kocalevant et al 2013 x x x
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Kulsoom & Afsar 2015 x x
Kumar et al 2012 x x x
Langvik et al 2016 x x x
Lee at al 2011 x x x x
Lei et al 2016 x x x
Levine 2013 x x x
Li et al 2014 x x x
Liang et al 2013 x x x x x
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Low et al 2012 x x x x x
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Lu et al 2015 x x x
Ludwig et al 2015 x x x
Lui et al, 2011 x x x x
Lundin et al 2016 x x x x
Lupo & Strous 2011 x x
Lyoo et al 2014 x x x
Lyrakos et al 2011 x x x x
Madhusudan et al 2018 x x x
Makhubela & Mashegoane 2016 x x x
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Mann et al 2011 x x x
Manos et al 2011 x x x
Marwat 2013 x x x
Maske et al 2016 x x x
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Maurer 2012 x x x x
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Moreno et al 2011 x x x
Mousa 2016 x x x
Mundia 2010 x x x
Nahas et al 2019 x x x
Naja et al 2016 x x x
Najafipour et al 2012 x x x
Navarro et al 2014 x x x
Neiuwenhuijsen et al 2003 x x x
Ngasa et al 2017 x x x
Nuevo et al 2009 x x x
Oh et al 2013 x x x
Olsonet al 2010 x x x x
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Osman et al 2012 x x x x
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Shafiullah et al 2016 x x
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Sugawara et al 2011 x x
Sunderland et al 2011 x x x x
Sunderland et al 2012 x x x
Tabuse et al 2007 x x x
Takahashi & Ohde 2016 x x x
Talkovsky & Norton 2015 x x x
Talwaret al 2017 x x x
Teismann et al 2016 x x x
Thibodeau et al 2014 x x x
Thompson et al 2010 x x x
Trainor et al 2013 x x x x
Tyrala et al 2015 x x x x
Uehara et al 2010 x x x
Uglesic et al 2014 x x x
Umegaki & Todo 2017 x x x x x
Van Dam & Earleywine, 2011 x x x
Vankar er ak 2014 x x x
Vasegh & Baadaran 2014 x x x
Venkatesh et al 2014 x x x
Vera-Villarroel et al 2010 x x x
Verger et al 2010 x x x
Verma 2011 x x x
Verma et al 2013 x x x
Videmova et al 2016 x x x x
Vilagut et al 2013 x x x
Vilagut et al 2016 x x x
Vivek et al 2011 x x x
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Appendix 1 – continued 
 
 
 
 
Voltmer er ak 2012 x x x
Vrublevska et al 2017 x x x
Vrublevska J., Rancans E., 
Trapencieris M., Snikere S. 
x
x x
Wahl et al 2013 x x x x x x x x x x x x
Watson et al 2007 x x x
Webler et al 2016 x x x x
Weir & Jose 2007 x x x
Whisman et al 2013 x x x
Wiltink et al 2011 x x x
Wood et al 2010 x x x
Wu et al 2016 x x x
Xu et al 2014 x x x
Yin et al 2018 x x x
Ying-Li ey al 2012 x x x
Yoon et al 2014 x x x
Yu 2013 x x x
Yu et al 2012 x x x
Yu et all 2011 x x x
Yusoff  et al 2013 x x x
Yusoff et al 2011 x x x
Zhang et al 2013 x x x x
Zong et al 2010 x x x
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n
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d
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Abas (2017) x x x
Abdel Wahed & Hassan 2017 x x x
Akin & Cetin(2007) x x x
Alfonsson et al (2017) x x x x
Alvi et al 2010 x x x
Andersen et al (2011) x x x x x
Antunez & Vinet (2012) x x x
Barton 2012 x x x
Bassols 2014 x x x
Bayani (2010) x x x
Baykan et al 2012 x x x
Beesdo-Baum et al (2014). x x x
Beiter et al 2015 x x x
Bilgel & Bayram 2010 x x x
Bitsika et al 2010 x x x
Bunevicius et al 2008 x x x x
Chan et al 2012 x x x
Chang et al 2019 x x x
De Lima et al (2011). x x x x
Deepak et al 2017 x x x
Dhariwal et al 2018 x x x
Dimopoulou et al 2013 x x x
Dunstan et al (2017) x x x x
Ediz et al 2017 x x x x
 235 
 
 
Appendix 2 – continued  
 
Eisenberg et al 2007 x x x
Fernandes 2018 x x x
Galvan-Molina et al 2017 x x x
Gelaye et al 2014 x x
Ghalechi & Kazemi 2010 x x
Hajebi et al 2018 x
x x
Hinz & Brahlerr (2011) x
x x
Hinz et al (2017) x x x
Ibrahim & Abdelreheem 2015 x x x x
Johansson et al 2013 x
x x
Kadri et al 2007 x x x
Karaloglu & Seker 2010 x x x
Kebede et al 2019 x x x
Keily & Butterworth (2015) x x x x
Khubchandani et al (2016) x x x
Knappe et al (2014) x x x
Kroenke et al (2009) x x x
Langvik et al 2016 x x x
Leray et al 2011 x x x
Lowe et al (2008) x x x
Lowe et al (2010) x x x
Lu et al 2015 x x x
Lyrakos et al (2011) x x x x
Maideen et al 2015 x x x
Manchevska & Pluncevic-
Gligoroska 2014
x x x
Mann et al 2011 x x
Matsudaira et al 2009 x x x
Mousa et al (2016) x x x
Mundia 2010 x x x
Norman et al (2011) x x x x x
Norton & Robinson (2010) x x x x x x
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Ohaeri et al (2010) x x
Osman et al 2012 x x x x x
Ozen et al 2010 x x x
Pez et al 2010 x x x x x
Pfalzgraf & Tipton (2013) x x x
Risal et al (2015) x x x
Robinson et al (2010) x x x x x
Ruiz et al 2017 x x x
Sahoo & Khess 2010 x x x
Schulte Van Maaren et al (2013) x x x x x x
Serra et al 2015 x x x
Simic-Vukomanovic 2016 x x x
Sujatha Baskaranet al 2018 x x x
Sunderland et al 2011 x x x x
Talkovsky & Norton, 2015 x x x x x
Talwar et al 2017 x x x
Thiboutot et al 2016 x x x
Thompson et al 2010 x x x
Van Ameringen et al (2009) x x x
Verger et al 2010 x x x
Wardenaar et al (2017) x x x
Weir et al 2007 x x x
Williamson 2015 x x
Wiltink et al 2011 x x x
Yin et al 2018 x x
Yusoff et al 2013 x x x
Zalta & Chambless (2012) x x x x
Zhao et al 2018 x x x
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Appendix 3 HADS completion sheet 
HADS questionnaire 
In order to match your responses to different parts of this study we 
would like to use a unique identifier.  To generate this please can we 
ask you for the first two letters of the answers to the following three 
questions? 
 
1. What was the name of your primary (or first) school? 
_________________ 
2. What is your mother’s first name? 
_________________________________ 
3. Name of town where you were born? 
_______________________________ 
 
The following questions are about how you are feeling most of the 
time (whether in medical school or in your own time). Please answer 
these how they best fit you and how they best reflect how you have 
felt over the last week. Don't spend too long thinking about each 
question, we would like your immediate response.  
 
1.  I feel tense or 'wound up'  
Most of the time  
A lot of the time  
From time to time, occasionally  
Not at all  
 
2.  I still enjoy the things I used to enjoy  
Definitely as much  
Not quite so much  
Only a little  
Hardly at all  
 
3.  I get a sort of frightened feeling as if something awful is about to 
happen  
Very definitely and quite badly  
Yes, but not too badly  
A little, but it doesn't worry me  
Not at all  
 
4.  I have lost interest in my appearance  
Definitely  
I don't take as much care as I 
should 
 
I may not take quite as much care  
I take just as much care as ever  
 
5.  Worrying thoughts go through my mind  
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A great deal of the time  
A lot of the time  
From time to time but not too 
often 
 
Only occasionally  
 
 
 
 
6.  I can laugh and see the funny side of things  
As much as I always could  
Not quite as much now  
Definitely not so much now  
Not at all  
 
 
7.  I can sit at ease and feel relaxed  
Definitely  
Usually  
Not often  
Not at all  
 
8.  I feel as if I am slowed down 
Nearly all of the time  
Very often  
Sometimes  
Not at all   
  
 
9.  I get a sort of frightened feeling like 'butterflies' in the stomach  
Not at all  
Occasionally  
Quite often  
Very often  
 
10.  I look forward with enjoyment to things  
As much as I ever did  
Rather less than I used to  
Definitely less than I used to  
Hardly at all  
 
11.  I feel restless as if I have to be on the move  
Very much indeed  
Quite a lot  
Not very much  
Not at all  
 
12.  I feel very cheerful  
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Never  
Not often  
Sometimes  
Most of the time  
 
 
 
 
13.  I get sudden feelings of panic  
Very often indeed  
Quite often  
Not very often  
Not at all  
 
14.  I can enjoy a good book or radio or TV programme  
Often  
Sometimes  
Not often  
Very seldom  
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Appendix 4 – Participant information sheet 
 
PARTICIPANT INFORMATION SHEET  
 
1. Study title 
Measuring prevalence of common mental health disorders among medical 
students 
 
2. Invitation paragraph 
You are being invited to take part in the above research study.  Before you 
decide whether to participate, it is important for you to understand why 
the research is being done and what it will involve.  Please take time to 
read the following information carefully and discuss it with others if you 
wish.  Ask us if there is anything that is not clear or if you would like more 
information.  Take time to decide whether or not you wish to take part. 
 
Thank you for reading this. 
 
3. What is the purpose of the study? 
Providing support for medical students is an area of growing concern in 
the UK and internationally. Despite existing support, there is clear 
evidence that we are not meeting students’ needs. The General Medical 
Council (GMC) has recently published a report outlining how medical 
schools can more effectively support their students with mental health 
concerns.  Gaining a better understanding of the prevalence of common 
mental health disorders (CMHD) can more effectively support medical 
students. This will ensure that support is tailored in the right area. The 
provision of effective support at medical school will improve coping 
strategies, and the health and wellbeing of both medical students and 
future doctors. 
 
A number of prevalence studies on psychological distress in medical 
students have been conducted but these have measured symptoms rather 
than the presence of a clinical disorder. The estimated prevalence varied 
widely across these studies, which related to the measures used and data 
interpretation.  As such, the true prevalence of CMHD in medical students 
is not known. Therefore a more robust study to evaluate the true 
prevalence of CMHD is required.  This study aims to investigate CMHD in 
medical students in more detail.   
 
4. Why have I been chosen? 
Medical students from Cardiff University are being invited to take part in a 
study looking at medical student wellbeing.   
 
5. Do I have to take part? 
It is up to you to decide whether or not to take part in an interview as part 
of this study.  If you wish to take part, page you will be asked to complete 
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a consent form.  If you consent to take part you are still free to withdraw 
at any time by providing your unique identifier (see question 7).    
 
 
 
6. What will happen to me if I take part? 
If you would like to take part, an interview will be arranged at a mutually 
convenient time.  The interviews will be held at the student support unit 
at 53-54 Park Place. Before the interview you will be asked to complete a 
short questionnaire asking about symptoms relating to depression and 
anxiety.  The interview will take no longer than 30 minutes.  The 
interviews will ask you questions about symptoms relating to depression 
and anxiety, you are not obliged to answer all questions.  Your interview 
data will be analysed along with your questionnaire data.  The interviews 
will be audio-recorded to allow the researchers to analyse the data as a 
team.   
 
7.      What about confidentiality? 
The interview data will be stored anonymously using your unique 
identifier.  In order to match your responses from different parts of the 
study you will be asked to produce a unique ID.  To generate this you will 
be asked to give the first two letters of the answers to the following three 
questions: 
What was the name of your primary (or first) school? 
What is your mother’s first name? 
Name of town where you were born? 
All data will be stored securely on password protected computers. This 
anonymised data may be retained indefinitely in accordance with the Data 
Protection Act (1998).  This is so that we can refer to the original data if 
anyone questions any findings in our final reports.   
  
8. What do I have to do? 
If you decide to take part in the study, please complete the consent form 
and send it to the researchers using the address below.  You will then be 
contacted by the researchers to arrange an interview.   
 
Are there any risks? 
This study contains minimal risk. We do request you consider all the 
above information carefully before you decide whether you would like to 
take part.  If you are distressed by any issues raised in this study please 
contact your student support services, or contact Dr Debbie Cohen at 
Cardiff University (see contact details below).  
 
 
9. What will happen to the results of the research study? 
This study will serve as a pilot to a further national longitudinal study and 
will form part of Naomi Marfell’s Mphil report.  The results of the study 
will be written up as a report. In addition the results may also be 
published in a peer review journal and presented at appropriate 
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conferences. You will not be identified in any publication related to this 
study; all data will be anonymous.  
 
 
 
10. Who is organising and funding the research? 
The research is being organised and funded by researchers from the 
Department of Primary Care and Public Health, Cardiff University. 
 
11. Contact for Further Information 
 
If you have any questions or queries about the project please contact 
Naomi Marfell at Cardiff University.   
Naomi Marfell  
53 -54 Park Place 
Cardiff 
CF10 3AT 
E: marfelln@cardiff.ac.uk 
 
 
If you are concerned or distress about anything concerning this study 
please contact Dr Debbie Cohen at Cardiff University  
 
Dr Debbie Cohen OBE 
Senior Medical Research Fellow and Director of The Individual Support 
Programme 
Centre for Psychosocial Research, Occupational and Physician Health 
(PROPH) 
53 -54 Park Place 
Cardiff 
CF10 3AT 
T: 02920 870686 
E: cohenda@cardiff.ac.uk 
 
THANK YOU FOR TAKING THE TIME TO READ THIS INFORMATION SHEET  
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Appendix 5 – Participant consent form 
CONSENT FORM - Interviews 
 
 
Title of Project: Measuring prevalence of common 
mental health disorders among medical students 
 
Name of Researcher: Naomi Marfell   
 
 
         Please initial box 
 
1. I confirm that I have read and understand the information 
sheet and have had the opportunity to ask questions. 
 
 
2. I understand that my participation is voluntary  
 
 
3. I agree to be audio-recorded 
 
4. I understand that the information provided by me will be recorded and 
will be stored anonymously using my unique identifier so that it is 
impossible to trace this information back to me individually. I understand 
that, in accordance with the Data Protection Act (1998), this information  
may be retained indefinitely. 
 
 
5. I understand that data collected may be presented at conferences and 
meetings. 
 
 
6. I understand that in completing this consent page I am giving my 
permissions for any data collected today to be used for research 
purposes. 
 
7. I agree to take part in the above study. 
 
  
 
8. I agree to give my unique identifier to the researchers to match my data 
  
 
 
 
Name of Participant _____________________________________ 
 
 
Date ________________________ 
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Appendix 6 – Participant debrief sheet 
PARTICIPANT DEBRIEF SHEET  
 
Measuring prevalence of common mental health disorders among medical 
students 
 
Thank you for your participation in this project.   
This study willserve as a pilot to a further national longitudinal study and 
will form part of Naomi Marfell’s Mphil report.  The results of the study 
will be written up as a report. In addition, the results may also be 
published in a peer review journal and presented at appropriate 
conferences. You will not be identified in any publication related to this 
study; all data will be anonymous.  
  
If you are concerned about any issues that this study has raised you can 
contact the Medic Support Unit at School of Medicine, Cardiff University.   
You can email Medic support at: medicsupport@cardiff.ac.uk or you can 
find out more information at 
 http://medicine.cf.ac.uk/medical-education/undergraduate/medic-
support-cardiff/student-support-unit/ 
 
Alternatively, you can contact your own GP or the student counselling 
services at Cardiff University if you have any health concerns.   
 
If you have any questions or queries about this project, please contact 
Naomi Marfell at Cardiff University.   
Naomi Marfell  
53 -54 Park Place 
Cardiff 
CF10 3AT 
E: marfelln@cardiff.ac.uk 
 
 
If you feel you need urgent help please contact: 
Samaritans (0845 790 9090)     http://www.samaritans.org/branches/cardiff-
district-samaritans 
 
BMA Doctors-for-Doctors (08459 200 169)   http://bma.org.uk/practical-support-
at-work/doctors-well-being/about-doctors-for-doctors 
 
Nightline (029 2087 0555)      
http://www.cardiffstudents.com/activities/studentled/nightline/  
